Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dermatology

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 1725 articles:
HTML format



Single Articles


    July 2021
  1. DATZMANN T, Schoffer O, Meier F, Seidler A, et al
    Patients benefit from participating in the German skin cancer screening program? A large cohort study based on administrative data.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20658.
    PubMed     Abstract available


  2. GONDO GC, Merola JF, Bell S, Blauvelt A, et al
    Decreased quality of life in people with psoriasis and psoriatic arthritis versus people with psoriasis alone: data from a national US survey.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20657.
    PubMed     Abstract available


  3. SAEKI H, Baba N, Ito K, Yokota D, et al
    Difamilast ointment, a selective phosphodiesterase 4 inhibitor, in paediatric patients with atopic dermatitis: A phase 3 randomised double-blind, vehicle-controlled trial.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20655.
    PubMed     Abstract available


  4. WHITE JML, Lui H, Chute CG, Jakob R, et al
    The WHO ICD-11 Classification of Dermatological Disorders: a new comprehensive online skin disease taxonomy designed by and for dermatologists.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20656.
    PubMed     Abstract available


  5. AFRA TP, Siraj MM, Razmi T M
    Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations': reply from authors.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20638.
    PubMed     Abstract available


  6. STOER NC, Botteri E, Busund M, Ghiasvand R, et al
    Menopausal hormone therapy and risk of melanoma: a population-based cohort study.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20640.
    PubMed     Abstract available


  7. VURAL S, Kerl K, Dogan PE, Vollmer S, et al
    Lesional activation of Tc 17 cells in Behcet's disease and psoriasis supports HLA-class I-mediated autoimmune responses.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20643.
    PubMed     Abstract available


  8. NAVRAZHINA K, Renert-Yuval Y, Frew JW, Grand D, et al
    Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20642.
    PubMed     Abstract available


  9. CATALA A, Munoz-Santos C, Galvan-Casas C, Roncero Riesco M, et al
    Cutaneous reactions after SARS-COV-2 vaccination: A cross-sectional Spanish nationwide study of 405 cases.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20639.
    PubMed     Abstract available


  10. SCATOLINI M, Patel A, Grosso E, Mello-Grand M, et al
    GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma.
    Br J Dermatol. 2021 Jul 8. doi: 10.1111/bjd.20629.
    PubMed     Abstract available


  11. SCHNEIDER AM, Nelson AM
    Food for thought: does host diet affect skin microbes?
    Br J Dermatol. 2021 Jul 8. doi: 10.1111/bjd.20573.
    PubMed    


  12. GAMBICHLER T, Boms S, Hessam S, Tischoff I, et al
    Primary cutaneous anaplastic large cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20630.
    PubMed     Abstract available


  13. PATHMARAJAH P, Gkini MA, Fox H, Muralidharan V, et al
    Patients with nodular prurigo commonly have pre-existing psychological disease which requires treatment concomitant with cutaneous treatments.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20627.
    PubMed     Abstract available


  14. VITALI F, Colucci R, Di Paola M, Pindo M, et al
    Early melanoma invasivity correlates with gut fungal and bacterial profiles.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20626.
    PubMed     Abstract available


  15. HOLLESTEIN LM, Arnspang Pedersen S
    Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?
    Br J Dermatol. 2021 Jul 5. doi: 10.1111/bjd.20526.
    PubMed    


  16. CHEN CB, Chung WH
    Current agreement on the management of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2021 Jul 5. doi: 10.1111/bjd.20515.
    PubMed    


  17. VOLC-PLATZER B
    Fumaric acid esters for paediatric psoriasis.
    Br J Dermatol. 2021;185:5-6.
    PubMed    



  18. Ceramide kinase-like protein promotes cutaneous squamous cell carcinoma.
    Br J Dermatol. 2021;185:e4-e33.
    PubMed     Abstract available


    June 2021
  19. KIM M, Park HE, Han K, Lee J, et al
    Risk of Psoriasis among Survivors of Adult-onset Cancer: A Nationwide Population-based Cohort Study.
    Br J Dermatol. 2021 Jun 30. doi: 10.1111/bjd.20610.
    PubMed     Abstract available


  20. ALTAYEB A, Dawood S, Atwan A, Mills C, et al
    Teledermoscopy: A Helpful Detection Tool for Amelanotic and Hypomelanotic Melanoma.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20609.
    PubMed     Abstract available


  21. HARGADON KM
    The Role of Interferons in Melanoma Resistance to Immune Checkpoint Blockade: Mechanisms of Escape and Therapeutic Implications.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20608.
    PubMed     Abstract available


  22. EGEBERG A, Meteran H, Gyldenlove M, Zachariae C, et al
    Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20602.
    PubMed     Abstract available


  23. O'KANE D, McCourt C, Meggitt S, D'Cruz DP, et al
    British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus (CLE) 2021.
    Br J Dermatol. 2021 Jun 25. doi: 10.1111/bjd.20597.
    PubMed     Abstract available


  24. PAPP KA, Lebwohl MG, Puig L, Ohtsuki M, et al
    Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.
    Br J Dermatol. 2021 Jun 22. doi: 10.1111/bjd.20595.
    PubMed     Abstract available


  25. PATHANIA YS
    Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations'.
    Br J Dermatol. 2021 Jun 22. doi: 10.1111/bjd.20590.
    PubMed     Abstract available


  26. SUGAYA M
    Search for the best biologic for psoriasis.
    Br J Dermatol. 2021 Jun 17. doi: 10.1111/bjd.20514.
    PubMed    


  27. BRODERICK C, Christian N, Apfelbacher C, Bosma AL, et al
    The BIOMarkers in Atopic Dermatitis and Psoriasis (BIOMAP) Glossary: developing a lingua franca to facilitate data harmonisation and cross-cohort analyses.
    Br J Dermatol. 2021 Jun 16. doi: 10.1111/bjd.20587.
    PubMed     Abstract available


  28. BEYLOT-BARRY M, Seneschal J, Tran D, Bachelez H, et al
    Characteristics of patients with PASI <10 psoriasis treated with biological agents: Results from the French PsoBioTeq cohort.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20585.
    PubMed     Abstract available


  29. KIRBY L, Gran S, Orekoya F, Owen C, et al
    Is urinary incontinence associated with vulval lichen sclerosus in females? A cross-sectional study.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20583.
    PubMed     Abstract available


  30. SKAYEM C, Beylot-Barry M, de Masson A, Dereure O, et al
    Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20580.
    PubMed     Abstract available


  31. ADAN F, Nelemans PJ, Kelleners-Smeets NWJ, Kessels JPHM, et al
    The additional diagnostic value of optical coherence tomography in clinically diagnosed basal cell carcinomas undergoing direct surgical excision.
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20579.
    PubMed     Abstract available


  32. ISKANDAR IYK, Lunt M, Thorneloe RJ, Cordingley L, et al
    Alcohol abuse associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study.
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20577.
    PubMed     Abstract available


  33. SILVERBERG JI
    Association of atopic dermatitis and autoimmune comorbidities: is it real?
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20497.
    PubMed    


  34. WIGGINS J, Polsky D
    Melanoma origins: data from early-stage tumours supports de novo and naevus-associated melanomas as distinct subtypes.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20396.
    PubMed    


  35. EVERS AWM, van Beugen S
    How stress affects the skin: from designs to mechanisms.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20397.
    PubMed    


  36. JOHANSSON EK
    Psychiatric conditions in children with atopic dermatitis.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20394.
    PubMed    


  37. LINDER M
    Using epidemiological methods to quantify the risk of serious infections in children with atopic dermatitis.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20395.
    PubMed    


  38. AHMADY S, Oyen EMM, Jansen MHE, Nelemans PJ, et al
    Patient-reported skin reactions of 5% 5-fluorouracil in treatment of actinic keratosis.
    Br J Dermatol. 2021 Jun 10. doi: 10.1111/bjd.20570.
    PubMed     Abstract available


  39. GUILLAUME T, Puzenat E, Popescu D, Aubin F, et al
    Cemiplimab-rwlc in Advanced Cutaneous Squamous Cell Carcinoma: a real-life experience in a French Dermatology Department.
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20569.
    PubMed     Abstract available


  40. REICH K, Gordon KB, Strober BE, Armstrong AW, et al
    Five-year maintenance of clinical response and improvements in health-related quality of life in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2.
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20568.
    PubMed     Abstract available


  41. JOSHI TP, Ren V
    Response to "Evaluating World Health Organization Essential Medicines List for Skin Disease".
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20565.
    PubMed     Abstract available


  42. GUHAN S, Klebanov N, Tsao H
    Melanoma genomics: a state-of-the-art review of practical clinical applications.
    Br J Dermatol. 2021 Jun 6. doi: 10.1111/bjd.20421.
    PubMed     Abstract available


  43. BRUNNER PM, Conrad C, Vender R, Grond S, et al
    Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab.
    Br J Dermatol. 2021 Jun 2. doi: 10.1111/bjd.20527.
    PubMed     Abstract available


  44. WELSH E, Cardenas-de la Garza JA, Cuellar-Barboza A, Franco-Marquez R, et al
    SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
    Br J Dermatol. 2021;184:1194-1195.
    PubMed    


  45. BERNIGAUD C, Guillemot D, Ahmed-Belkacem A, Grimaldi-Bensouda L, et al
    Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality.
    Br J Dermatol. 2021;184:1207-1209.
    PubMed    



  46. Measuring the success of treatments for squamous cell cancer of the skin.
    Br J Dermatol. 2021;184:e196-e223.
    PubMed     Abstract available


  47. HASHIMOTO T
    Pathogenic role of ST18 in pemphigus vulgaris.
    Br J Dermatol. 2021;184:1001-1002.
    PubMed    


  48. GUCKIAN J, Rajan N, Kibbi N
    Incompletely excised keratinocyte carcinomas: more common than once thought?
    Br J Dermatol. 2021;184:991.
    PubMed    


  49. COTTER C, Kretz M, Rajan N
    Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage in vitiligo.
    Br J Dermatol. 2021;184:999-1000.
    PubMed    


  50. BLOME C, Klein TM
    Classifying the severity of bullous pemphigoid disease.
    Br J Dermatol. 2021;184:997-998.
    PubMed    


  51. ZOUBOULIS CC
    Pain Index: a new prospective hidradenitis suppurativa patient-reported outcome measure instrument.
    Br J Dermatol. 2021;184:1203-1204.
    PubMed    


  52. BUONOMO M, Mansh MD, Thorpe D, Goldfarb N, et al
    Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy.
    Br J Dermatol. 2021;184:1192-1194.
    PubMed    


  53. GUPTA R, Simonette RA, Doan HQ, Rady PL, et al
    Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment.
    Br J Dermatol. 2021;184:1185-1187.
    PubMed    


  54. SCHMUTH M, Reichelt J, Gruber R
    Advancing novel therapies for ichthyoses.
    Br J Dermatol. 2021;184:998-999.
    PubMed    


  55. GAO JM, Garioch JJ, Fadhil M, Tan E, et al
    Planning slow Mohs excision margins for lentigo maligna: a retrospective nonrandomized cohort study comparing reflectance confocal microscopy margin mapping vs. visual inspection with dermoscopy.
    Br J Dermatol. 2021;184:1182-1183.
    PubMed    


  56. SMITH J, Ezekwe N, Pourang A, Hamzavi I, et al
    Multifocal myositis and elevated creatine phosphokinase associated with the use of ustekinumab for hidradenitis suppurativa.
    Br J Dermatol. 2021;184:1181-1182.
    PubMed    


  57. GRAIER T, Salmhofer W, Jonak C, Weger W, et al
    Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
    Br J Dermatol. 2021;184:1094-1105.
    PubMed     Abstract available


  58. FELDMAN SR, Huang WW
    Evidence is lacking for or against palmoplantar pustulosis treatments: what does this mean for the clinician.
    Br J Dermatol. 2021;184:990.
    PubMed    


  59. CHACKO AM, Lagace F, Jafarian F
    Ultraviolet index and sun safety: are we all on the same page?
    Br J Dermatol. 2021;184:1175-1176.
    PubMed    


  60. ASSAF S, Malki L, Mayer T, Mohamad J, et al
    ST18 affects cell-cell adhesion in pemphigus vulgaris in a tumour necrosis factor-alpha-dependent fashion.
    Br J Dermatol. 2021;184:1153-1160.
    PubMed     Abstract available


  61. MASMOUDI W, Vaillant M, Vassileva S, Patsatsi A, et al
    International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
    Br J Dermatol. 2021;184:1106-1112.
    PubMed     Abstract available


  62. LI D, Ryu E, Saeidian AH, Youssefian L, et al
    GGCX mutations in a patient with overlapping pseudoxanthoma elasticum/cutis laxa-like phenotype.
    Br J Dermatol. 2021;184:1170-1174.
    PubMed     Abstract available


  63. WAN B, Ganier C, Du-Harpur X, Harun N, et al
    Applications and future directions for optical coherence tomography in dermatology.
    Br J Dermatol. 2021;184:1014-1022.
    PubMed     Abstract available


  64. OBEID G, Do G, Kirby L, Hughes C, et al
    Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments.
    Br J Dermatol. 2021;184:1023-1032.
    PubMed     Abstract available


  65. NARLA S, Azzam M, Townsend S, Vellaichamy G, et al
    Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils.
    Br J Dermatol. 2021;184:1004-1013.
    PubMed     Abstract available


  66. EBENS CL, McGrath JA, Riedl JA, Keith AR, et al
    Immune tolerance of allogeneic haematopoietic cell transplantation supports donor epidermal grafting of recessive dystrophic epidermolysis bullosa chronic wounds.
    Br J Dermatol. 2021;184:1161-1169.
    PubMed     Abstract available


    May 2021
  67. YEH I, Bastian BC
    Melanoma pathology: new approaches and classification.
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20427.
    PubMed     Abstract available


  68. VENABLES ZC
    Icelandic study of cutaneous squamous cell carcinoma (cSCC) epidemiology highlights the worldwide burden of disease and challenges of in situ and invasive cSCC registry data.
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20422.
    PubMed    


  69. TAIEB A, Katoh N
    Regional differences between Japan and the Netherlands in atopic dermatitis patient-reported outcome measures: which interpretation?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20424.
    PubMed    


  70. MAHAMAT-SALEH Y
    Is consumption of citrus associated with a higher risk of melanoma?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20408.
    PubMed    


  71. VESTERGAARD C
    How clinical phenotypes can translate into taxonomy: can we judge atopic dermatitis by its cover?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20434.
    PubMed    


  72. GALLON R, Kibbi N, Cook S, Santibanez-Koref M, et al
    Sebaceous tumours: A prototypical class of skin tumour for universal germline genetic testing.
    Br J Dermatol. 2021 May 29. doi: 10.1111/bjd.20522.
    PubMed     Abstract available


  73. NASR I, McGrath EJ, Harwood CA, Botting J, et al
    British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021.
    Br J Dermatol. 2021 May 29. doi: 10.1111/bjd.20524.
    PubMed     Abstract available


  74. YU W, Barrett J, Liu P, Parameswaran A, et al
    Novel Evidence of Androgen Receptor Immunoreactivity in Skin Tunnels of Hidradenitis Suppurativa: Assessment of Gender and Individual Variability.
    Br J Dermatol. 2021 May 28. doi: 10.1111/bjd.20520.
    PubMed     Abstract available


  75. LWIN SM, Snowden JA, Griffiths CEM
    The Promise and Challenges of Cell Therapy for Psoriasis.
    Br J Dermatol. 2021 May 26. doi: 10.1111/bjd.20517.
    PubMed     Abstract available


  76. RAZMI T M, Afra TP, Mohammed TP, Ashik PTM, et al
    COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations.
    Br J Dermatol. 2021 May 25. doi: 10.1111/bjd.20425.
    PubMed    


  77. JONAK C, Alkon N, Rindler K, Rojahn TB, et al
    Single-cell RNAseq profiling in a patient with discordant primary cutaneous B and T cell lymphoma reveals micromilieu-driven immune skewing.
    Br J Dermatol. 2021 May 21. doi: 10.1111/bjd.20512.
    PubMed     Abstract available


  78. ROSELEUR J, Gonzalez-Chica DA, Emery J, Stocks NP, et al
    Skin checks and skin cancer diagnosis in Australian general practice before and during the COVID pandemic, 2011-2020.
    Br J Dermatol. 2021 May 19. doi: 10.1111/bjd.20494.
    PubMed     Abstract available


  79. KHURANA A, Mittal A, Jain R, Mishra A, et al
    Rarity of cutaneous findings among asymptomatic to mildly symptomatic COVID-19 patients admitted to a COVID Care facility in Delhi, India: An observational study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20488.
    PubMed     Abstract available


  80. QUEIROS C, Silva L, Miroux Catarino A, Labareda J, et al
    Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20487.
    PubMed     Abstract available


  81. THACI D, Eyerich K, Pinter A, Sebastian M, et al
    Direct Comparison of Risankizumab and Fumaric Acid Esters in Systemic-Therapy-Naive Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20481.
    PubMed     Abstract available


  82. DALAL G, Wright SJ, Vass CM, Davison NJ, et al
    Patient preferences for stratified medicine in psoriasis: a discrete choice experiment.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20482.
    PubMed     Abstract available


  83. GRETHER-BECK S, Felsner I, Brenden H, Marini A, et al
    Air pollution-induced tanning of human skin.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20483.
    PubMed     Abstract available


  84. CLAESON M, Baade P, Marchetti M, Brown S, et al
    Comparative performance of predictors of death from thin (
    Br J Dermatol. 2021 May 12. doi: 10.1111/bjd.20480.
    PubMed     Abstract available


  85. VAZQUEZ T, Feng R, Williams KJ, Werth VP, et al
    Immunological and clinical heterogeneity in cutaneous lupus erythematosus.
    Br J Dermatol. 2021 May 9. doi: 10.1111/bjd.20085.
    PubMed    


  86. SANGERS TE, Wakkee M, Kramer-Noels EC, Nijsten T, et al
    Views on Mobile Health Apps for Skin Cancer Screening in the General Population: An In-Depth Qualitative Exploration of Perceived Barriers and Facilitators.
    Br J Dermatol. 2021 May 7. doi: 10.1111/bjd.20441.
    PubMed     Abstract available


  87. GAUNT N, Green RL, Motta LF, Jamieson LA, et al
    Skin cancers in lockdown: no impact on pathological tumour staging.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20438.
    PubMed     Abstract available


  88. FLEDDERUS AC, Pasmans SGMA, Wolkerstorfer A, Oei W, et al
    Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research, part 2 (the OCOMEN project).
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20437.
    PubMed     Abstract available


  89. CHEN Y, Andre M, Adhikari K, Blin M, et al
    A GWAS identifies novel gene associations with facial skin wrinkling and mole count in Latin-Americans.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20436.
    PubMed     Abstract available


  90. NGUYEN C, Yale K, Casale F, Ghigi A, et al
    SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20435.
    PubMed     Abstract available


  91. BECHER G, Burden AD
    Psoriasis, COVID-19 and shielding.
    Br J Dermatol. 2021 May 5. doi: 10.1111/bjd.20055.
    PubMed    


  92. SCHNUCH A
    Hand eczema in young people: atopic dermatitis and beyond.
    Br J Dermatol. 2021 May 4. doi: 10.1111/bjd.20142.
    PubMed    


  93. ZIMMERMANN C, Boisson M, Ram-Wolff C, Sadoux A, et al
    Diagnostic performance of high throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma.
    Br J Dermatol. 2021 May 3. doi: 10.1111/bjd.20432.
    PubMed     Abstract available


  94. VENABLES ZC, Ahmed S, Bleiker T, Broggio J, et al
    The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020.
    Br J Dermatol. 2021 May 3. doi: 10.1111/bjd.20409.
    PubMed     Abstract available


  95. WOLKERSTORFER A
    Evidence for efficacy of home-based narrowband ultraviolet B therapy.
    Br J Dermatol. 2021;184:790.
    PubMed    


  96. EMTESTAM L, Lapins J, Sartorius K
    A growing family of outcome measurement proposals for hidradenitis suppurativa.
    Br J Dermatol. 2021;184:796-798.
    PubMed    


  97. HERISSE AL, Charlesworth A, Bellon N, Leclerc-Mercier S, et al
    Genotypic and phenotypic analysis of 34 cases of inherited junctional epidermolysis bullosa caused by COL17A1 mutations.
    Br J Dermatol. 2021;184:960-962.
    PubMed    


  98. JERJEN R, Koh WL, Sinclair R, Bhoyrul B, et al
    Low-dose oral minoxidil improves global hair density and length in children with loose anagen hair syndrome.
    Br J Dermatol. 2021;184:977-978.
    PubMed    


  99. ZOUBOULIS CC, Altenburg A
    Interleukin-18 is a sensitive marker of flare initiation in Adamantiades-Behcet disease.
    Br J Dermatol. 2021;184:973-975.
    PubMed    


  100. ZIGLER CK, Roberts A
    A child's experience of itch: the first step towards patient-centred measures.
    Br J Dermatol. 2021;184:795-796.
    PubMed    


  101. MOLLOY K, Vico C, Ortiz-Romero PL, Scarisbrick JJ, et al
    Real-world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2021;184:978-981.
    PubMed    


  102. KRAIN RL, Bax CE, Chakka S, Ahmed S, et al
    Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area Index.
    Br J Dermatol. 2021;184:975-977.
    PubMed    


  103. MARQUES E, Arenberger P, Smetanova A, Gkalpakiotis S, et al
    Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha.
    Br J Dermatol. 2021;184:966-967.
    PubMed    


  104. ONOUFRIADIS A, Boulouadnine B, Dachy G, Higashino T, et al
    A germline mutation in the platelet-derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis.
    Br J Dermatol. 2021;184:967-970.
    PubMed    


  105. BERTOLOTTI A, Sbidian E, Join-Lambert O, Bourgault-Villada I, et al
    Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
    Br J Dermatol. 2021;184:963-965.
    PubMed    


  106. RICAR J, Cetkovska P
    Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab.
    Br J Dermatol. 2021;184:e148.
    PubMed    


  107. BHANOT A, Peters TJ, Ridd MJ
    Assessing the validity, responsiveness and reliability of the Recap measure of eczema control.
    Br J Dermatol. 2021;184:955-957.
    PubMed    


  108. BROWN SJ
    Translational genetics: a challenging but important path.
    Br J Dermatol. 2021;184:800-801.
    PubMed    


  109. LEB-REICHL V, Guttmann-Gruber C, Pinon Hofbauer J
    Linked in: the extracellular matrix network in tumour dissemination.
    Br J Dermatol. 2021;184:799.
    PubMed    


  110. COTTER C, Ferguson J
    'Ruxolitinib cream for the treatment of vitiligo: a randomised, controlled, phase 2 trial': a critical appraisal.
    Br J Dermatol. 2021;184:826-827.
    PubMed    


  111. SIBBALD C
    Long-term safety of dupilumab in children.
    Br J Dermatol. 2021;184:792-793.
    PubMed    


  112. ROGERS A, Akram P, Batchelor JM, Crutchley J, et al
    Quality assurance and characterization of narrowband ultraviolet B devices for use at home: lessons from the HI-Light Vitiligo Trial.
    Br J Dermatol. 2021;184:954-955.
    PubMed    


  113. ASCOTT A, Mansfield KE, Schonmann Y, Mulick A, et al
    Atopic eczema and obesity: a population-based study.
    Br J Dermatol. 2021;184:871-879.
    PubMed     Abstract available


  114. THOMAS KS, Batchelor JM, Akram P, Chalmers JR, et al
    Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Br J Dermatol. 2021;184:828-839.
    PubMed     Abstract available


  115. GOLDFARB N, Lowes MA, Butt M, King T, et al
    Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
    Br J Dermatol. 2021;184:905-912.
    PubMed     Abstract available


  116. SACH TH, Thomas KS, Batchelor JM, Perways A, et al
    An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
    Br J Dermatol. 2021;184:840-848.
    PubMed     Abstract available


  117. PAPANIKOLAOU M, Onoufriadis A, Mellerio JE, Nattkemper LA, et al
    Prevalence, pathophysiology and management of itch in epidermolysis bullosa.
    Br J Dermatol. 2021;184:816-825.
    PubMed     Abstract available


  118. ONOUFRIADIS A, Cabezas A, Ng JCF, Canales J, et al
    Autosomal recessive hypotrichosis with loose anagen hairs associated with TKFC mutations.
    Br J Dermatol. 2021;184:935-943.
    PubMed     Abstract available


  119. LOUSADA MB, Lachnit T, Edelkamp J, Rouille T, et al
    Exploring the human hair follicle microbiome.
    Br J Dermatol. 2021;184:802-815.
    PubMed     Abstract available


    April 2021
  120. IZNARDO H, Vilarrasa E, Lopez-Ferrer A, Puig L, et al
    Real world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20416.
    PubMed     Abstract available


  121. GOTTLIEB AB, Merola JF, Reich K, Behrens F, et al
    Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with concomitant moderate to severe plaque psoriasis: Results from the EXCEED, a randomised, double-blind head-to-head monotherapy study.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20413.
    PubMed     Abstract available


  122. MORENO-ARRONES OM, Ortega-Quijano D, Perez-Brocal V, Fernandez-Nieto D, et al
    Dysbiotic gut microbiota in inflammatory rosacea patients: another clue towards the existence of a brain-gut-skin axis.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20411.
    PubMed     Abstract available


  123. CHAN AA, Noguti J, Yang CT, Feldman SR, et al
    Association between Menopausal Hormone Therapy and Incidence of Psoriasis: A Secondary Analysis from the Women's Health Initiative Randomized Clinical Trials.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20410.
    PubMed     Abstract available


  124. PENSO L, Dray-Spira R, Weill A, Zureik M, et al
    Drop in biological initiation for patients with psoriasis during the COVID-pandemic.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20406.
    PubMed     Abstract available


  125. DOUSSET L, Martins C, Jacquemin C, Amico S, et al
    Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with high frequency of melanoma-infiltrating CXCR3(+) resident memory CD8(+) T cells and multiple chemokine pathways.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20405.
    PubMed     Abstract available


  126. SUTARIA N, Parthasarathy V, Roh YS, Choi J, et al
    Itch in Skin of Color: A multicenter cross-sectional study.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20403.
    PubMed     Abstract available


  127. JI-XU A, Lei DK, Nguyen KA, Yang JJ, et al
    The Burden of Immune-Mediated Skin Disease in HIV/AIDS Inpatients.
    Br J Dermatol. 2021 Apr 22. doi: 10.1111/bjd.20401.
    PubMed     Abstract available


  128. DESSINIOTI C, Geller AC, Whiteman DC, Garbe C, et al
    Not all melanomas are created equal: A review and call for more research into nodular melanoma.
    Br J Dermatol. 2021 Apr 16. doi: 10.1111/bjd.20388.
    PubMed     Abstract available


  129. RAIKER R, Pakhchanian H, Hussain A, Deng M, et al
    Outcomes of COVID-19 in Patients with Skin Cancer.
    Br J Dermatol. 2021 Apr 10. doi: 10.1111/bjd.20386.
    PubMed     Abstract available


  130. MAUL JT, Augustin M, Sorbe C, Conrad C, et al
    Association of gender and systemic therapy treatment outcomes in psoriasis: a two-country, multi-centre, prospective, non-interventional registry study.
    Br J Dermatol. 2021 Apr 10. doi: 10.1111/bjd.20387.
    PubMed     Abstract available


  131. LEBWOHL M, Deodhar A, Griffiths CEM, Menter MA, et al
    The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data.
    Br J Dermatol. 2021 Apr 8. doi: 10.1111/bjd.20136.
    PubMed     Abstract available


  132. CHAN WH, Srivastava R, Damaraju N, Do H, et al
    Automated detection of skin reactions in epicutaneous patch testing using machine learning.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20141.
    PubMed     Abstract available


  133. GEIFMAN N, Azadbakht N, Zeng J, Wilkinson T, et al
    Defining Trajectories of Response in Psoriasis Patients Treated with Biologic Therapies.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20140.
    PubMed     Abstract available


  134. YKEMA BLM, Adan F, Crijns MB, Bleeker FE, et al
    Cutaneous squamous cell carcinoma is associated with Lynch syndrome; widening the spectrum of Lynch syndrome associated tumours.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20139.
    PubMed     Abstract available


  135. VAN DELFT LCJ, Kelleners-Smeets NWJ
    Interventions for basal cell carcinoma: from evidence to personalized treatment.
    Br J Dermatol. 2021 Apr 6. doi: 10.1111/bjd.20059.
    PubMed    


  136. KITTLER H
    Total body photography for secondary prevention of melanoma.
    Br J Dermatol. 2021 Apr 6. doi: 10.1111/bjd.20058.
    PubMed    


  137. BAURECHT H, Welker C, Baumeister SE, Weidnger S, et al
    Relationship between Atopic Dermatitis, Depression and Anxiety: a two-sample Mendelian randomization study.
    Br J Dermatol. 2021 Apr 4. doi: 10.1111/bjd.20092.
    PubMed     Abstract available


  138. JENDOUBI F, Shourick J, Negretto M, Laurent C, et al
    Cutaneous mastocytosis in adult patients with serum tryptase level under 20 ng/ml: why we should investigate further.
    Br J Dermatol. 2021 Apr 3. doi: 10.1111/bjd.20098.
    PubMed     Abstract available


  139. CARVALHO AF, Machado MO, Mallia E, Liu X, et al
    The Association Between Schizophrenia Spectrum Disorders and Psoriasis: a large-scale population-based case-control study.
    Br J Dermatol. 2021 Apr 2. doi: 10.1111/bjd.20094.
    PubMed     Abstract available


  140. ABO-TABIK M, Parisi R, Willis SC, Griffiths CEM, et al
    Development of clinical diagnostic criteria for chronic plaque psoriasis: an international e-Delphi study.
    Br J Dermatol. 2021 Apr 2. doi: 10.1111/bjd.20096.
    PubMed     Abstract available


  141. SCHMITT T, Egu DT, Walter E, Sigmund AM, et al
    Ca(2+) signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus.
    Br J Dermatol. 2021 Apr 1. doi: 10.1111/bjd.20091.
    PubMed     Abstract available


  142. TOLLENAERE MAX, Hebsgaard J, Ewald DA, Lovato P, et al
    Signaling of multiple IL-17 family cytokines through IL-17RA drive psoriasis-related inflammatory pathways.
    Br J Dermatol. 2021 Apr 1. doi: 10.1111/bjd.20090.
    PubMed     Abstract available



  143. What is the best surgical treatment for dermatofibrosarcoma protuberans?
    Br J Dermatol. 2021;184:e126-e147.
    PubMed     Abstract available


  144. PORCU P, Nikbakht N
    New insights on treatment utilization and outcomes in early-stage mycosis fungoides.
    Br J Dermatol. 2021;184:594-595.
    PubMed    


  145. VEERABAGU SA, Lauth MJ, Obayomi A, Correa M, et al
    Hair stylists as screeners for scarring hair loss within the African American community: a cross-sectional study.
    Br J Dermatol. 2021;184:769-770.
    PubMed    


  146. MACHADO MO, Lu JD, Brar R, Kirby JS, et al
    Hidradenitis suppurativa odour and drainage scale: a novel method for evaluating odour and drainage in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:772-774.
    PubMed    


  147. FROMMHERZ LH, Schempp CM, Has C
    Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency.
    Br J Dermatol. 2021;184:770-772.
    PubMed    


  148. ZHANG J, Qin W, Hua S, Li M, et al
    Cafe au lait macules overlying segmental macular hyperpigmentation in a paediatric patient: an early sign for mosaic neurofibromatosis type 1.
    Br J Dermatol. 2021;184:742-743.
    PubMed    


  149. GUTTMANN-GRUBER C, Pinon Hofbauer J
    Transforming growth factor-beta messaging: #ContextMatters.
    Br J Dermatol. 2021;184:592-593.
    PubMed    


  150. BRUINSMA RL, Fajgenbaum K, Yang Y, Del Mar Melendez-Gonzalez M, et al
    Assessment of familial risk in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:753-754.
    PubMed    


  151. VAN DEN BOS RR
    Dermatofibrosarcoma protuberans: slowly gathering evidence for optimal treatment of a slow-growing tumour.
    Br J Dermatol. 2021;184:595.
    PubMed    


  152. AGRAWAL R, Tso S, Eltigani EA, Busam KJ, et al
    PRAME immunohistochemistry as an adjunct in the diagnosis of paucicellular lentigo maligna in a young man.
    Br J Dermatol. 2021;184:e122.
    PubMed    


  153. AMRANI A, Das A
    Cydnidae pigmentation: unusual location on the abdomen and back.
    Br J Dermatol. 2021;184:e125.
    PubMed    


  154. BONIFAZ A, Fernandez-Samar D, Tirado-Sanchez A, Vazquez-Gonzalez D, et al
    Hidradenitis suppurativa associated with actinomycosis owing to Actinomyces meyeri.
    Br J Dermatol. 2021;184:e123-e124.
    PubMed    


  155. OH J, Lee RW, Lee HR, Lee SB, et al
    Classification of facial and truncal segmental vitiligo and its clinical courses including recurrence rate and patterns: a retrospective review of 956 patients.
    Br J Dermatol. 2021;184:750-753.
    PubMed    


  156. ZOUBOULIS CC, Readhead B, Dudley JT
    An additional drug repurposing study for hidradenitis suppurativa/acne inversa.
    Br J Dermatol. 2021;184:748-750.
    PubMed    


  157. CAPOZZA K
    Never the twain shall meet? Bridging the divide between patient perspectives and health professionals and systems.
    Br J Dermatol. 2021;184:587-588.
    PubMed    


  158. ELEFTHERIADOU V
    Outcomes for Pressure Ulcer Trials (OUTPUTs) project: first key step on a long journey.
    Br J Dermatol. 2021;184:587.
    PubMed    


  159. WORTSMAN X
    Strong validation of ultrasound as an imaging biomarker in hidradenitis suppurativa.
    Br J Dermatol. 2021;184:591-592.
    PubMed    


  160. GRAND D, Frew JW, Navrazhina K, Krueger JG, et al
    Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.
    Br J Dermatol. 2021;184:688-696.
    PubMed     Abstract available


  161. KIRBY JS, Hereford B, Thorlacius L, Villumsen B, et al
    Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:681-687.
    PubMed     Abstract available


  162. DURACK A, Gran S, Gardiner MD, Jain A, et al
    A 10-year review of surgical management of dermatofibrosarcoma protuberans.
    Br J Dermatol. 2021;184:731-739.
    PubMed     Abstract available


  163. TEASDALE E, Muller I, Sivyer K, Ghio D, et al
    Views and experiences of managing eczema: systematic review and thematic synthesis of qualitative studies.
    Br J Dermatol. 2021;184:627-637.
    PubMed     Abstract available


  164. LECHNER A, Kottner J, Coleman S, Muir D, et al
    Outcomes for Pressure Ulcer Trials (OUTPUTs) project: review and classification of outcomes reported in pressure ulcer prevention research.
    Br J Dermatol. 2021;184:617-626.
    PubMed     Abstract available


    March 2021
  165. MARLEY AR, Li M, Champion VL, Song Y, et al
    The Association between Citrus Consumption and Melanoma Risk in the UK Biobank.
    Br J Dermatol. 2021 Mar 30. doi: 10.1111/bjd.19896.
    PubMed     Abstract available


  166. GHIASVAND R
    Divergent pathways for melanoma: what is the role of genetics?
    Br J Dermatol. 2021 Mar 25. doi: 10.1111/bjd.19887.
    PubMed    


  167. RUNDLE CW, Fortugno AP, Maghfour J, Presley CL, et al
    Evaluating World Health Organization Essential Medicines List for Skin Disease.
    Br J Dermatol. 2021 Mar 25. doi: 10.1111/bjd.20081.
    PubMed     Abstract available


  168. VAN VOORHEES AS, Stein Gold L, Lebwohl M, Strober B, et al
    Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: results up to 32 weeks from a randomised, phase 3 study.
    Br J Dermatol. 2021 Mar 24. doi: 10.1111/bjd.20083.
    PubMed     Abstract available


  169. PARK S, Ha KH, Kim TG, Kim HC, et al
    Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea.
    Br J Dermatol. 2021 Mar 24. doi: 10.1111/bjd.20079.
    PubMed     Abstract available


  170. O'SHAUGHNESSY RFL
    Ceramide kinase-like protein, 'the kinase that isn't', finds a role in skin cancer stress relief.
    Br J Dermatol. 2021 Mar 23. doi: 10.1111/bjd.19888.
    PubMed    


  171. HEPPT MV, Steeb T, Berking C
    One set to collect them all? The development of a core domain set for medium-to-giant congenital melanocytic naevi.
    Br J Dermatol. 2021 Mar 23. doi: 10.1111/bjd.19878.
    PubMed    


  172. SHAH P, Svigos K, Yin L, Soter N, et al
    Differences in the Clinical Presentation of Bullous Pemphigoid in Skin of Color and White Patients.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20068.
    PubMed     Abstract available


  173. SILVERBERG JI, Lai JS, Cella D
    Reliability and meaningful change of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire(R) (PIQ) Item-Banks in adults with atopic dermatitis.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20066.
    PubMed     Abstract available


  174. TSAI TF
    Secukinumab 2-weekly vs. 4-weekly dosing in plaque-type psoriasis.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.19570.
    PubMed    


  175. MOITINHO-SILVA L, Boraczynski N, Emmert H, Baurecht H, et al
    Host traits, lifestyle and environment are associated with the human skin bacteria.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20072.
    PubMed     Abstract available


  176. THOMPSON LL, Li EB, Krasnow NA, Chang MS, et al
    Effect of Dermatologic Consultation on Survival in Patients with Checkpoint Inhibitor Associated Cutaneous Toxicity.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20074.
    PubMed     Abstract available


  177. YIU ZZN, Harding G, Griffiths CEM, Warren RB, et al
    Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single centre, cross-sectional study.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20062.
    PubMed     Abstract available


  178. MIRZA FN, Wang A, Ramachandran SM, Damsky W, et al
    Dupilumab induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo IL-17A expression: a case report.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20064.
    PubMed     Abstract available


  179. RAMIEN ML, Bahubeshi A, Lara-Corrales I, Pope E, et al
    Blistering severe cutaneous adverse reactions in children: Proposal for pediatric-focused clinical criteria.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20063.
    PubMed     Abstract available


  180. SCHONMANN Y, Mansfield KE, Mulick A, Roberts A, et al
    Inflammatory Skin Diseases and the Risk of Chronic Kidney Disease - Population-Based Case-control and Cohort analyses.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20067.
    PubMed     Abstract available


  181. OKOJI UK, Taylor SC, Lipoff JB
    Equity in skin typing: why it's time to replace the Fitzpatrick scale.
    Br J Dermatol. 2021 Mar 5. doi: 10.1111/bjd.19932.
    PubMed     Abstract available


  182. NALDI L
    The skin as a target for SARS-CoV-2 infection: exploiting the web for suitable data.
    Br J Dermatol. 2021 Mar 4. doi: 10.1111/bjd.19877.
    PubMed    


  183. PEREZ M, Chakraborty A, Lau LS, Mohammed NBB, et al
    Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19891.
    PubMed     Abstract available


  184. BRUGGEN MC, Le ST, Walsh S, Toussi A, et al
    Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19893.
    PubMed     Abstract available


  185. DE WIJS LEM, Fujimoto RFT, Andrinopoulou ER, Nijsten TEC, et al
    Dupilumab treatment in atopic dermatitis patients in the Netherlands versus Japan: a comparative cohort study revealing a discrepancy in patient-reported outcome measures.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19897.
    PubMed     Abstract available


  186. MORRISON PJ, Suhrkamp I, Gerdes S, Mrowietz U, et al
    Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of psoriasis patients that are linked with skin improvement.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19899.
    PubMed     Abstract available


  187. EL SHAROUNI MA, Varey AHR, Witkamp AJ, Ahmed T, et al
    Predicting sentinel node positivity in melanoma patients: external validation of a risk-prediction calculator (the MIA nomogram) using a large European population-based patient cohort.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19895.
    PubMed     Abstract available


  188. VERMEER M
    Epidemiology of cutaneous lymphoma.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19829.
    PubMed    


  189. MULICK AR, Mansfield KE, Silverwood RJ, Buddu-Aggrey A, et al
    Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort.
    Br J Dermatol. 2021 Mar 2. doi: 10.1111/bjd.19885.
    PubMed     Abstract available


  190. LEITER U
    What is new in the 2020 British guidelines for cutaneous squamous cell carcinoma?
    Br J Dermatol. 2021;184:384-385.
    PubMed    


  191. HUGO J, Arenbergerova M, Arenberger P, Gkalpakiotis S, et al
    Coexistence of palmoplantar pustulosis and ichthyosis vulgaris treated by risankizumab.
    Br J Dermatol. 2021 Mar 1. doi: 10.1111/bjd.19835.
    PubMed    


  192. O'NEILL H, Narang I, Buckley DA, Phillips TA, et al
    Occupational dermatoses during the COVID-19 pandemic: a multicentre audit in the UK and Ireland.
    Br J Dermatol. 2021;184:575-577.
    PubMed    


  193. BOUAZZI D, McPhie ML, Kjaersgaard Andersen R, Alavi A, et al
    Hidradenitis suppurativa and perceived stigmatization in a diverse Canadian clinic population: a pilot study.
    Br J Dermatol. 2021;184:570-571.
    PubMed    


  194. BAX CE, Ravishankar A, Yan D, Concha J, et al
    Identifying the required degree of disease clearance to improve quality of life in pemphigus vulgaris.
    Br J Dermatol. 2021;184:573-575.
    PubMed    


  195. MA Y, Zhao C, Li R, Wang X, et al
    Actinomycetoma caused by Nocardia asiatica associated with traditional Chinese medicine foot bath.
    Br J Dermatol. 2021;184:e55.
    PubMed    


  196. HADDAD N, Delyon J, Trabelsi Messai S, Herms F, et al
    Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy.
    Br J Dermatol. 2021;184:564-566.
    PubMed    


  197. DE VERE HUNT I, McNiven A, McPherson T
    A qualitative exploration of the experiences of adolescents with alopecia areata and their messages for healthcare professionals.
    Br J Dermatol. 2021;184:557-559.
    PubMed    


  198. LU JD, Milakovic M, Piguet V, Alavi A, et al
    Antidrug antibodies to tumour necrosis factor inhibitors in hidradenitis suppurativa: a systematic review.
    Br J Dermatol. 2021;184:555-557.
    PubMed    


  199. YAO Y, Jorgensen AR, Ring HC, Thomsen SF, et al
    Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study.
    Br J Dermatol. 2021;184:552-553.
    PubMed    


  200. MORENO ARTERO E, Schinkel N, Chaumon S, Corset I, et al
    Efficacy of topical ropivacaine in children and young adults with hereditary epidermolysis bullosa.
    Br J Dermatol. 2021;184:550-552.
    PubMed    


  201. JIYAD Z, Marquart L, Green AC
    A call to standardize the BCC:SCC ratio.
    Br J Dermatol. 2021;184:545.
    PubMed    


  202. PARARAJASINGAM A, Atwan A, Srivastava P, Chowdhury MMU, et al
    Shades of grey: an outbreak of tattoo-associated Mycobacterium chelonae.
    Br J Dermatol. 2021;184:e54.
    PubMed    


  203. HODAK E, Sherman S, Papadavid E, Bagot M, et al
    Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
    Br J Dermatol. 2021;184:524-531.
    PubMed     Abstract available


  204. GABES M, Jourdan C, Schramm K, Masur C, et al
    Hyperhidrosis Quality of Life Index (HidroQoL(c)): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial.
    Br J Dermatol. 2021;184:473-481.
    PubMed     Abstract available


  205. BODEMER C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA, et al
    Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.
    Br J Dermatol. 2021;184:393-400.
    PubMed     Abstract available


    February 2021
  206. KOGAME T, Kambe N, Takimoto-Ito R, Nomura T, et al
    Skin-associated lymphoid tissue could be a sign of systemic disease: reply from authors.
    Br J Dermatol. 2021 Feb 22. doi: 10.1111/bjd.19884.
    PubMed     Abstract available


  207. WANG C
    Skin-associated lymphoid tissue could be a sign of systemic disease.
    Br J Dermatol. 2021 Feb 21. doi: 10.1111/bjd.19881.
    PubMed     Abstract available


  208. SCHNEIDER R, Reinau D, Stoffel S, Jick SS, et al
    Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19880.
    PubMed     Abstract available


  209. ADALSTEINSSON JA, Olafsdottir E, Ratner D, Waldman R, et al
    Invasive and In-Situ Squamous Cell Carcinoma of the Skin: A Nationwide Study in Iceland.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19879.
    PubMed     Abstract available


  210. SOTIRIOU E, Bakirtzi K, Papadimitriou I, Paschou E, et al
    Intention of COVID-19 vaccination among psoriatic patients compared to immunosuppressed patients with other skin diseases and factors influencing their decision.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19882.
    PubMed     Abstract available


  211. PILKINGTON SM
    The importance of keratinocyte-dendritic cell interactions in understanding fragrance allergy.
    Br J Dermatol. 2021 Feb 18. doi: 10.1111/bjd.19828.
    PubMed    


  212. ABUABARA K, Nicholls SG, Langan SM, Guttman-Yassky E, et al
    Priority research questions in atopic dermatitis: An International Eczema Council eDelphi consensus.
    Br J Dermatol. 2021 Feb 11. doi: 10.1111/bjd.19874.
    PubMed     Abstract available


  213. HODGES WT, Bhat T, Raval NS, Herbosa C, et al
    Biologics utilization for psoriasis is lower in Black compared to Caucasian patients.
    Br J Dermatol. 2021 Feb 10. doi: 10.1111/bjd.19876.
    PubMed     Abstract available


  214. OMODAKA T, Minagawa A, Okuyama R
    Ultraviolet-related skin cancers distribute differently on the face surface.
    Br J Dermatol. 2021 Feb 10. doi: 10.1111/bjd.19875.
    PubMed     Abstract available


  215. VERMEER HAB, Rashid H, Esajas MD, Oldhoff JM, et al
    The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina.
    Br J Dermatol. 2021 Feb 6. doi: 10.1111/bjd.19870.
    PubMed     Abstract available


  216. TAYLOR MT, Noe MH, Horton DB, Barbieri JS, et al
    Trends in opioid prescribing at outpatient visits for psoriasis and psoriatic arthritis.
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19865.
    PubMed     Abstract available


  217. WOLNER ZJ, Flowers NI, Yushak ML, Chen SC, et al
    Exploring the melanoma survivorship experience: a qualitative study.
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19868.
    PubMed     Abstract available


  218. THACI D, Piaserico S, Warren RB, Gupta AK, et al
    Five-year efficacy and safety of tildrakizumab in patients with moderate to severe psoriasis who respond at week 28: pooled analyses of two randomised phase 3 clinical trials (reSURFACE 1 and reSURFACE 2).
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19866.
    PubMed     Abstract available


  219. NAPOLITANO M, Caiazzo G, Fabbrocini G, Balato A, et al
    Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment.
    Br J Dermatol. 2021;184:341-343.
    PubMed    


  220. WINGE MCG, Iberri DJ, Novoa RA, Kwong BY, et al
    Telescope punch biopsy of normal-appearing skin to diagnose intravascular lymphoma.
    Br J Dermatol. 2021 Feb 1. doi: 10.1111/bjd.19711.
    PubMed    


  221. LUCAS JA
    Using electronic health records to examine links between atopic dermatitis and obesity.
    Br J Dermatol. 2021 Feb 1. doi: 10.1111/bjd.19758.
    PubMed    


  222. FLOHR C, Hay R
    Putting the burden of skin diseases on the global map.
    Br J Dermatol. 2021;184:189-190.
    PubMed    



  223. Somatostatin receptors: an alternative treatment target for advanced Merkel cell carcinoma.
    Br J Dermatol. 2021;184:e32-e52.
    PubMed     Abstract available


  224. CUST AE
    A different finding on whether naevus numbers change during adulthood.
    Br J Dermatol. 2021;184:193.
    PubMed    


  225. FREW JW, Navrazhina K, Sullivan-Whalen M, Gilleaudeau P, et al
    Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study.
    Br J Dermatol. 2021;184:350-352.
    PubMed    


  226. GONCALO M, Gimenez-Arnau A, Al-Ahmad M, Ben-Shoshan M, et al
    The global burden of chronic urticaria for the patient and society.
    Br J Dermatol. 2021;184:226-236.
    PubMed     Abstract available


  227. LERTPHANICHKUL C, Smith GP
    Evaluation of malignancy risk in scleroderma by antibody profile.
    Br J Dermatol. 2021;184:369-371.
    PubMed    


  228. GARCOVICH S, Tricarico PM, Meddour CN, Giovanardi G, et al
    Comorbid acne inversa and Dowling-Degos disease due to a single NCSTN mutation: is there enough evidence? Reply from the authors.
    Br J Dermatol. 2021;184:375-376.
    PubMed    


  229. HERMASCH MA, Schon MP, Frank J
    Comorbid acne inversa and Dowling-Degos disease due to a single NCSTN mutation: is there enough evidence?
    Br J Dermatol. 2021;184:374.
    PubMed    


  230. SAMIMI M, Becker J
    There is still a place for tumour-targeted therapies in Merkel cell carcinoma in the era of immune checkpoint inhibitors.
    Br J Dermatol. 2021;184:195-197.
    PubMed    


  231. RAMELYTE E, Restivo G, Imhof L, Nageli MC, et al
    How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?
    Br J Dermatol. 2021;184:359-361.
    PubMed    


  232. MIURA H, Takada M, Fujiwara M, Fujiwara S, et al
    Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma.
    Br J Dermatol. 2021;184:e30.
    PubMed    


  233. LAYTON AM, Thiboutot D, Tan J
    Reviewing the global burden of acne: how could we improve care to reduce the burden?
    Br J Dermatol. 2021;184:219-225.
    PubMed     Abstract available


  234. ARDON CB, Wang C, Prens EP, van Straalen KR, et al
    Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches.
    Br J Dermatol. 2021;184:343-345.
    PubMed    


  235. SALEVA-STATEVA M, Technau-Hafsi K, Frommherz L, Gruninger G, et al
    Recurrent MVD mutation in European patients with disseminated porokeratosis.
    Br J Dermatol. 2021;184:347-348.
    PubMed    


  236. BARBIERI JS
    New oral antifungals for onychomycosis: interesting potential and the need for comparative effectiveness trials.
    Br J Dermatol. 2021;184:191.
    PubMed    


  237. ELEWSKI B, Brand S, Degenhardt T, Curelop S, et al
    A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.
    Br J Dermatol. 2021;184:270-280.
    PubMed     Abstract available


  238. RIBERO S, Zugna D, Spector T, Bataille V, et al
    Natural history of naevi: a two-wave study.
    Br J Dermatol. 2021;184:289-295.
    PubMed     Abstract available


  239. COX V, Fuller LC, Engelman D, Steer A, et al
    Estimating the global burden of scabies: what else do we need?
    Br J Dermatol. 2021;184:237-242.
    PubMed     Abstract available


  240. LONEY T, Paulo MS, Modenese A, Gobba F, et al
    Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review.
    Br J Dermatol. 2021;184:208-218.
    PubMed     Abstract available


  241. AKAIKE T, Qazi J, Anderson A, Behnia FS, et al
    High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma.
    Br J Dermatol. 2021;184:319-327.
    PubMed     Abstract available


    January 2021
  242. ENDRE KMA, Landro L, LeBlanc M, Gjersvik P, et al
    Diagnosing Atopic Dermatitis in Infancy Using Established Diagnostic Criteria: A Cohort Study.
    Br J Dermatol. 2021 Jan 28. doi: 10.1111/bjd.19831.
    PubMed     Abstract available


  243. SHIIYA C, Aoki S, Nakabayashi K, Hata K, et al
    Linear and disseminated porokeratosis in one family showing identical and independent second hits in MVD among skin lesions, respectively: A proof of concept study.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19824.
    PubMed     Abstract available


  244. TASCILAR K, Bayindir O, Dogru A, Tinazzi I, et al
    Association of Disease Characteristics with the Temporal Sequence of Skin and Musculoskeletal Disease Onset in Psoriatic Arthritis.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19826.
    PubMed     Abstract available


  245. WEHKAMP U, Mitteldorf C, Stendel S, Stranzenbach R, et al
    Most rare subtypes of cutaneous lymphoma display variable CD30 expression. Analysis of the German Cutaneous Lymphoma Network.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19823.
    PubMed     Abstract available


  246. DROITCOURT C, Vittrup I, Dupuy A, Egeberg A, et al
    The risk of systemic infections requiring hospitalisation in children with atopic dermatitis: a Danish retrospective nationwide cohort study.
    Br J Dermatol. 2021 Jan 21. doi: 10.1111/bjd.19825.
    PubMed     Abstract available


  247. DESSINIOTI C, Geller AC, Stergiopoulou A, Dimou N, et al
    A multicenter study of nevus-associated melanoma versus de novo melanoma, tumor thickness and body site differences.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19819.
    PubMed     Abstract available


  248. SILVERBERG JI, Warshaw EM, Maibach HI, DeKoven JG, et al
    Hand Eczema in Children Referred for Patch Testing: North American Contact Dermatitis Group Data, 2000-2016.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19818.
    PubMed     Abstract available


  249. VITTRUP I, Andersen YMF, Droitcourt C, Skov L, et al
    Association between hospital-diagnosed atopic dermatitis and psychiatric disorders and medication use in childhood.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19817.
    PubMed     Abstract available


  250. NAGORE E, Martinez-Garcia MA, Gomez-Olivas JD, Manrique-Silva E, et al
    Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: An observational multi-centric study in 443 patients with melanoma.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19813.
    PubMed     Abstract available


  251. HICKERSON RP, Conneely MJ, Tsutsumi SKH, Wood K, et al
    Minimal, superficial DNA damage in human skin from filtered far-ultraviolet-C (UV-C).
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19816.
    PubMed     Abstract available


  252. VORNWEG J, Glaser S, Ahmad-Anwar M, Zimmer AD, et al
    Identification of compound heterozygous mutations in AP1B1 leading to the newly-described recessive keratitis-ichthyosis-deafness (KIDAR) syndrome.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19815.
    PubMed     Abstract available


  253. LESTER JC, Clark L Jr, Linos E, Daneshjou R, et al
    Clinical Photography in Skin of Color: Tips and Best Practices.
    Br J Dermatol. 2021 Jan 15. doi: 10.1111/bjd.19811.
    PubMed     Abstract available


  254. THOMSON J, Hogan S, Leonardi-Bee J, Williams HC, et al
    Interventions for basal cell carcinoma: abridged Cochrane systematic review and grade assessments.
    Br J Dermatol. 2021 Jan 15. doi: 10.1111/bjd.19809.
    PubMed     Abstract available


  255. VISCONTI A, Bataille V, Rossi N, Kluk J, et al
    Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection.
    Br J Dermatol. 2021 Jan 14. doi: 10.1111/bjd.19807.
    PubMed     Abstract available


  256. KAMIDO H, Shimomiya D, Kogame T, Takimoto-Ito R, et al
    Inducible skin-associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema.
    Br J Dermatol. 2021 Jan 14. doi: 10.1111/bjd.19808.
    PubMed     Abstract available



  257. Revolutionizing Atopic Dermatitis, 13-14 December 2020.
    Br J Dermatol. 2021 Jan 11. doi: 10.1111/bjd.19722.
    PubMed    


  258. ABADIAS-GRANADO I, Navarro-Bielsa A, Morales-Callaghan AM, Roc L, et al
    COVID-19-associated cutaneous manifestations: does HHV-6 play an etiological role?
    Br J Dermatol. 2021 Jan 8. doi: 10.1111/bjd.19806.
    PubMed     Abstract available


  259. GIANOTTI R, Barberis M, Fellegara G, Galvan-Casas C, et al
    COVID-19 related dermatosis in November 2019. Could this case be Italy's patient zero?
    Br J Dermatol. 2021 Jan 7. doi: 10.1111/bjd.19804.
    PubMed     Abstract available


  260. KELLY A, Meurling J, Kirthi Jeyarajah S, Ryan C, et al
    Obstructive Sleep Apnea in Psoriasis and Hidradenitis Suppurativa.
    Br J Dermatol. 2021 Jan 6. doi: 10.1111/bjd.19802.
    PubMed     Abstract available


  261. LAN Y, Zeng W, Dong X, Lu H, et al
    Opsin 5 is a key regulator of ultraviolet radiation induced melanogenesis in human epidermal melanocytes.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19797.
    PubMed     Abstract available


  262. ZHU JL, Tran LT, Smith M, Zheng F, et al
    Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19800.
    PubMed     Abstract available


  263. LOH AYT, Ho CM, Muthiah S, Venkatesh B, et al
    Huriez syndrome caused by a large deletion that abrogates the skin-specific isoform of SMARCAD1.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19799.
    PubMed     Abstract available


  264. MEYER JM, Lee E, Celli A, Park K, et al
    CERKL is upregulated in cutaneous squamous cell carcinoma and maintains cellular sphingolipids and resistance to oxidative stress.
    Br J Dermatol. 2021 Jan 4. doi: 10.1111/bjd.19753.
    PubMed     Abstract available


  265. GAULT A, Anderson AE, Plummer R, Stewart C, et al
    Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors.
    Br J Dermatol. 2021 Jan 4. doi: 10.1111/bjd.19750.
    PubMed     Abstract available


  266. SOARES CD, Mosqueda-Taylor A, de Carvalho MGF, de Almeida OP, et al
    Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.
    Br J Dermatol. 2021;184:e6.
    PubMed    


  267. DERRICK KM, Mazori DR, Heilman ER, Glick SA, et al
    Prurigo pigmentosa and new-onset type 1 diabetes in a black female patient testing positive for SARS-CoV-2 IgG.
    Br J Dermatol. 2021;184:e5.
    PubMed    


  268. NUNO-GONZALEZ A, Martin-Carrillo P, Magaletsky K, Martin Rios MD, et al
    Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings.
    Br J Dermatol. 2021;184:184-185.
    PubMed    


  269. LIMA XT, Cueva MA, Alora MB
    COVID-19 in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:182-184.
    PubMed    


  270. FERGUSON FJ, Street G, Cunningham L, White IR, et al
    Occupational dermatology in the time of the COVID-19 pandemic: a report of experience from London and Manchester, UK.
    Br J Dermatol. 2021;184:180-182.
    PubMed    


  271. MAGRO CM, Mulvey JJ, Laurence J, Sanders S, et al
    The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
    Br J Dermatol. 2021;184:141-150.
    PubMed     Abstract available


  272. CHEN E, Ghannoum M, Elewski BE
    Treatment-resistant tinea corporis, a potential public health issue.
    Br J Dermatol. 2021;184:164-165.
    PubMed    



  273. Trim21 promotes inflammation in keratinocytes of psoriatic patients.
    Br J Dermatol. 2021;184:e7-e28.
    PubMed     Abstract available


  274. OHYAMA M
    Caffeine relaxes hair follicles in androgenetic alopecia.
    Br J Dermatol. 2021;184:7-8.
    PubMed    


  275. GUPTA V, Taneja N, Sati HC, Sreenivas V, et al
    Evaluation of 'not relevant' responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo.
    Br J Dermatol. 2021;184:168-169.
    PubMed    


  276. EXPOSITO-SERRANO V, Curto-Barredo L, Aguilera Peiro P, Gomez Armayones S, et al
    Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
    Br J Dermatol. 2021;184:167-168.
    PubMed    


  277. NARAYAN VS, Uitentuis SE, Bekkenk MW, Wolkerstorfer A, et al
    What is successful repigmentation in vitiligo from the point of view of patients?
    Br J Dermatol. 2021;184:165-166.
    PubMed    


  278. FERNANDEZ JM, Thompson AM, Kirby JS, Hsiao JL, et al
    Characterizing physical symptoms of flare in hidradenitis suppurativa: a patient survey.
    Br J Dermatol. 2021;184:160-162.
    PubMed    


  279. BOONCHAI W
    What should be in the facial patch testing series for 2020?
    Br J Dermatol. 2021;184:13.
    PubMed    


  280. BAX CE, Werth VP
    The incidence of bullous pemphigoid continues to increase in England.
    Br J Dermatol. 2021;184:5-6.
    PubMed    


  281. ZOUBOULIS CC
    First real-world data provide evidence for a 'window of opportunity' in treatment of hidradenitis suppurativa/acne inversa.
    Br J Dermatol. 2021;184:10-11.
    PubMed    


  282. PERSSON MSM, Harman KE, Vinogradova Y, Langan SM, et al
    Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study.
    Br J Dermatol. 2021;184:68-77.
    PubMed     Abstract available


  283. MARZANO AV, Genovese G, Casazza G, Moltrasio C, et al
    Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
    Br J Dermatol. 2021;184:133-140.
    PubMed     Abstract available


  284. INGRAM JR, Ahluwalia A
    The pharmacology of itch.
    Br J Dermatol. 2021;184:e1-e2.
    PubMed    


    December 2020
  285. TOLAND AE
    The influence of sex, age and sunlight exposure on mutational processes in melanoma.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19336.
    PubMed    


  286. VAN DER KRAAIJ GE, van Huizen AM, Baerveldt EM, Boshuizen M, et al
    Online decision aid for patients with psoriasis.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19761.
    PubMed     Abstract available


  287. JI-XU A, Dinnes J, Matin RN
    Total Body Photography for the Diagnosis of Cutaneous Melanoma in Adults: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19759.
    PubMed     Abstract available


  288. MAHIL SK, Yates M, Langan SM, Yiu ZZN, et al
    Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
    Br J Dermatol. 2020 Dec 23. doi: 10.1111/bjd.19755.
    PubMed     Abstract available


  289. PUIG L
    Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all races.
    Br J Dermatol. 2020 Dec 21. doi: 10.1111/bjd.19696.
    PubMed    


  290. MORRA DE, Drucker AM
    Tralokinumab for atopic dermatitis: a promising new therapy.
    Br J Dermatol. 2020 Dec 21. doi: 10.1111/bjd.19699.
    PubMed    


  291. KASSARDJIAN AA, Chat VS, Archuleta L, Hekmatjah J, et al
    Words Matter: A randomized controlled study evaluating the impact of decision-framing on treatment preferences in adults with psoriasis and psoriatic arthritis.
    Br J Dermatol. 2020 Dec 17. doi: 10.1111/bjd.19746.
    PubMed     Abstract available


  292. HAMM H, Wilsmann-Theis D, Tsianakas A, Gambichler T, et al
    Efficacy and safety of fumaric acid esters in young patients aged 10 to 17 years with moderate-to-severe plaque psoriasis - A randomised, double-blinded, placebo-controlled trial.
    Br J Dermatol. 2020 Dec 17. doi: 10.1111/bjd.19747.
    PubMed     Abstract available


  293. GREIG A, Aloni K, Orchard G, Shams M, et al
    Treatment of multiple facial basal cell carcinomas in a child with xeroderma pigmentosum complementation group C with Mohs micrographic surgery.
    Br J Dermatol. 2020 Dec 16. doi: 10.1111/bjd.19323.
    PubMed    


  294. TOBIN DJ
    Unpicking the Gordian knot of identifying metastasis development-relevant proteins in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Dec 16. doi: 10.1111/bjd.19697.
    PubMed    


  295. RUINI C, Schuh S, Hartmann D, French L, et al
    Noninvasive real-time imaging of mite skin infestations with line-field confocal optical coherence tomography.
    Br J Dermatol. 2020 Dec 14. doi: 10.1111/bjd.19318.
    PubMed    


  296. BERGQVIST C, Stern RS, Chosidow O
    Psoriasis: an example of the complexity of decision-making.
    Br J Dermatol. 2020 Dec 10. doi: 10.1111/bjd.19715.
    PubMed     Abstract available


  297. GEHLHAUSEN JR, Ko CJ, Damsky W
    Response to Tembhre et al.: 'Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2'.
    Br J Dermatol. 2020 Dec 10. doi: 10.1111/bjd.19714.
    PubMed     Abstract available


  298. DESCALZO MA, Garcia-Doval I
    Association of skin diseases, biological treatment and COVID-19 during the first wave of the pandemic.
    Br J Dermatol. 2020 Dec 4. doi: 10.1111/bjd.19683.
    PubMed    


  299. MEYER JM, Lee E, Celli A, Park K, et al
    CERKL is Upregulated in Cutaneous Squamous Cell Carcinoma and Maintains Cellular Sphingolipids and Resistance to Oxidative Stress.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19707.
    PubMed     Abstract available


  300. VUONG K, Armstrong BK, Espinoza D, Hopper JL, et al
    An independent external validation of melanoma risk prediction models using the Australian Melanoma Family Study.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19706.
    PubMed     Abstract available


  301. LASKAR R, Ferreiro-Iglesias A, Bishop DT, Iles MM, et al
    Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19705.
    PubMed     Abstract available


  302. MCALEER MA, Jakasa I, Stefanovic N, McLean WHI, et al
    Topical Corticosteroids Normalize both Skin and Systemic Inflammatory Markers in Infant Atopic Dermatitis.
    Br J Dermatol. 2020 Dec 2. doi: 10.1111/bjd.19703.
    PubMed     Abstract available


  303. PAN CX, Jee YH, Moore KJ, Kraft P, et al
    Relationship Between Body Mass Index and Atopic Dermatitis: Critical Appraisal of a Mendelian Randomization Approach in Exploring Causality.
    Br J Dermatol. 2020 Dec 1. doi: 10.1111/bjd.19702.
    PubMed     Abstract available


  304. BABAKINEJAD P, Hampton PJ
    New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens?
    Br J Dermatol. 2020;183:984-985.
    PubMed    



  305. Why don't people with psoriasis take enough exercise?
    Br J Dermatol. 2020;183:e191-e200.
    PubMed     Abstract available


  306. PENDSE RS, Schwartz BL, Jia JL, Bailey EE, et al
    Paucity of COVID-19 dermatology literature from low- and middle-income countries.
    Br J Dermatol. 2020;183:1142-1143.
    PubMed    


  307. XU R, Zhou Y, Cai L, Wang L, et al
    Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19.
    Br J Dermatol. 2020;183:1145-1147.
    PubMed    


  308. RENCZ F
    A new self-reported measure of disease severity of scalp hair loss in alopecia areata.
    Br J Dermatol. 2020;183:986-987.
    PubMed    


    November 2020
  309. BESSIS D
    Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window.
    Br J Dermatol. 2020 Nov 29. doi: 10.1111/bjd.19596.
    PubMed    


  310. OEI W, Fledderus AC, Spuls PI, Eggen CAM, et al
    Development of an international core domain set for medium, large and giant congenital melanocytic nevi as a first step towards a core outcome set for clinical practice and research.
    Br J Dermatol. 2020 Nov 25. doi: 10.1111/bjd.19694.
    PubMed     Abstract available


  311. REYNOLDS KA, Schlessinger DI, Yanes AF, Godinez-Puig V, et al
    Development of a Core Outcome Set for Cutaneous Squamous Cell Carcinoma Trials: Identification of Core Domains and Outcomes.
    Br J Dermatol. 2020 Nov 25. doi: 10.1111/bjd.19693.
    PubMed     Abstract available


  312. REICH K, Sorbe C, Griese L, Reich JLK, et al
    The value of subcutaneous versus oral methotrexate - real-world data from the German psoriasis registry PsoBest.
    Br J Dermatol. 2020 Nov 21. doi: 10.1111/bjd.19690.
    PubMed     Abstract available


  313. PATEL S, Cadwell JB, Lambert WC
    Comparison of adult versus paediatric staphylococcal scalded skin syndrome inpatients: A retrospective database analysis.
    Br J Dermatol. 2020 Nov 20. doi: 10.1111/bjd.19691.
    PubMed     Abstract available


  314. NAKAMURA M, Obayashi M, Yoshimitsu M, Kato H, et al
    Comparative whole-exome sequencing of an ultra-late recurrent malignant melanoma.
    Br J Dermatol. 2020 Nov 18. doi: 10.1111/bjd.19680.
    PubMed     Abstract available


  315. LICHTER J, Silva E Sousa M, Peter N, Sahli F, et al
    Skin sensitisation to fragrance hydroperoxides: interplay between dendritic cells, keratinocytes and free radicals.
    Br J Dermatol. 2020 Nov 18. doi: 10.1111/bjd.19685.
    PubMed     Abstract available


  316. ZIAJ S, Tseliou F, Datta D, Abbott RA, et al
    Skin cancer awareness and prevention behaviour in Wales.
    Br J Dermatol. 2020 Nov 11. doi: 10.1111/bjd.19676.
    PubMed     Abstract available


  317. GROOT J, Blegvad C, Nybo Andersen AM, Zachariae C, et al
    Presence of streptococci and frequent tonsillitis among adolescents with psoriasis.
    Br J Dermatol. 2020 Nov 10. doi: 10.1111/bjd.19672.
    PubMed     Abstract available


  318. MIYANO T, Tanaka RJ
    Identification of keratinocyte subpopulations in transcriptome to evaluate drug effects in atopic dermatitis.
    Br J Dermatol. 2020 Nov 8. doi: 10.1111/bjd.19615.
    PubMed    


  319. VAZQUEZ T, Concha JSS, Werth VP
    Patient-oriented outcomes for atopic dermatitis.
    Br J Dermatol. 2020 Nov 8. doi: 10.1111/bjd.19614.
    PubMed    


  320. VERMEER MH, Nicolay JP, Scarisbrick JJ, Zinzani PL, et al
    The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
    Br J Dermatol. 2020 Nov 6. doi: 10.1111/bjd.19669.
    PubMed     Abstract available


  321. TEMBHRE MK, Parihar AS, Sharma VK, Imran S, et al
    Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2.
    Br J Dermatol. 2020 Nov 6. doi: 10.1111/bjd.19670.
    PubMed     Abstract available


  322. VAN WINDEN MEC, Ter Haar ELM, Groenewoud JMM, van de Kerkhof PCM, et al
    Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups.
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19665.
    PubMed     Abstract available


  323. BRAHMBHATT HD, Gupta R, Gupta A, Rastogi S, et al
    Long non-coding RNA MALAT1 suppresses miR-211 to confer protection from UV-mediated DNA damage in vitiligo epidermis by upregulating SIRT1.
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19666.
    PubMed     Abstract available


  324. MURRAY G, Roche D, Ridge A, Hackett C, et al
    Response to "Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic".
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19667.
    PubMed     Abstract available


  325. KEOHANE SG, Botting J, Budny PG, Dolan OM, et al
    British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.
    Br J Dermatol. 2020 Nov 4. doi: 10.1111/bjd.19621.
    PubMed     Abstract available


  326. PATALAY R
    Which method is better for the diagnosis of basal cell carcinoma: biopsy vs. reflectance confocal microscopy?
    Br J Dermatol. 2020 Nov 2. doi: 10.1111/bjd.19571.
    PubMed    



  327. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS((R)) ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.
    Br J Dermatol. 2020;183:e149-e170.
    PubMed     Abstract available


  328. SIMONSEN AB, Ruge IF, Quaade AS, Johansen JD, et al
    High incidence of hand eczema in Danish schoolchildren following intensive hand hygiene during the COVID-19 pandemic: a nationwide questionnaire study.
    Br J Dermatol. 2020;183:975-976.
    PubMed    


  329. VAN DELFT LCJ, Essers BAB, Nelemans PJ, Mosterd K, et al
    Development of a patient decision aid for superficial basal-cell carcinoma.
    Br J Dermatol. 2020 Nov 1. doi: 10.1111/bjd.19662.
    PubMed     Abstract available


  330. WANG HL, Sun J, Qian ZM, Gong YQ, et al
    Association between Air Pollution and Atopic Dermatitis in Guangzhou, China: Modification by Age and Season.
    Br J Dermatol. 2020 Nov 1. doi: 10.1111/bjd.19645.
    PubMed     Abstract available


  331. ELEWSKI B
    A call for antifungal stewardship.
    Br J Dermatol. 2020;183:798-799.
    PubMed    


  332. MATOS TR
    Is targeting circulating T blood cells a therapeutic option for vitiligo?
    Br J Dermatol. 2020;183:803.
    PubMed    


  333. SCHUTTELAAR MLA
    The value of ongoing surveillance on the prevalence of contact sensitization.
    Br J Dermatol. 2020;183:800-801.
    PubMed    


  334. ELEFTHERIADOU V
    Reliability and validity of the Vitiligo Signs of Activity Score.
    Br J Dermatol. 2020;183:801-802.
    PubMed    


  335. KIRBY B, Fitzgerald O
    A new biomarker for psoriatic arthritis?
    Br J Dermatol. 2020;183:805-806.
    PubMed    


  336. BELLON T, Kardaun SH
    CXCL10/IP-10, an early biomarker for late sequelae in DRESS?
    Br J Dermatol. 2020;183:804-805.
    PubMed    


    October 2020
  337. NOLAN GS, Kiely AL, Totty JP, Wormald J, et al
    Incomplete surgical excision of keratinocyte skin cancers: a systematic review and meta-analysis.
    Br J Dermatol. 2020 Oct 31. doi: 10.1111/bjd.19660.
    PubMed     Abstract available


  338. DOBOS G, de Masson A, Ram-Wolff C, Beylot-Barry M, et al
    Epidemiological changes in cutaneous lymphomas: an analysis of 8,593 patients from the French Cutaneous Lymphoma Registry.
    Br J Dermatol. 2020 Oct 31. doi: 10.1111/bjd.19644.
    PubMed     Abstract available


  339. SEARS AV, Woolf RT, Gribaleva E, Abdelrahman W, et al
    Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one-year observational cohort study of the first 100 patients treated.
    Br J Dermatol. 2020 Oct 27. doi: 10.1111/bjd.19631.
    PubMed     Abstract available


  340. CHARVET E, Kramkimel N, Chaplain L, Gantzer A, et al
    Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-PD-1 monoclonal antibodies.
    Br J Dermatol. 2020 Oct 24. doi: 10.1111/bjd.19629.
    PubMed     Abstract available


  341. IVERT LU, Wahlgren CF, Lindelof B, Dal H, et al
    Association between atopic dermatitis and autoimmune diseases: a population-based case-control study.
    Br J Dermatol. 2020 Oct 22. doi: 10.1111/bjd.19624.
    PubMed     Abstract available


  342. MARUTHAPPU T, Bewley A
    A changed life: the life experiences of patients with psoriasis receiving biological treatment.
    Br J Dermatol. 2020 Oct 21. doi: 10.1111/bjd.19623.
    PubMed     Abstract available


  343. WOLINER-VAN DER WEG W, Peppelman M, van Erp PEJ, Lubeek SFK, et al
    Lost in translation: True Clinical Impact of RCM Overlooked in "Biopsy outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial": reply from au
    Br J Dermatol. 2020 Oct 15. doi: 10.1111/bjd.19605.
    PubMed     Abstract available


  344. GILL M, Pellacani G, Grant-Kels JM, Ardigo M, et al
    Lost in Translation: True Clinical Impact of RCM Overlooked in "Biopsy outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial".
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19602.
    PubMed     Abstract available


  345. SORIANO LF, Bertram CG, Chowdhury MMU, Cousen P, et al
    Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland.
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19603.
    PubMed     Abstract available


  346. GHIASVAND R, Khosrotehrani K, Hughes MCB, von Schuckmann LA, et al
    Patient age and risk of recurrence of primary melanoma at high risk of spread.
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19601.
    PubMed     Abstract available


  347. SCHMITT-EGENOLF M
    Complete skin clearance and beyond.
    Br J Dermatol. 2020 Oct 8. doi: 10.1111/bjd.19544.
    PubMed    


  348. LAUGHTER MR, Maymone MBC, Mashayekhi S, Arents BWM, et al
    The global burden of atopic dermatitis: lessons from the GBD Study - 1990 to 2017.
    Br J Dermatol. 2020 Oct 2. doi: 10.1111/bjd.19580.
    PubMed     Abstract available


  349. REICH K
    A new treatment option for paediatric psoriasis.
    Br J Dermatol. 2020;183:606-607.
    PubMed    


  350. CASELLI D, Chironna M, Loconsole D, Nigri L, et al
    No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
    Br J Dermatol. 2020;183:784-785.
    PubMed    


  351. NAIK HB, Alhusayen R, Frew J, Guilbault S, et al
    Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices.
    Br J Dermatol. 2020;183:780-781.
    PubMed    


  352. SANTONJA C, Heras F, Nunez L, Requena L, et al
    COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
    Br J Dermatol. 2020;183:778-780.
    PubMed    


  353. COLMENERO I, Santonja C, Alonso-Riano M, Noguera-Morel L, et al
    SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Br J Dermatol. 2020;183:729-737.
    PubMed     Abstract available


  354. MOHD MUSTAPA MF, de Berker D, McGregor JM, Exton LS, et al
    Suspension of marketing authorization for ingenol mebutate.
    Br J Dermatol. 2020;183:792.
    PubMed    


  355. POPE E
    Epidermolysis bullosa: a 2020 perspective.
    Br J Dermatol. 2020;183:603.
    PubMed    


  356. BLOME C
    Percentage of scalp-hair loss as a primary endpoint in alopecia areata trials.
    Br J Dermatol. 2020;183:609.
    PubMed    


  357. CLARK KEN, Denton CP
    The patient knows best: a new self-reported outcome measure for systemic sclerosis.
    Br J Dermatol. 2020;183:610.
    PubMed    


  358. STEEB T, Heppt MV, Berking C
    Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
    Br J Dermatol. 2020;183:612.
    PubMed    


  359. HAUGAARD JH, Egeberg A
    Do we need to fear methotrexate?
    Br J Dermatol. 2020;183:608-609.
    PubMed    


    September 2020
  360. SILVERBERG JI, Toth D, Bieber T, Alexis AF, et al
    Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19573.
    PubMed     Abstract available


  361. WOLLENBERG A, Blauvelt A, Guttman-Yassky E, Worm M, et al
    Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19574.
    PubMed     Abstract available


  362. REDDY R, Pannu S, Fiumara K, Kahn J, et al
    Efficacy of in-class IL-23 inhibitor switching: Risankizumab following Guselkumab failure in moderate-to-severe psoriasis treatment.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19575.
    PubMed     Abstract available


  363. NETTIS E, Fabbrocini G, Ortoncelli M, Pellacani G, et al
    Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19577.
    PubMed     Abstract available


  364. CORK MJ, Thaci D, Eichenfield LF, Arkwright PD, et al
    Dupilumab provides favourable long-term safety and efficacy in children aged >/= 6 to < 12 years with uncontrolled, severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.
    Br J Dermatol. 2020 Sep 24. doi: 10.1111/bjd.19460.
    PubMed     Abstract available


  365. POLAK ME
    Early life regulation of inflammation in atopic dermatitis by microRNA.
    Br J Dermatol. 2020 Sep 20. doi: 10.1111/bjd.19475.
    PubMed    


  366. JOHNSON MC, Heron CE, Feldman SR
    Long-term efficacy of certolizumab pegol for psoriasis.
    Br J Dermatol. 2020 Sep 20. doi: 10.1111/bjd.19537.
    PubMed    


  367. LEUTZ A, Pinter A, Thaci D, Augustin M, et al
    Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment.
    Br J Dermatol. 2020 Sep 17. doi: 10.1111/bjd.19558.
    PubMed     Abstract available


  368. VALENTIN F, Wiegmann H, Tarinski T, Nikolenko H, et al
    Development of a Pathogenesis-Based Therapy for Peeling Skin Syndrome Type 1.
    Br J Dermatol. 2020 Sep 14. doi: 10.1111/bjd.19546.
    PubMed     Abstract available


  369. SALMAN A
    What determines the treatment persistence in paediatric psoriasis?
    Br J Dermatol. 2020 Sep 10. doi: 10.1111/bjd.19436.
    PubMed    


  370. DELALEU J, Battistella M, Rathana K, Vignon-Pennamen MD, et al
    Identification of Clonal Skin Myeloid Cells by Next Generation Sequencing in Myelodysplasia Cutis.
    Br J Dermatol. 2020 Sep 10. doi: 10.1111/bjd.19547.
    PubMed     Abstract available


  371. THOMPSON LL, Chang MS, McCormack L, Polyakov N, et al
    Patterns of cutaneous immune-related adverse events in adults and children with advanced sarcoma: A retrospective cohort study.
    Br J Dermatol. 2020 Sep 7. doi: 10.1111/bjd.19540.
    PubMed     Abstract available


  372. MIRZA FN, Yumeen S, Walter FM
    The Epidemiology of Malignant Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma in the United Kingdom from 2004-2014: A Population-Based Cohort Analysis using the Clinical Practice Research Datalink.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19542.
    PubMed     Abstract available


  373. FANG MM, Nowinski CJ, Lai J, Shaunfield S, et al
    Characteristics and Impacts of Itch in Children with Inflammatory Skin Disorders.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19541.
    PubMed     Abstract available


  374. THOMPSON LL, Chen ST
    Tocilizumab and other targeted therapies for severe cutaneous immune-related adverse events.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19322.
    PubMed    


  375. MOSTAFA A, Murata T, Kabashima K
    Light in the dark: distinct effects of dimethyl fumarate on different T-cell subsets in psoriasis treatment.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19407.
    PubMed    


  376. ELSARAFY S, Tobiss H, Veitch D, Bhuchar M, et al
    Ruptured hair follicles of the scalp mimicking malignant melanoma.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19476.
    PubMed    


  377. NAVARRO-NAVARRO I, Jimenez-Gallo D, Valenzuela-Ubina S, Dominguez-Gomez M, et al
    Infantile bullous pemphigoid following serogroup B meningococcal vaccination.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19480.
    PubMed    


  378. CHO SI, Kim YE, Jo SJ
    Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.
    Br J Dermatol. 2020 Sep 2. doi: 10.1111/bjd.19507.
    PubMed     Abstract available


  379. DAVILA-SEIJO P
    Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed.
    Br J Dermatol. 2020 Sep 2. doi: 10.1111/bjd.19434.
    PubMed    


  380. BLAUVELT A, Leonardi C, Elewski B, Crowley JJ, et al
    A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 24-Week Efficacy and Safety Results from a Randomised, Double-Blinded Trial.
    Br J Dermatol. 2020 Sep 2. doi: 10.1111/bjd.19509.
    PubMed     Abstract available



  381. Assessing work-related productivity loss and indirect costs of psoriasis across six countries.
    Br J Dermatol. 2020;183:e65-e90.
    PubMed     Abstract available


  382. GABES M
    Are existing quality-of-life instruments in cutaneous T-cell lymphoma of sufficient quality?
    Br J Dermatol. 2020 Sep 1. doi: 10.1111/bjd.19408.
    PubMed    


  383. ORMEROD AD
    Spoiled for choice? Are you confused by the number of biological options for psoriasis?
    Br J Dermatol. 2020 Sep 1. doi: 10.1111/bjd.19401.
    PubMed    


  384. KORKMAZ P, Boyvat A
    The importance of provided information in contact allergy: key predictors on the road to success in the control of allergic contact dermatitis.
    Br J Dermatol. 2020 Sep 1. doi: 10.1111/bjd.19432.
    PubMed    


  385. KIM Y, Jorgenson E, Asgari MM
    Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.
    Br J Dermatol. 2020;183:415-416.
    PubMed    


  386. HAMPTON PJ
    Expanding treatment options for rosacea.
    Br J Dermatol. 2020;183:412-413.
    PubMed    


  387. DRABO EF, Levy JF, Gaskin DJ
    Yes, accurately measuring and valuing health-related productivity loss is important, but can we afford any longer not to prevent and address it?
    Br J Dermatol. 2020;183:420-421.
    PubMed    


  388. PATTINSON R, Bundy C
    Self-management: PROMs can prompt support.
    Br J Dermatol. 2020;183:418-419.
    PubMed    


    August 2020
  389. GAWKRODGER DJ, Hunter JAA
    Skin disease case mix in the early 1920s: diagnoses prevalent at the time of the founding of the British Association of Dermatologists.
    Br J Dermatol. 2020 Aug 31. doi: 10.1111/bjd.19506.
    PubMed     Abstract available


  390. MALHI IS, Yiu ZZN
    Algorithm based smartphone apps to assess risk of skin cancer in adults: critical appraisal of a systematic review.
    Br J Dermatol. 2020 Aug 31. doi: 10.1111/bjd.19502.
    PubMed     Abstract available


  391. OLSEN CM, Pandeya N, Dusingize JC, Thompson BS, et al
    Reproductive factors, hormone use and melanoma risk: an Australian prospective cohort study.
    Br J Dermatol. 2020 Aug 27. doi: 10.1111/bjd.19498.
    PubMed     Abstract available


  392. MULDER EEAP, Dwarkasing JT, Tempel D, van A, et al
    Validation of a Clinicopathological and Gene Expression Profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma.
    Br J Dermatol. 2020 Aug 26. doi: 10.1111/bjd.19499.
    PubMed     Abstract available


  393. WADE R, Sharif-Hurst S, Smith C, Dias S, et al
    Characteristics modifying response to biologic treatments for psoriasis: considering subgroups in network meta-analysis.
    Br J Dermatol. 2020 Aug 19. doi: 10.1111/bjd.19494.
    PubMed     Abstract available


  394. D'INCAN M, Ingen-Housz-Oro S, Beylot-Barry M, Joly P, et al
    Locoregional nodal extension does not impair prognosis of primary cutaneous anaplastic lymphomas.
    Br J Dermatol. 2020 Aug 18. doi: 10.1111/bjd.19495.
    PubMed     Abstract available


  395. CHIRICO A, Henderson Berg MH, Roberge D, Pehr K, et al
    Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma.
    Br J Dermatol. 2020 Aug 15. doi: 10.1111/bjd.19490.
    PubMed     Abstract available


  396. SHAPANIS A, Lai C, Smith S, Coltart G, et al
    Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.
    Br J Dermatol. 2020 Aug 13. doi: 10.1111/bjd.19485.
    PubMed     Abstract available


  397. DE BENEDETTO A
    Tight junctions in the skin: still a lot to learn.
    Br J Dermatol. 2020 Aug 10. doi: 10.1111/bjd.19390.
    PubMed    


  398. MAHON C, McHugh K, Alband N, Rampling D, et al
    Routine liver ultrasound screening does not alter clinical management in a cohort study of multiple cutaneous infantile haemangioma.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19472.
    PubMed     Abstract available


  399. LONG F, He F, Wang J, Wang L, et al
    Nail fold capillary abnormalities: a possible cause for nail psoriasis?
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19466.
    PubMed     Abstract available


  400. KIM HS, Ahn HS
    Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea': reply from authors.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19465.
    PubMed     Abstract available


  401. CALEY MP, Martins VL, Moore K, Lashari M, et al
    Loss of Laminin alpha3 induces cell invasion and macrophage infiltration in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19471.
    PubMed     Abstract available


  402. REDDY VD, Myers BA, Chan SY, Thibodeaux QG, et al
    A review of current phase III clinical trials of plaque psoriasis: Underrepresentation of non-white subjects and need for reform.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19468.
    PubMed     Abstract available


  403. TOUSSAINT F, Erdmann M, Grosch E, Schliep S, et al
    Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19470.
    PubMed     Abstract available


  404. HINDELANG B, Aguirre J, Berezhnoi A, Biedermann T, et al
    Quantification of skin sensitivity to ultraviolet radiation using ultra-wideband optoacoustic mesoscopy.
    Br J Dermatol. 2020 Aug 6. doi: 10.1111/bjd.19463.
    PubMed     Abstract available


  405. NAPOLITANO M, Caiazzo G, Fabbrocini G, Balato A, et al
    Increased expression of IL-23A in lesional skin of atopic dermatitis patients with psoriasiform reaction during dupilumab treatment.
    Br J Dermatol. 2020 Aug 6. doi: 10.1111/bjd.19464.
    PubMed     Abstract available


  406. RUSSELL E, Walker S, McPherson T
    Diagnosis of Mycoplasma aetiology in Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.
    Br J Dermatol. 2020 Aug 5. doi: 10.1111/bjd.19458.
    PubMed     Abstract available


  407. SILVERBERG JI, Lei D, Yousaf M, Janmohamed SR, et al
    What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study.
    Br J Dermatol. 2020 Aug 5. doi: 10.1111/bjd.19457.
    PubMed     Abstract available


  408. SAMIMI M, Kelleners-Smeets N
    Innovative devices for actinic keratoses: a hot-button issue.
    Br J Dermatol. 2020;183:197-199.
    PubMed    


  409. NIXON J
    Silicone dressings for pressure ulcer prevention.
    Br J Dermatol. 2020;183:200-201.
    PubMed    


  410. PRIOR J
    Understanding how young people perceive acne and acne treatments.
    Br J Dermatol. 2020;183:208-209.
    PubMed    


  411. MEIER K, Ghoreschi K
    Among the brightest antipsoriatic stars.
    Br J Dermatol. 2020;183:201-202.
    PubMed    


  412. MAGIN P
    A novel approach to understanding potential risk factors for venous leg ulceration.
    Br J Dermatol. 2020;183:207-208.
    PubMed    


  413. ARENTS BWM, Leonardi-Bee J
    Eczema and water hardness: another piece of the puzzle found?
    Br J Dermatol. 2020;183:203-204.
    PubMed    


  414. PATEL ZS, Hoffman LK, Sutton L, Cohen SR, et al
    The patient experience of pain in hidradenitis suppurativa.
    Br J Dermatol. 2020;183:401-402.
    PubMed    


    July 2020
  415. SPEECKAERT R, Lambert J, Delbaere L, Lesseliers T, et al
    The reliability of the self-assessment cutaneous inflammatory disease extent score (SA-CIDES) and the rule of hands to assess the involved body surface area in psoriasis and eczema.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19430.
    PubMed     Abstract available


  416. KITTLER H, Tschandl P, Weninger W
    Cutaneous signs in SARS CoV-2 infection: A plea for more rigorous peer-review in the time of COVID-19.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19429.
    PubMed     Abstract available


  417. CLAYTON K, Vallejo A, Sirvent S, Davies J, et al
    Machine learning applied to atopic dermatitis transcriptome reveals distinct therapy-dependent modification of the keratinocyte immunophenotype.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19431.
    PubMed     Abstract available


  418. PEREYRA-RODRIGUEZ JJ, Dominguez-Cruz J, Ruiz-Villaverde R, Silvestre JF, et al
    Drug survival of systemic and biologic treatments for moderate-to-severe atopic dermatitis in adults: a multicenter retrospective observational study.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19428.
    PubMed     Abstract available


  419. MIRZA FN, Yumeen S, Girardi M
    Disparities in Outcomes of CD8(+) Cutaneous T Cell Lymphoma by Race and Presenting Lesion Location.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19426.
    PubMed     Abstract available


  420. WILKINSON MJ, Gyorki DE
    Extent of ulceration in cutaneous melanoma: is this biomarker ready for primetime?
    Br J Dermatol. 2020 Jul 29. doi: 10.1111/bjd.19386.
    PubMed    


  421. DAYAL JHS, Mason SM, Salas-Alanis JC, McGrath JA, et al
    Heterogeneous addiction to TGFbeta signalling in recessive dystrophic epidermolysis bullosa associated cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Jul 29. doi: 10.1111/bjd.19421.
    PubMed     Abstract available


  422. GLOOR AD, Feldmeyer L, Rammlmair A, Schlapbach C, et al
    A relapsing localized variant of neutrophilic dermatosis triggered by tissue injury.
    Br J Dermatol. 2020 Jul 29. doi: 10.1111/bjd.19418.
    PubMed     Abstract available


  423. RAFEI-SHAMSABADI D
    GNAQ/11 mutant nonuveal melanoma: same same but different.
    Br J Dermatol. 2020 Jul 28. doi: 10.1111/bjd.19335.
    PubMed    


  424. JIANG X, Lin Z, Wang H
    Multiple lentigines and cutaneous hyperpigmentation caused by a KIT mutation.
    Br J Dermatol. 2020 Jul 27. doi: 10.1111/bjd.19295.
    PubMed    


  425. SMRKE A, Benson C
    Eribulin for recurrent cutaneous angiosarcoma.
    Br J Dermatol. 2020 Jul 27. doi: 10.1111/bjd.19333.
    PubMed    


  426. LANGTRY J, Rajan N
    Pre-emptive intra-auricular electrosurgical resurfacing of cylindromas to prevent conductive deafness in CYLD cutaneous syndrome.
    Br J Dermatol. 2020 Jul 27. doi: 10.1111/bjd.19331.
    PubMed    


  427. SHEEN YS, Chu CY
    Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma.
    Br J Dermatol. 2020 Jul 22. doi: 10.1111/bjd.19416.
    PubMed    


  428. O'SHAUGHNESSY RFL
    Ubiquitin, a novel therapeutic target in psoriasis?
    Br J Dermatol. 2020 Jul 21. doi: 10.1111/bjd.19332.
    PubMed    


  429. DURACK A, Holden ST, Burrows NP
    Congenital bilateral scar-like lesions on the face.
    Br J Dermatol. 2020 Jul 21. doi: 10.1111/bjd.19328.
    PubMed    


  430. BEHBAHANI S, Malerba S, Samie FH
    Racial and Ethnic Differences in the Clinical Presentation and Outcomes of Acral Lentiginous Melanoma.
    Br J Dermatol. 2020 Jul 19. doi: 10.1111/bjd.19406.
    PubMed     Abstract available


  431. DRUCKER AM
    Is baricitinib up next for atopic dermatitis?
    Br J Dermatol. 2020 Jul 13. doi: 10.1111/bjd.19226.
    PubMed    


  432. GOETH H, Koller M, Hegemann MV, Drexler K, et al
    Active versus standard sun protection in patients with melanoma stage I or II: A randomised controlled feasibility trial assessing compliance with sun protection and quality of life.
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19395.
    PubMed     Abstract available


  433. BAI X, Flaherty KT
    Targeted and immunotherapies in BRAF mutant melanoma - where we are standing and what to expect.
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19394.
    PubMed     Abstract available


  434. REICH A
    Reliable assessment of atopic dermatitis severity: do we need more tools?
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19392.
    PubMed     Abstract available


  435. GORDON KB, Warren RB, Gottlieb AB, Blauvelt A, et al
    Long-Term Efficacy of Certolizumab Pegol for the Treatment of Plaque Psoriasis: Three-Year Results from Two Randomised Phase 3 Trials (CIMPASI-1 and CIMPASI-2).
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19393.
    PubMed     Abstract available


  436. REICH K, Korber A, Mrowietz U, Sticherling M, et al
    Secukinumab two weekly versus four weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study.
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19398.
    PubMed     Abstract available


  437. NUSSBAUM L, Chen YL, Ogg GS
    Role of regulatory T cells in psoriasis pathogenesis and treatment.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19380.
    PubMed     Abstract available


  438. WOLINER-VAN DER WEG W, Peppelman M, Elshot YS, Visch MB, et al
    Biopsy Outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19381.
    PubMed     Abstract available


  439. PEINEMANN F, Harari M, Peternel S, Chan T, et al
    Indoor salt water baths followed by artificial ultraviolet B-light for chronic plaque psoriasis: abridged Cochrane review.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19385.
    PubMed     Abstract available


  440. ALFONSO JH, Martinsen JI, Weiderpass E, Pukkala E, et al
    Occupation and cutaneous melanoma: a 45-year historical cohort study of 14.9 million people in five Nordic countries.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19379.
    PubMed     Abstract available


  441. HAY RJ
    A viral rash: the impact of COVID-19 infection on the skin.
    Br J Dermatol. 2020;183:1-2.
    PubMed    



  442. A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis.
    Br J Dermatol. 2020;183:e4-e30.
    PubMed     Abstract available


  443. LIM SYD, Tey HL
    Response to: "Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases": Vesicular eruption in COVID-19 - to exclude varicella.
    Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19347.
    PubMed     Abstract available



  444. Five common skin manifestations of COVID-19 identified.
    Br J Dermatol. 2020;183:e16.
    PubMed     Abstract available



  445. Identificadas las principales manifestaciones en la piel de la COVID-19.
    Br J Dermatol. 2020;183:e17.
    PubMed     Abstract available


  446. DOIRON P
    Topical condyloma treatment: comparative evidence for a common problem.
    Br J Dermatol. 2020;183:5-6.
    PubMed    


  447. ACHARYA P, Mathur M
    Low-dose naltrexone in Hailey-Hailey disease: the importance of dosing.
    Br J Dermatol. 2020;183:193.
    PubMed    


  448. SHEN MX, Chen X
    Minimally important change: approach to interpretation of patient-reported outcomes.
    Br J Dermatol. 2020;183:8-9.
    PubMed    


    June 2020
  449. WARREN RB, Blauvelt A, Poulin Y, Beeck S, et al
    Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial.
    Br J Dermatol. 2020 Jun 28. doi: 10.1111/bjd.19341.
    PubMed     Abstract available


  450. LEE JYW, McGrath JA
    Mutations in genes encoding desmosomal proteins: spectrum of cutaneous and extracutaneous abnormalities.
    Br J Dermatol. 2020 Jun 27. doi: 10.1111/bjd.19342.
    PubMed     Abstract available


  451. MERAD Y, Behague L, Valot S, Basmaciyan L, et al
    Epigastric cutaneous discharge: think amoebiasis.
    Br J Dermatol. 2020 Jun 25. doi: 10.1111/bjd.19246.
    PubMed    


  452. GALVAN-CASAS C, Catala A, Carretero Hernandez G, Garcia-Doval I, et al
    Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from authors.
    Br J Dermatol. 2020 Jun 22. doi: 10.1111/bjd.19317.
    PubMed     Abstract available


  453. FERNANDEZ AP
    QuantiFERON TB-gold conversion is not uncommon in psoriasis patients under anti-TNF-alpha: reply from author.
    Br J Dermatol. 2020 Jun 22. doi: 10.1111/bjd.19316.
    PubMed     Abstract available


  454. DE BRUIN-WELLER M
    Systemic treatment in atopic dermatitis after 2018: from experienced-based treatment to evidence-based treatment?
    Br J Dermatol. 2020 Jun 21. doi: 10.1111/bjd.19227.
    PubMed    


  455. MAHIL SK, Ezejimofor MC, Exton LS, Manounah L, et al
    Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.
    Br J Dermatol. 2020 Jun 20. doi: 10.1111/bjd.19325.
    PubMed     Abstract available


  456. GHADIRI SJ, Brennan P, Calonje E, Carmichael AJ, et al
    Co-inheritance of Naevoid Basal Cell Carcinoma Syndrome and Neurofibromatosis Type 1 associated with an exceptional spectrum of tumours.
    Br J Dermatol. 2020 Jun 20. doi: 10.1111/bjd.19324.
    PubMed     Abstract available


  457. VERHAGE EJ, Nelemans PJ, van Kuijk SMJ, Christiaans MHL, et al
    External validation of a model to predict risk of keratinocyte skin cancer after a renal transplantation in a Western European cohort.
    Br J Dermatol. 2020 Jun 20. doi: 10.1111/bjd.19326.
    PubMed     Abstract available


  458. GALVAN CASAS C, Catala A, Carretero Hernandez G, Garcia-Doval I, et al
    SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from the authors.
    Br J Dermatol. 2020 Jun 17. doi: 10.1111/bjd.19321.
    PubMed     Abstract available


  459. OOSTERHAVEN JAF
    How to measure itch in atopic dermatitis?
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19225.
    PubMed    


  460. NALDI L
    Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemic.
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19190.
    PubMed    


  461. HOLLESTEIN LM, Nijsten T
    Survival is excellent for most patients with thin melanoma, but patients may die from thin melanoma.
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19208.
    PubMed    


  462. DRAGO F, Ciccarese G, Rebora A, Muzic SI, et al
    Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations.
    Br J Dermatol. 2020 Jun 13. doi: 10.1111/bjd.19311.
    PubMed     Abstract available


  463. MEGNA M, Ruggiero A, Ferrillo M, Fabbrocini G, et al
    QuantiFERON TB-gold conversion is not uncommon in psoriasis patients under anti-TNF-alpha.
    Br J Dermatol. 2020 Jun 12. doi: 10.1111/bjd.19310.
    PubMed     Abstract available


  464. BLAUVELT A, Paul C, van de Kerkhof P, Warren RB, et al
    Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomised, Placebo-Controlled Studies.
    Br J Dermatol. 2020 Jun 12. doi: 10.1111/bjd.19314.
    PubMed     Abstract available


  465. VEYSEY E
    Biologics for psoriasis: what does drug survival tell us?
    Br J Dermatol. 2020 Jun 10. doi: 10.1111/bjd.19189.
    PubMed    


  466. JARRETT P
    What are the barriers to physical activity in patients with chronic plaque psoriasis?
    Br J Dermatol. 2020 Jun 10. doi: 10.1111/bjd.19209.
    PubMed    


  467. OLSEN CM
    Global trends in melanoma mortality differ by sex and age.
    Br J Dermatol. 2020 Jun 8. doi: 10.1111/bjd.19166.
    PubMed    


  468. BRUINS FM, Bronckers IMGJ, Cai R, Groenewoud HMM, et al
    Treatment persistence in paediatric and adolescent psoriasis patients followed into young adulthood: from topical to systemic treatment - a prospective, longitudinal, observational cohort study of 448 patients.
    Br J Dermatol. 2020 Jun 8. doi: 10.1111/bjd.19301.
    PubMed     Abstract available


  469. BHAT TS, Herbosa CM, Rosenberg AR, Sogade O, et al
    Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.
    Br J Dermatol. 2020 Jun 8. doi: 10.1111/bjd.19298.
    PubMed     Abstract available


  470. MANRIQUE-SILVA E, Rachakonda S, Millan-Esteban D, Garcia-Casado Z, et al
    Clinical, environmental, and histological distribution of BRAF, NRAS and TERT promoter mutations among cutaneous melanoma patients. A retrospective study of 563 patients.
    Br J Dermatol. 2020 Jun 7. doi: 10.1111/bjd.19297.
    PubMed     Abstract available


  471. EARNSHAW CH, Hunter HJA, McMullen E, Griffiths CEM, et al
    Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.
    Br J Dermatol. 2020 Jun 4. doi: 10.1111/bjd.19267.
    PubMed     Abstract available


  472. MARZANO AV, Cassano N, Genovese G, Moltrasio C, et al
    Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19264.
    PubMed     Abstract available


  473. QUAGLINO P, Prince HM, Cowan R, Vermeer M, et al
    Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study).
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19252.
    PubMed     Abstract available


  474. CARUGNO A, Sena P, Raponi F, Robustelli Test E, et al
    Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19266.
    PubMed     Abstract available


  475. REICH K, Sullivan J, Arenberger P, Jazayeri S, et al
    Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19262.
    PubMed     Abstract available


  476. NOUSBECK J, McAleer MA, Hurault G, Kenny E, et al
    miRNA analysis of Childhood Atopic Dermatitis reveals a role for miR-451a.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19254.
    PubMed     Abstract available


  477. WOLLENBERG A, Beck LA, Blauvelt A, Simpson EL, et al
    Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.
    Br J Dermatol. 2020;182:e186-e209.
    PubMed     Abstract available


  478. TAO J, Song Z, Yang L, Huang C, et al
    Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department.
    Br J Dermatol. 2020;182:1477-1478.
    PubMed    


  479. VAN ZUUREN EJ, Arents BWM, Flohr C, Ingram JR, et al
    Publication of national dermatology guidelines as a Research Letter in the BJD: can less ever be enough?
    Br J Dermatol. 2020;182:1319-1320.
    PubMed    


  480. FIFE K
    Hedgehog pathway inhibitors come of age.
    Br J Dermatol. 2020;182:1322-1323.
    PubMed    


  481. WEISS JM
    Osteopontin regulatory functions in the hair follicle open a therapeutic approach for hypertrichosis.
    Br J Dermatol. 2020;182:1324-1325.
    PubMed    


  482. LAIMER M
    Growth profile and anaemia in children with epidermolysis bullosa.
    Br J Dermatol. 2020;182:1327-1328.
    PubMed    


  483. WEHNER MR
    Comparing the efficacy of field treatments for actinic keratosis: a critical appraisal of a randomized trial in the New England Journal of Medicine.
    Br J Dermatol. 2020;182:1343-1344.
    PubMed     Abstract available


  484. BELLON N, Hadj-Rabia S, Moulin F, Lambe C, et al
    The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19265.
    PubMed     Abstract available


    May 2020
  485. JANDA M, Swetter SM, Horsham C, Soyer HP, et al
    Virtual melanoma checks during a pandemic.
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19255.
    PubMed     Abstract available


  486. GOODRUM CA, Leighton PA, Simpson RC
    Outcome domains in Lichen Sclerosus.
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19253.
    PubMed     Abstract available


  487. LESTER JC, Jia JL, Zhang L, Okoye GA, et al
    Absence of Skin of Colour Images in Publications of COVID-19 Skin Manifestations.
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19258.
    PubMed     Abstract available


  488. HARDMAN-SMART JA, Purba TS, Panicker S, Farjo B, et al
    Does mitochondrial dysfunction of hair follicle epithelial stem cells play a role in the pathobiology of lichen planopilaris?
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19259.
    PubMed     Abstract available


  489. HUGHES M, Rogers S, Lepri G, Bruni C, et al
    Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
    Br J Dermatol. 2020 May 27. doi: 10.1111/bjd.19243.
    PubMed     Abstract available


  490. AFACH S, Chaimani A, Evrenoglou T, Penso L, et al
    Meta-analysis results do not reflect the real safety of biologics in psoriasis.
    Br J Dermatol. 2020 May 23. doi: 10.1111/bjd.19244.
    PubMed     Abstract available


  491. SULAIMANI J, Cluxton D, Clowry J, Petrasca A, et al
    Dimethyl fumarate modulates the Treg:Th17 cell axis in psoriasis patients.
    Br J Dermatol. 2020 May 21. doi: 10.1111/bjd.19229.
    PubMed     Abstract available


  492. GAMBICHLER T, Steuke AK, Schmitz L, Stockfleth E, et al
    Altered hydroxymethylation in cutaneous squamous cell carcinoma and keratoacanthoma.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19219.
    PubMed     Abstract available


  493. MARRA E, van Rijsingen MCJ, Alkemade JAC, Groenewoud JMM, et al
    The effect of a dermato-oncologic training program on the diagnostic skills and quality of referrals for suspicious skin lesions by general practitioners.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19214.
    PubMed     Abstract available


  494. WAN MT, Takeshita J
    Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis: a critical appraisal.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19216.
    PubMed     Abstract available


  495. BEHBAHANI S, Malerba S, Samie FH
    Acral Lentiginous Melanoma: Clinicopathologic Characteristics and Survival Outcomes in the United States National Cancer Database 2004 -2016.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19211.
    PubMed     Abstract available


  496. LLAMAS-VELASCO M, Munoz-Hernandez P, Lazaro-Gonzalez J, Reolid-Perez A, et al
    Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19222.
    PubMed     Abstract available


  497. DANGIEN A, Ram-Wolff C, Brice P, Battistella M, et al
    Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19220.
    PubMed     Abstract available


  498. BURGER B, Ghosh A, Ng CKY, Piscuoglio S, et al
    Discovery of heterozygous KRT10 alterations in MAUIE patients underlines the importance of regular skin cancer screening in ichthyosis with confetti-patients.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19218.
    PubMed     Abstract available


  499. REN F, Bai X, Elston DM
    Erythroderma in a newborn infant suggesting Omenn syndrome.
    Br J Dermatol. 2020 May 12. doi: 10.1111/bjd.19138.
    PubMed    


  500. MITRI F, Haenssle H, Enk A, Toberer F, et al
    Congenital multiple clustered dermatofibroma on the abdomen.
    Br J Dermatol. 2020 May 10. doi: 10.1111/bjd.19139.
    PubMed    


  501. TALAGANIS JA, Gregoriou S, Stratigos AJ
    Stress and melanoma. Myth or reality?
    Br J Dermatol. 2020 May 10. doi: 10.1111/bjd.19035.
    PubMed    


  502. TAKESHITA J
    Taking aim at identifying treatment targets for psoriasis.
    Br J Dermatol. 2020;182:1075-1076.
    PubMed    


  503. RUTTER KJ, Ashraf I, Cordingley L, Rhodes LE, et al
    A review of studies looking at quality of life and psychological impact in people with photodermatoses - skin diseases triggered by sunlight.
    Br J Dermatol. 2020;182:e161-e182.
    PubMed     Abstract available


  504. ISKANDAR IYK, Parisi R, Griffiths CEM, Ashcroft DM, et al
    Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender.
    Br J Dermatol. 2020 May 1. doi: 10.1111/bjd.19169.
    PubMed     Abstract available


  505. SCORER M, Setterfield JF, Harman KE
    Rituximab with prednisolone as first-line treatment in pemphigus vulgaris.
    Br J Dermatol. 2020;182:1078-1079.
    PubMed    


  506. WALBURN J, Sarkany RPE
    Quality of life in the photodermatoses: the hidden toll of photosensitivity.
    Br J Dermatol. 2020;182:1077.
    PubMed    


  507. THORNTON MJ
    Shedding more light on photoageing.
    Br J Dermatol. 2020;182:1086-1087.
    PubMed    


  508. VAN LAARHOVEN AIM, Holle H
    Optimizing audiovisual itch induction: the role of attention and expectancy.
    Br J Dermatol. 2020;182:1088-1089.
    PubMed    


  509. ELEWSKI B
    Rosacea treatment: a patient-centric approach.
    Br J Dermatol. 2020;182:1090-1091.
    PubMed    


  510. STROWD LC, Feldman SR
    A hands-off approach may be more successful in treating chronic hand eczema.
    Br J Dermatol. 2020;182:1078.
    PubMed    


  511. BASHYAM AM, Feldman SR
    Dermatology Life Quality Index: does improving the instrument make it better?
    Br J Dermatol. 2020;182:1082-1083.
    PubMed    


  512. ARDELEANU M, Shumel B, Rossi AB, Graham NMH, et al
    Response to R. Waldman et al.: 'Does IL-4 inhibition play a role in dupilumab-associated conjunctivitis?'
    Br J Dermatol. 2020;182:1310-1312.
    PubMed    


    April 2020
  513. AHOUACH B, Harant S, Ullmer A, Martres P, et al
    Cutaneous lesions in a patient with COVID-19: are they related?
    Br J Dermatol. 2020 Apr 30. doi: 10.1111/bjd.19168.
    PubMed     Abstract available


  514. VALLERAND IA, Lewinson RT, Parsons LM, Lowerison MW, et al
    Depression as a risk factor for the development of psoriasis: a retrospective cohort study in the United Kingdom.
    Br J Dermatol. 2020 Apr 30. doi: 10.1111/bjd.19160.
    PubMed     Abstract available


  515. MAHIL SK, Yiu ZZN, Mason KJ, Dand N, et al
    Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19161.
    PubMed     Abstract available


  516. SILVERBERG JI, Lei D, Yousaf M, Janmohamed SR, et al
    Measurement properties of the Rajka-Langeland severity score in children and adults with atopic dermatitis.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19159.
    PubMed     Abstract available


  517. EL-CHAMI C, Foster AR, Johnson C, Clausen RP, et al
    Organic osmolytes increase expression of specific tight junction proteins in skin and alter barrier function in keratinocytes.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19162.
    PubMed     Abstract available


  518. GALVAN CASAS C, Catala A, Carretero Hernandez G, Rodriguez-Jimenez P, et al
    Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19163.
    PubMed     Abstract available


  519. GISONDI P, Facheris P, Dapavo P, Piaserico S, et al
    The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience.
    Br J Dermatol. 2020 Apr 28. doi: 10.1111/bjd.19158.
    PubMed     Abstract available


  520. PANDEYA N
    Rising incidence of basal cell carcinoma in women in Iceland: is it sunbed use?
    Br J Dermatol. 2020 Apr 27. doi: 10.1111/bjd.19114.
    PubMed    


  521. LIN Z, Niu Y, Jiang Y, Chen B, et al
    Protective effects of dietary fish-oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: A pilot randomised, double-blind, placebo-controlled trial.
    Br J Dermatol. 2020 Apr 25. doi: 10.1111/bjd.19156.
    PubMed     Abstract available


  522. VON KOBYLETZKI LB
    Partner bereavement can increase the incidence of atopic dermatitis but has no effect on psoriasis.
    Br J Dermatol. 2020 Apr 22. doi: 10.1111/bjd.19046.
    PubMed    


  523. JACHIET M, Bieuvelet S, Argoud AL, Vallee M, et al
    Sleep disturbance in atopic dermatitis: a case-control study using actigraphy and smartphone-collected questionnaires.
    Br J Dermatol. 2020 Apr 22. doi: 10.1111/bjd.19058.
    PubMed     Abstract available


  524. PALLER AS, Seyger MMB, Magarinos GA, Bagel J, et al
    Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Paediatric Patients with Moderate-to-Severe Plaque Psoriasis (IXORA-PEDS).
    Br J Dermatol. 2020 Apr 21. doi: 10.1111/bjd.19147.
    PubMed     Abstract available


  525. MURDOCH ME
    Mapping the burden of onchocercal skin disease.
    Br J Dermatol. 2020 Apr 17. doi: 10.1111/bjd.19143.
    PubMed     Abstract available


  526. ZOMORODI N, Butt M, Maczuga S, Marks J, et al
    Cost and Diagnostic Characteristics of Toxicodendron Dermatitis in the United States: A retrospective cross-sectional analysis.
    Br J Dermatol. 2020 Apr 15. doi: 10.1111/bjd.19130.
    PubMed     Abstract available


  527. HIBLER BP, Markova A
    Treatment of severe cutaneous adverse reaction with tocilizumab.
    Br J Dermatol. 2020 Apr 14. doi: 10.1111/bjd.19129.
    PubMed     Abstract available


  528. PAPP K, Menter A, Leonardi C, Soung J, et al
    Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomised phase 3 trial (AMAGINE-1).
    Br J Dermatol. 2020 Apr 14. doi: 10.1111/bjd.19132.
    PubMed     Abstract available


  529. VEYSEY E
    Choosing a biologic for psoriasis: is it a sprint or a marathon?
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19038.
    PubMed    


  530. LOTZ M, Budden T, Furney SJ, Viros A, et al
    Molecular subtype, biological sex and age shape melanoma tumour evolution.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19128.
    PubMed     Abstract available


  531. PORTELLI F, Galli F, Cattaneo L, Cossa M, et al
    The prognostic impact of the extent of ulceration in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI).
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19120.
    PubMed     Abstract available


  532. ROLLS S, Owen E, Bertram CG, Bourke JF, et al
    What's in? What's out? Updating the British Society for Cutaneous Allergy Facial Series.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19127.
    PubMed     Abstract available


  533. BASU P, Tong Y, Hinds BR, Schneider JA, et al
    Nivolumab-induced toxic epidermal necrolysis with retiform purpura.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19031.
    PubMed    


  534. DIZDAREVIC A, Troensegaard W, Uldahl A, Bergendorff O, et al
    Intervention Study to Evaluate the Importance of Information Given to Patients with Contact Allergy. A randomized, investigator-blinded clinical trial.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19119.
    PubMed     Abstract available


  535. ELEFTHERIADOU V, Roche L, Bourke JF, Buckley DA, et al
    Allergic contact dermatitis to non-methacrylate nail allergens in the UK.
    Br J Dermatol. 2020 Apr 10. doi: 10.1111/bjd.19116.
    PubMed     Abstract available


  536. DORR MM, Guignard R, Auger FA, Rochette PJ, et al
    The use of tissue-engineered skin to demonstrate the negative effect of CXCL5 on epidermal UV radiation-induced CPD repair efficiency.
    Br J Dermatol. 2020 Apr 9. doi: 10.1111/bjd.19117.
    PubMed     Abstract available


  537. MUTHIAH S, Polubothu S, Husain A, Oliphant T, et al
    A mosaic variant in MAP2K1 is associated with giant naevus-spilus type congenital melanocytic naevus and melanoma development.
    Br J Dermatol. 2020 Apr 9. doi: 10.1111/bjd.19118.
    PubMed     Abstract available


  538. AFRA TP, Namitha R, Khader A, Bishnoi A, et al
    Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: erythrocyanotic vascular patches associated with an underlying rib plasmacytoma.
    Br J Dermatol. 2020 Apr 9. doi: 10.1111/bjd.19037.
    PubMed    


  539. LIN P, Zhu S, Huang Y, Li L, et al
    Adverse Skin Reactions Among Healthcare Workers During the Coronavirus Disease 2019 Outbreak: A Survey in Wuhan and Its Surrounding Regions.
    Br J Dermatol. 2020 Apr 7. doi: 10.1111/bjd.19089.
    PubMed     Abstract available


  540. RAJAN MB, Budania A, Vishwajeet V
    Drawstring papules in an Indian woman.
    Br J Dermatol. 2020 Apr 6. doi: 10.1111/bjd.19032.
    PubMed    


  541. KIM MS, Lee S, Park SB, Kim KY, et al
    Magnolol induces adipogenic differentiation in human skin.
    Br J Dermatol. 2020 Apr 5. doi: 10.1111/bjd.19063.
    PubMed     Abstract available



  542. Revolutionizing Atopic Dermatitis, 5 April 2020.
    Br J Dermatol. 2020 Apr 3. doi: 10.1111/bjd.19043.
    PubMed    


  543. CUST AE
    Gene-environment interactions and melanoma risk.
    Br J Dermatol. 2020 Apr 1. doi: 10.1111/bjd.18986.
    PubMed    


  544. FERRIS LK
    Skin cancer screening: it's a matter of time.
    Br J Dermatol. 2020 Apr 1. doi: 10.1111/bjd.18974.
    PubMed    


  545. THOMPSON AR, Cockayne S
    It's the worry that got him in the end: the importance in treating melanoma holistically and dealing with fear of recurrence.
    Br J Dermatol. 2020;182:821-822.
    PubMed    


  546. SBIDIAN E, Le Cleach L
    'COre SUBgroup SETs (COSUBSET)' initiative is needed.
    Br J Dermatol. 2020;182:824-825.
    PubMed    


  547. WEHNER MR
    WHO can decrease indoor tanning?
    Br J Dermatol. 2020;182:824.
    PubMed    


  548. UTER W
    Patient recall may be of limited use in establishing the clinical relevance of positive patch test reactions (to fragrances).
    Br J Dermatol. 2020;182:831-832.
    PubMed    


  549. LUDWIG RJ
    Tissue-specific personalized medicine: the next level of individualized treatment.
    Br J Dermatol. 2020;182:833-834.
    PubMed    


  550. LACARRUBBA F, Verzi AE, Musumeci ML, Micali G, et al
    High capillary diameter in psoriatic plaques of the lower legs.
    Br J Dermatol. 2020;182:1064-1065.
    PubMed    


  551. NICHOLSON LT, Haemel A
    Outcome measures in dermatomyositis: quality of life and the patient perspective.
    Br J Dermatol. 2020;182:830-831.
    PubMed    


  552. COLEBUNDERS R, Wafula ST, Hotterbeekx A, Siewe-Fodjo JN, et al
    Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programmes.
    Br J Dermatol. 2020;182:1064.
    PubMed    


  553. HOWELLS L
    Knowing the score - it's not quite enough anymore.
    Br J Dermatol. 2020;182:828-829.
    PubMed    


  554. WALKER SL
    New therapeutics for leprosy.
    Br J Dermatol. 2020;182:837-838.
    PubMed    


  555. O'SHAUGHNESSY RFL
    Understanding actinic keratosis to reduce squamous cell carcinoma incidence.
    Br J Dermatol. 2020;182:834-835.
    PubMed    


  556. KOVACS D, Hegyi K, Szegedi A, Deak D, et al
    Isotretinoin is indirectly effective in sebocytes.
    Br J Dermatol. 2020;182:1052-1054.
    PubMed    


  557. FREW JW
    Putting nodule counts behind us: hidradenitis suppurativa outcome measures independent of descriptive semantics.
    Br J Dermatol. 2020;182:829-830.
    PubMed    


    March 2020
  558. BRANS R
    Hand dermatitis in nurses: is promotion of protective behaviour ineffective?
    Br J Dermatol. 2020 Mar 30. doi: 10.1111/bjd.18973.
    PubMed    


  559. YANG L, Zhang T, Zhang C, Xiao C, et al
    Upregulated E3 ligase Trim21 in psoriatic epidermis ubiquitylates NF-kappaB p65 subunit and promotes inflammation in keratinocytes.
    Br J Dermatol. 2020 Mar 30. doi: 10.1111/bjd.19057.
    PubMed     Abstract available


  560. FREDEAU L, Bohelay G, Shourick J, Piver D, et al
    Paraneoplastic neutrophilic leukemoid reaction in a melanoma patient: association between tumour volume and leukocytosis.
    Br J Dermatol. 2020 Mar 30. doi: 10.1111/bjd.19059.
    PubMed     Abstract available


  561. TRUONG A, Secrest AM, Fino NF, Laggis CW, et al
    Homeless status and associations with treatment disparities for common skin conditions.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19051.
    PubMed     Abstract available


  562. YIU ZZN, Parisi R, Lunt M, Warren RB, et al
    Risk of Hospitalisation and Death due to Infection in People with Psoriasis: a Population-based Cohort Study using the Clinical Practice Research Datalink.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19052.
    PubMed     Abstract available


  563. STAUGHTON RCD, Bridgett CK, Noren P, Goulding JMR, et al
    Habitual scratching amplifies and perpetuates atopic dermatitis.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19049.
    PubMed     Abstract available


  564. ROBINSON JK, Abou-El-Seoud D, Reavy R, Turrisi R, et al
    Persistence of partner-assisted skin self-examination supported by "being in this together": a randomized trial.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19048.
    PubMed     Abstract available


  565. ROBERT J, Tavernier E, Boccara O, Mashiah J, et al
    Modalities of use of oral propranolol in proliferative infantile hemangiomas: an international survey among practitioners.
    Br J Dermatol. 2020 Mar 27. doi: 10.1111/bjd.19047.
    PubMed     Abstract available


  566. FUJISAWA Y, Fujimura T, Matsushita S, Yamamoto Y, et al
    The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multi-center, prospective, observational study.
    Br J Dermatol. 2020 Mar 20. doi: 10.1111/bjd.19042.
    PubMed     Abstract available


  567. BEDAIR K, Elhadad A, Hamad S, Ferguson J, et al
    No association between whole-body UVA1 phototherapy and skin cancers in humans: a cancer registry linkage study.
    Br J Dermatol. 2020 Mar 20. doi: 10.1111/bjd.19041.
    PubMed     Abstract available


  568. KINOSHITA-ISE M
    Lichen planopilaris and frontal fibrosing alopecia: branches from the same tree bear different fruits.
    Br J Dermatol. 2020 Mar 20. doi: 10.1111/bjd.18972.
    PubMed    


  569. SMITH CH, Yiu ZZ, Bale T, Burden AD, et al
    British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020 - a rapid update.
    Br J Dermatol. 2020 Mar 18. doi: 10.1111/bjd.19039.
    PubMed     Abstract available


  570. PHILIPP S, Menter A, Nikkels AF, Barber K, et al
    Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients (>/=6 to <12 years of age): efficacy, safety, pharmacokinetic, and biomarker results from the open-label CADMUS Jr study.
    Br J Dermatol. 2020 Mar 16. doi: 10.1111/bjd.19018.
    PubMed     Abstract available


  571. JUNEJO MH, Kentley J, Rajpopat M, Tan XL, et al
    Therapeutic options for erosive pustular dermatosis of the scalp: a systematic review.
    Br J Dermatol. 2020 Mar 12. doi: 10.1111/bjd.19026.
    PubMed     Abstract available


  572. YEN H, Yen H, Chi CC
    Is psoriasis associated with dementia or cognitive impairment? A Critically Appraised Topic.
    Br J Dermatol. 2020 Mar 11. doi: 10.1111/bjd.19025.
    PubMed     Abstract available


  573. SCHNEEWEISS MC, Perez-Chada L, Gottlieb AB, Merola J, et al
    Older adults on systemic treatment for psoriasis and risk of infection: a propensity score matched population-based study.
    Br J Dermatol. 2020 Mar 11. doi: 10.1111/bjd.19028.
    PubMed     Abstract available


  574. MAJEED-ARISS R, McPhee M, McAteer H, Griffiths CEM, et al
    "Mind the gap": What patients and clinicians believe is "unknown" about psoriasis.
    Br J Dermatol. 2020 Mar 9. doi: 10.1111/bjd.19023.
    PubMed     Abstract available


  575. OLAMIJU B, Leventhal JS
    Near total body vitiligo secondary to immunotherapy for metastatic melanoma.
    Br J Dermatol. 2020 Mar 9. doi: 10.1111/bjd.18944.
    PubMed    


  576. PARK YM, Seo SJ
    Evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis is currently lacking.
    Br J Dermatol. 2020 Mar 5. doi: 10.1111/bjd.18895.
    PubMed    


  577. VON SCHUCKMANN LA, Khosrotehrani K, Ghiasvand R, Hughes MCB, et al
    Statins may reduce disease recurrence in patients with ulcerated primary melanoma.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19012.
    PubMed     Abstract available


  578. GISONDI P, Virga C, Piaserico S, Meneguzzo A, et al
    Switching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19013.
    PubMed     Abstract available


  579. ISAKSSON K, Mikiver R, Eriksson H, Lapins J, et al
    Survival in 31 670 patients with thin melanomas - a Swedish population-based study.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19015.
    PubMed     Abstract available


  580. YANG DD, Salciccioli JD, Marshall DC, Sheri A, et al
    Trends in malignant melanoma mortality in 31 countries from 1985 to 2015.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19010.
    PubMed     Abstract available


  581. WONG AYS, Froslev T, Dearing L, Forbes HJ, et al
    The association between partner bereavement and melanoma: cohort studies in the U.K. and Denmark.
    Br J Dermatol. 2020 Mar 3. doi: 10.1111/bjd.18889.
    PubMed     Abstract available


  582. YIU ZZN, Mason KJ, Hampton PJ, Reynolds NJ, et al
    Drug Survival of Adalimumab, Ustekinumab, and Secukinumab in Patients with Psoriasis: a Prospective Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18981.
    PubMed     Abstract available


  583. GOLLINS C, Shah A, Sinha K, Khan S, et al
    Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK.
    Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18982.
    PubMed     Abstract available


  584. HARADA K, Irisawa R, Ito T, Uchiyama M, et al
    The effectiveness of dupilumab in alopecia areata patients with atopic dermatitis: a case series of seven patients.
    Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18976.
    PubMed     Abstract available


  585. STEELE L, O'Toole EA
    Pachyonychia congenita, a paradigm for rare skin disorders.
    Br J Dermatol. 2020;182:521-522.
    PubMed    


  586. INGRAM J
    Editor's Choice: rare skin diseases themed issue.
    Br J Dermatol. 2020;182:ix.
    PubMed    


  587. OGDIE A, Eder L
    The need for strategies to address obesity and psoriatic arthritis prevention in psoriasis.
    Br J Dermatol. 2020;182:523-524.
    PubMed    


  588. MORDAUNT DA
    Sharing (data) is caring for patients with pachyonychia congenita.
    Br J Dermatol. 2020;182:537.
    PubMed    


  589. YOUSSEFIAN L, Vahidnezhad H
    Management of symptomatic mucosal involvement in paediatric pachyonychia congenita.
    Br J Dermatol. 2020;182:536-537.
    PubMed    


  590. THOMAS BR, Sahota A
    Pachyonychia congenita and botulinum toxin.
    Br J Dermatol. 2020;182:531-532.
    PubMed    


  591. LEUBE RE, Schwarz N
    Current mysteries of pachyonychia congenita.
    Br J Dermatol. 2020;182:525-526.
    PubMed    


  592. MATE K
    Itching for the right treatment.
    Br J Dermatol. 2020;182:541.
    PubMed    


  593. MOSS C
    Podiatrists gaining a foothold.
    Br J Dermatol. 2020;182:527-528.
    PubMed    


  594. NELSON PA
    Good practice in dermatological patient-reported outcome measure development: an example from localized scleroderma.
    Br J Dermatol. 2020;182:529.
    PubMed    


  595. VETTER A, Magin TM
    Old mitochondria accumulate in pachyonychia congenita.
    Br J Dermatol. 2020;182:529-530.
    PubMed    


  596. MAGLIE R, Hertl M
    Improving the diagnosis of autoimmune blistering dermatoses of the oral mucosa.
    Br J Dermatol. 2020;182:539-540.
    PubMed    


  597. UITTO J
    Epidermolysis bullosa: diagnostic guidelines in the laboratory setting.
    Br J Dermatol. 2020;182:526-527.
    PubMed    


  598. HAUSSER I
    Diagnosis of Ehlers-Danlos syndrome: data deficiency still does not allow establishment of a complete history of the disease and its pathomechanisms.
    Br J Dermatol. 2020;182:535-536.
    PubMed    


  599. DAMIANI G
    Apremilast does not appear to outlast methotrexate.
    Br J Dermatol. 2020;182:534-535.
    PubMed    


    February 2020
  600. JUNG F, Sibbald C, Bohdanowicz M, Ingram JR, et al
    Systematic Review of Efficacies and Adverse Effects of Treatments for Pityriasis Lichenoides.
    Br J Dermatol. 2020 Feb 28. doi: 10.1111/bjd.18977.
    PubMed     Abstract available


  601. AUKER L, Cordingley L, Pye DR, Griffiths CEM, et al
    What are the barriers to physical activity in patients with chronic plaque psoriasis?
    Br J Dermatol. 2020 Feb 27. doi: 10.1111/bjd.18979.
    PubMed     Abstract available


  602. SILVERBERG JI, Lai JS, Patel K, Singam V, et al
    Measurement properties of the PROMIS Itch Questionnaire - itch severity assessments in adults with atopic dermatitis.
    Br J Dermatol. 2020 Feb 27. doi: 10.1111/bjd.18978.
    PubMed     Abstract available


  603. UTER W, Gefeller O, Mahler V, Geier J, et al
    Trends and current spectrum of contact allergy in Central Europe: Results of the Information Network of Departments of Dermatology (IVDK), 2007 - 2018.
    Br J Dermatol. 2020 Feb 27. doi: 10.1111/bjd.18946.
    PubMed     Abstract available


  604. PROBY CM, Harwood CA
    Skin cancer burden in lung transplant recipients: we need to do better!
    Br J Dermatol. 2020 Feb 25. doi: 10.1111/bjd.18903.
    PubMed    


  605. CHI CC
    Dermoscopy and reflectance confocal microscopy for early diagnosis of amelanotic/hypomelanotic melanoma: still a long way to go?
    Br J Dermatol. 2020 Feb 23. doi: 10.1111/bjd.18893.
    PubMed    


  606. TAYLOR N
    Mercury exposure and nonmelanoma skin cancer: what're the odds?
    Br J Dermatol. 2020 Feb 23. doi: 10.1111/bjd.18919.
    PubMed    


  607. HALLING AS, Bager P, Skov L, Zachariae C, et al
    The interaction between filaggrin mutations and hard domestic water on the risk of early-onset atopic dermatitis.
    Br J Dermatol. 2020 Feb 21. doi: 10.1111/bjd.18965.
    PubMed     Abstract available


  608. SENCHYNA A, Simon S, Cisse H, Ginouves M, et al
    American Cutaneous Leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate.
    Br J Dermatol. 2020 Feb 20. doi: 10.1111/bjd.18964.
    PubMed     Abstract available


  609. CHOONG CK, Merola JF, Han J, Li X, et al
    Indoor tanning use is associated with psoriasis from the Nurses' Health Study II.
    Br J Dermatol. 2020 Feb 20. doi: 10.1111/bjd.18963.
    PubMed     Abstract available


  610. HWANG S, Johnson A, Fabbro S, Hastings J, et al
    Topical imiquimod monotherapy for indolent primary cutaneous B-cell lymphomas (PCBCL): a single-institution experience.
    Br J Dermatol. 2020 Feb 20. doi: 10.1111/bjd.18961.
    PubMed     Abstract available


  611. YOULDEN DR, Baade PD
    Ongoing cancer burden after a diagnosis of cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Feb 19. doi: 10.1111/bjd.18900.
    PubMed    


  612. STEEB T, Wessely A, Heppt F, Harlass M, et al
    Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of existing evidence.
    Br J Dermatol. 2020 Feb 18. doi: 10.1111/bjd.18957.
    PubMed     Abstract available


  613. LIVINGSTONE E, Zaremba A, Horn S, Ugurel S, et al
    GNAQ and GNA11 mutant non-uveal melanoma, a subtype distinct from both cutaneous and uveal melanoma.
    Br J Dermatol. 2020 Feb 16. doi: 10.1111/bjd.18947.
    PubMed     Abstract available


  614. CHAMBRELAN E, Barbarot S, Bekel L, Poizeau F, et al
    Drug survival and post-drug survival of systemic treatments in a national French cohort of children with atopic dermatitis.
    Br J Dermatol. 2020 Feb 9. doi: 10.1111/bjd.18941.
    PubMed     Abstract available


  615. ABJI F, Lee K, Math M, Pollock RA, et al
    Declining levels of serum CXCL10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: A new biomarker?
    Br J Dermatol. 2020 Feb 9. doi: 10.1111/bjd.18940.
    PubMed     Abstract available


  616. KIBBI N, Rajan N
    Reading through genetic 'stop signs': a therapeutic strategy in genetic skin disease.
    Br J Dermatol. 2020 Feb 9. doi: 10.1111/bjd.18870.
    PubMed    


  617. PRICE KN, Krase JM, Loh TY, Hsiao JL, et al
    Racial and Ethnic Disparities in Global Atopic Dermatitis Clinical Trials.
    Br J Dermatol. 2020 Feb 7. doi: 10.1111/bjd.18938.
    PubMed     Abstract available


  618. ADALSTEINSSON JA, Ratner D, Olafsdottir E, Grant-Kels J, et al
    Basal cell carcinoma: an emerging epidemic in women in Iceland.
    Br J Dermatol. 2020 Feb 7. doi: 10.1111/bjd.18937.
    PubMed     Abstract available


  619. RHEE J, Vance TM, Lim R, Christiani DC, et al
    Association of blood mercury levels with nonmelanoma skin cancer in the U.S.A. using National Health and Nutrition Examination Survey data (2003-2016).
    Br J Dermatol. 2020 Feb 5. doi: 10.1111/bjd.18797.
    PubMed     Abstract available


  620. FILONI A, Lospalluti L, Zanframundo G, De Marco A, et al
    Light brown structureless areas as predictor of melanoma in situ.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18926.
    PubMed     Abstract available


  621. CHENG BT, Silverberg JI
    Long-term and multiple hospital readmissions after discharge for Stevens-Johnson Syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18923.
    PubMed     Abstract available


  622. HAS C, Bauer JW, Bodemer C, Bolling M, et al
    Consensus re-classification of inherited epidermolysis bullosa and other disorders with skin fragility.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18921.
    PubMed     Abstract available


  623. LEI D, Yousaf M, Janmohamed SR, Vakharia PP, et al
    Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in Adults With Atopic Dermatitis.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18920.
    PubMed     Abstract available


  624. TSAI TF
    Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment.
    Br J Dermatol. 2020 Feb 3. doi: 10.1111/bjd.18869.
    PubMed    


  625. BLOME C
    Measuring what's important to adolescents with psoriasis.
    Br J Dermatol. 2020 Feb 3. doi: 10.1111/bjd.18872.
    PubMed    


  626. CUST AE
    Who dies from thin melanoma?
    Br J Dermatol. 2020 Feb 3. doi: 10.1111/bjd.18871.
    PubMed    


  627. NAVARRETE-DECHENT C, Marghoob AA, Chen CJ
    The road to real-time, bedside, optical imaging pathology: basal cell carcinoma and beyond.
    Br J Dermatol. 2020;182:257-259.
    PubMed    


  628. POLUBOTHU S, McGuire N, Al-Olabi L, Baird W, et al
    Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
    Br J Dermatol. 2020;182:e55-e84.
    PubMed     Abstract available


  629. BAHADORAN P
    Dermoscopy in general dermatology: a 'Delphinitive' step forward.
    Br J Dermatol. 2020;182:260-261.
    PubMed    


  630. VON KOBYLETZKI LB
    Most eczema smartphone apps do not conform to clinical guidelines.
    Br J Dermatol. 2020;182:276.
    PubMed    


  631. KRIDIN K, Cohen AD
    Hidradenitis suppurativa and infections.
    Br J Dermatol. 2020;182:267.
    PubMed    


  632. DELEURAN M, Vestergaard C
    Real-world evidence vs. randomized control trials.
    Br J Dermatol. 2020;182:275-276.
    PubMed    


  633. HUNTER HJA
    Remember to assess the 'whole' patient: a further immune-related adverse event of programmed cell death 1 checkpoint inhibition.
    Br J Dermatol. 2020;182:276-277.
    PubMed    


  634. KIRBY JS, Leiphart P
    Standing up together to the shame and stigma associated with hidradenitis suppurativa.
    Br J Dermatol. 2020;182:267-268.
    PubMed    


  635. KOTTNER J
    The clinical relevance of nonblanchable erythema in pressure ulcer prevention.
    Br J Dermatol. 2020;182:262-263.
    PubMed    


  636. MORITA A, Ikumi K
    Can the dose and dosing interval of biologics be optimized?
    Br J Dermatol. 2020;182:264-266.
    PubMed    


  637. SLADDEN M, Zagarella S, Popescu C, Bigby M, et al
    The sentinel node biopsy has not come of age.
    Br J Dermatol. 2020;182:518.
    PubMed    


  638. VAN LEE CB, Mooyaart AL, van den Bos RR
    Mohs micrographic surgery vs. standard surgical excision?: reply from authors.
    Br J Dermatol. 2020;182:517-518.
    PubMed    


  639. SLATER DN
    Mohs micrographic surgery vs. standard surgical excision?
    Br J Dermatol. 2020;182:517.
    PubMed    


  640. SHEARER SM, Milani-Nejad N, Kaffenberger BH
    Advances in acute exanthemas.
    Br J Dermatol. 2020;182:268-269.
    PubMed    


  641. MORRIS-JONES R
    Toenail onychomycosis - it's no fungi to have around: treatment analysis to the rescue!
    Br J Dermatol. 2020;182:263.
    PubMed    


  642. BILGIC A, Murrell DF
    Novel diagnostic method to differentiate antilaminin-332 pemphigoid from other forms of pemphigoid.
    Br J Dermatol. 2020;182:270-271.
    PubMed    


    January 2020
  643. BUJA A, Rivera M, De Polo A, Zorzi M, et al
    Real-world data for direct stage-specific costs of melanoma healthcare.
    Br J Dermatol. 2020 Jan 29. doi: 10.1111/bjd.18896.
    PubMed     Abstract available


  644. SIMPSON EL, Lacour JP, Spelman L, Galimberti R, et al
    Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Topical Corticosteroids: Results from Two Randomised Monotherapy Phase 3 Trials.
    Br J Dermatol. 2020 Jan 29. doi: 10.1111/bjd.18898.
    PubMed     Abstract available


  645. MADAN I, Parsons V, Ntani G, Coggon D, et al
    A behaviour change package to prevent hand dermatitis in nurse working in the National Health Service: results of a cluster randomised controlled trial.
    Br J Dermatol. 2020 Jan 27. doi: 10.1111/bjd.18862.
    PubMed     Abstract available


  646. POLESIE S, Gillstedt M, Paoli J, Osmancevic A, et al
    Methotrexate treatment for psoriasis patients and risk of cutaneous melanoma: a nested case-control study.
    Br J Dermatol. 2020 Jan 25. doi: 10.1111/bjd.18887.
    PubMed     Abstract available


  647. OLABI B, Tasker F, Williams HC
    'Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial'; a critical appraisal.
    Br J Dermatol. 2020 Jan 24. doi: 10.1111/bjd.18891.
    PubMed     Abstract available


  648. RONCONI G, Piccinni C, Dondi L, Calabria S, et al
    Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real-world data from a large Italian database.
    Br J Dermatol. 2020 Jan 23. doi: 10.1111/bjd.18888.
    PubMed     Abstract available


  649. WARD SV, Gibbs DC, Orlow I, Thomas NE, et al
    Association of IRF4 SNP rs12203592 with melanoma-specific survival.
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18881.
    PubMed     Abstract available


  650. DARLING TN
    Mosaic forms of an autosomal dominant skin disorder.
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18847.
    PubMed    


  651. FUXENCH ZCC
    Pain in atopic dermatitis: it's time we addressed this symptom further.
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18785.
    PubMed    


  652. KRENGEL S
    Congenital melanocytic naevi. Who benefits from a therapy?
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18706.
    PubMed    


  653. DAI W, Liu H, Liu Y, Xu X, et al
    Genetic variants in the folate metabolic pathway genes predict melanoma-specific survival.
    Br J Dermatol. 2020 Jan 18. doi: 10.1111/bjd.18878.
    PubMed     Abstract available


  654. TRETTIN B, Feldman S, Andersen F, Danbjorg DB, et al
    A changed life: The life experiences of patients with psoriasis receiving biological treatment.
    Br J Dermatol. 2020 Jan 17. doi: 10.1111/bjd.18876.
    PubMed     Abstract available


  655. YIU ZZN
    Repurposing existing trial data to infer relative efficacy of biologics: guselkumab vs. ustekinumab for psoriasis.
    Br J Dermatol. 2020 Jan 14. doi: 10.1111/bjd.18848.
    PubMed    


  656. TOROK KS
    Assigning values to the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) score indicating degree of severity and responsiveness: fostering practical use in clinic and therapeutic studies for morphoea/localized scleroderma.
    Br J Dermatol. 2020 Jan 14. doi: 10.1111/bjd.18782.
    PubMed    


  657. CHIN YPH, Hou ZY, Lee MY, Chu HM, et al
    A Patient-Oriented, General Practitioner-Level, Deep Learning-based Cutaneous Pigmented Lesion Risk Classifier on Smartphone.
    Br J Dermatol. 2020 Jan 6. doi: 10.1111/bjd.18859.
    PubMed     Abstract available


  658. AL-JANABI A, Warren RB
    Risankizumab versus adalimumab for moderate-to-severe plaque psoriasis: a critical appraisal.
    Br J Dermatol. 2020 Jan 3. doi: 10.1111/bjd.18856.
    PubMed     Abstract available


  659. CRAIG S, Viros A
    New biomarkers improve stratification of patients with melanoma.
    Br J Dermatol. 2020;182:5-6.
    PubMed    


  660. GILABERTE Y
    Light-emitting textiles: an innovative and friendly way to perform photodynamic therapy.
    Br J Dermatol. 2020;182:11-12.
    PubMed    


  661. NAVRAZHINA K, Frew JW
    Consensus definitions of disease activity in hidradenitis suppurativa: crossing the semantic gap.
    Br J Dermatol. 2020;182:7.
    PubMed    


  662. ZENKER M
    The mosaic hedgehog spectrum: another lesson on the polymorphy of mosaicism.
    Br J Dermatol. 2020;182:22-23.
    PubMed    


  663. TAN J
    Evaluating rosacea noninvasively and objectively.
    Br J Dermatol. 2020;182:10-11.
    PubMed    


  664. CHANDLER DJ, Fuller LC
    Removing the mystery of mite isolation - opening up scabies diagnosis?
    Br J Dermatol. 2020;182:21-22.
    PubMed    


  665. WALDMAN RA, DeWane ME, Sloan SB
    Does interleukin-4 inhibition play a role in dupilumab-associated conjunctivitis?
    Br J Dermatol. 2020;182:251.
    PubMed    


  666. ALHUSAYEN R
    The pain of hidradenitis suppurativa: 'We only see what we know'.
    Br J Dermatol. 2020;182:17-18.
    PubMed    


  667. OHYAMA M
    Does skewing of cytokine production link alopecia areata and depression?
    Br J Dermatol. 2020;182:15-16.
    PubMed    


    December 2019
  668. BLAUVELT A, Papp K, Gottlieb A, Jarell A, et al
    A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 12-Week Efficacy, Safety, and Speed of Response from a Randomized, Double-Blinded Trial.
    Br J Dermatol. 2019 Dec 30. doi: 10.1111/bjd.18851.
    PubMed     Abstract available


  669. MEGNA M, Fabbrocini G
    Psoriasis and atopic dermatitis: different entities with unsolved challenges.
    Br J Dermatol. 2019 Dec 29. doi: 10.1111/bjd.18789.
    PubMed    


  670. MORRIS-JONES R
    Oral ivermectin for infants and children under 15 kg appears to be a safe and effective treatment for scabies.
    Br J Dermatol. 2019 Dec 29. doi: 10.1111/bjd.18788.
    PubMed    


  671. HARRIES M, Hardman J, Chaudhry I, Poblet E, et al
    Profiling the human hair follicle immune system in lichen planopilaris and frontal fibrosing alopecia: Can macrophage polarization differentiate these two conditions microscopically?
    Br J Dermatol. 2019 Dec 28. doi: 10.1111/bjd.18854.
    PubMed     Abstract available


  672. KEARNEY N, Gallagher C, Lally A
    Image Gallery: Neglected skin cancer in an elderly patient with cognitive impairment.
    Br J Dermatol. 2019 Dec 26. doi: 10.1111/bjd.18542.
    PubMed    


  673. FERNANDEZ AP
    The skin myositis Delphi group puts the details in 'skin-predominant' dermatomyositis.
    Br J Dermatol. 2019 Dec 25. doi: 10.1111/bjd.18790.
    PubMed    


  674. THOMPSON JF, Friedman EB
    The intriguing association between smoking and reduced melanoma risk.
    Br J Dermatol. 2019 Dec 23. doi: 10.1111/bjd.18728.
    PubMed    


  675. WANG H, Wang X, Yang B, Liu H, et al
    Image Gallery: Onychomadesis in linear IgA bullous dermatosis.
    Br J Dermatol. 2019 Dec 22. doi: 10.1111/bjd.18744.
    PubMed    


  676. HARTMAN RI, Xue Y, Singer S, Markossian TW, et al
    Modeling the Value of Risk Stratified Skin Cancer Screening of Asymptomatic Patients by Dermatologists.
    Br J Dermatol. 2019 Dec 22. doi: 10.1111/bjd.18816.
    PubMed     Abstract available


  677. MAURELLI M, Gisondi P, Danese E, Gelati M, et al
    Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis.
    Br J Dermatol. 2019 Dec 19. doi: 10.1111/bjd.18807.
    PubMed     Abstract available


  678. WAY M, Marquart L, Chambers DC, Hopkins P, et al
    Skin cancer multiplicity in lung transplant recipients: prospective, population-based study.
    Br J Dermatol. 2019 Dec 19. doi: 10.1111/bjd.18812.
    PubMed     Abstract available


  679. CHATTOPADHYAY S, Zheng G, Hemminki A, Forsti A, et al
    Influence of family history on risk of second primary cancers and survival in squamous cell skin cancer patients.
    Br J Dermatol. 2019 Dec 19. doi: 10.1111/bjd.18809.
    PubMed     Abstract available


  680. LEE HY, Creamer D
    Stevens-Johnson syndrome/toxic epidermal necrolysis: a chronic condition?
    Br J Dermatol. 2019 Dec 18. doi: 10.1111/bjd.18726.
    PubMed    


  681. DOCAMPO-SIMON A, Sanchez-Pujol MJ, Belinchon-Romero I, Niveiro M, et al
    Image Gallery: Haematogenous metastasis of melanoma mimicking lymphangioma.
    Br J Dermatol. 2019 Dec 17. doi: 10.1111/bjd.18723.
    PubMed    


  682. VILLACORTA R, Teeple A, Lee S, Fakharzadeh S, et al
    A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis.
    Br J Dermatol. 2019 Dec 16. doi: 10.1111/bjd.18798.
    PubMed     Abstract available


  683. BORRONI RG, Costanzo A
    Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis.
    Br J Dermatol. 2019 Dec 15. doi: 10.1111/bjd.18717.
    PubMed    


  684. BETZ-STABLEIN B, Koh U, Plasmeijer E, Janda M, et al
    Self-reported naevus density may lead to misclassification of melanoma risk.
    Br J Dermatol. 2019 Dec 12. doi: 10.1111/bjd.18802.
    PubMed     Abstract available


  685. TALPUR R
    Quality of life, Skindex-29, mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2019 Dec 11. doi: 10.1111/bjd.18710.
    PubMed    


  686. GESSER B, Rasmussen MK
    Psoriatic epidermis expresses high level of inflammatory mediators and the CDK2/4 cyclin-dependent kinases are involved in the regulation of cell-cycle progression in epidermal cells.
    Br J Dermatol. 2019 Dec 11. doi: 10.1111/bjd.18713.
    PubMed    


  687. PUIG L
    Psoriasis Area and Severity Index vs. pharmacokinetics: can monitoring 4-week postinjection ustekinumab concentrations in patients with suboptimal response be clinically relevant?
    Br J Dermatol. 2019 Dec 11. doi: 10.1111/bjd.18709.
    PubMed    


  688. SUN J, Wang Y
    KIR3DL2 in cutaneous T-cell lymphoma: from a promising biomarker to a potential therapeutic target.
    Br J Dermatol. 2019 Dec 5. doi: 10.1111/bjd.18682.
    PubMed    


  689. HENDRICKS AJ, Eichenfield LF, Shi VY
    The Impact of Airborne Pollution on Atopic Dermatitis-A Literature Review.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18781.
    PubMed     Abstract available


  690. BLAKEWAY H, Van-de-Velde V, Allen VB, Kravvas G, et al
    What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? - A systematic review.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18778.
    PubMed     Abstract available


  691. MCMENIMAN EK, Duffy DL, Jagirdar K, Lee KJ, et al
    The interplay of sun-damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18777.
    PubMed     Abstract available


  692. LAW MH
    Making sense of different measures of skin ageing.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18700.
    PubMed    


  693. HART PH
    The changing transcriptome in human skin following in vivo exposure to erythemal solar-simulated ultraviolet radiation.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18683.
    PubMed    


  694. TRAN B, Guffey D, Noland M
    Image Gallery: Otic lichen planus complicated by tympanic membrane rupture successfully treated with topical 1% tacrolimus.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18687.
    PubMed    


  695. O'REILLY P, Kennedy C, Meskell P, Coffey A, et al
    The psychological impact of Stevens-Johnson syndrome and toxic epidermal necrolysis on patients' lives: A critically appraised topic.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18746.
    PubMed     Abstract available


  696. HALLING-OVERGAARD AS, Thyssen JP
    Modifiable risk factors in paediatric atopic dermatitis: is the sun finally shining?
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18690.
    PubMed    


  697. KIM JH
    Personalized dosing of ixekizumab for psoriasis.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18701.
    PubMed    


  698. CHO SY, Kim AY, Kim J, Choi DH, et al
    Impact of oxytocin on skin ageing.
    Br J Dermatol. 2019;181:e148-e171.
    PubMed     Abstract available


    November 2019
  699. BELL KJL
    Causal inference in melanoma epidemiology using Mendelian randomization.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18646.
    PubMed    


  700. WONG AYS, Froslev T, Forbes HJ, Kjaersgaard A, et al
    Partner bereavement and risk of psoriasis and atopic eczema: cohort studies in the United Kingdom and Denmark.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18740.
    PubMed     Abstract available


  701. EMAM S, Du AX, Surmanowicz P, Thomsen SF, et al
    Predicting the Long-term Outcomes of Biologics in Psoriasis Patients using Machine Learning.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18741.
    PubMed     Abstract available


  702. GOLDBERG I, Mashiah J, Kutz A, Derowe A, et al
    Symptomatic mucosal involvement in pachyonychia congenita: the challenges in infants and young children.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18742.
    PubMed     Abstract available


  703. ROBINSON JK
    Frequency of 'regular' skin checks by dermatologists for melanoma survivors.
    Br J Dermatol. 2019 Nov 27. doi: 10.1111/bjd.18626.
    PubMed    


  704. ISMAIL N, Bray N
    Atopic dermatitis: economic burden and strategies for high-quality care.
    Br J Dermatol. 2019 Nov 27. doi: 10.1111/bjd.18636.
    PubMed    


  705. WEBER J, Glutsch V, Geissinger E, Haug L, et al
    Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease.
    Br J Dermatol. 2019 Nov 26. doi: 10.1111/bjd.18739.
    PubMed     Abstract available


  706. SIBBALD C
    Dupilumab in adolescent atopic dermatitis: interpreting the data.
    Br J Dermatol. 2019 Nov 25. doi: 10.1111/bjd.18627.
    PubMed    


  707. BERGQVIST C, Mezzarobba M, Weil A, Sbidian E, et al
    Persistence of treatment with conventional systemic agents for patients with psoriasis: a real-world analysis of 73,168 new-users from the French National Health Insurance database (SNDS).
    Br J Dermatol. 2019 Nov 23. doi: 10.1111/bjd.18734.
    PubMed     Abstract available


  708. DE WIJS LEM, Nguyen NT, Kunkeler ACM, Nijsten T, et al
    Clinical and histopathological characterization of paradoxical head and neck erythema in atopic dermatitis patients treated with dupilumab: a case series.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18730.
    PubMed     Abstract available


  709. OLSEN CM, Pandeya N, Law MH, MacGregor S, et al
    Does polygenic risk influence associations between sun exposure and melanoma?: a prospective cohort analysis.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18703.
    PubMed     Abstract available


  710. LAN J, Wen J, Cao S, Yin T, et al
    The diagnostic accuracy of dermoscopy and reflectance confocal microscopy for amelanotic/hypomelanotic melanoma: a systematic review and meta-analysis.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18722.
    PubMed     Abstract available


  711. FUJIMURA T, Tanita K, Sato Y, Lyu C, et al
    Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18721.
    PubMed     Abstract available


  712. RANDA H, Khoury LR, Gronborg TK, Lomholt JJ, et al
    Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument (APso-QOL): a disease-specific measure of quality of life in adolescents with psoriasis.
    Br J Dermatol. 2019 Nov 19. doi: 10.1111/bjd.18719.
    PubMed     Abstract available


  713. WALSH S, Creamer D
    Shaping specialist treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Br J Dermatol. 2019 Nov 19. doi: 10.1111/bjd.18612.
    PubMed    


  714. JOHANSSON P
    Differences between acral and nonacral melanoma genomes.
    Br J Dermatol. 2019 Nov 19. doi: 10.1111/bjd.18615.
    PubMed    


  715. GARCIA-SOUTO F
    Recurrent headache and facial ecchymosis: a case of dermatitis artefacta? Reply from authors.
    Br J Dermatol. 2019 Nov 17. doi: 10.1111/bjd.18699.
    PubMed     Abstract available


  716. HU C, Nijsten T, Pasmans SGMA, de Jongste JC, et al
    Associations of eczema phenotypes with emotional and behavioural problems from birth until school age. The Generation R Study.
    Br J Dermatol. 2019 Nov 15. doi: 10.1111/bjd.18705.
    PubMed     Abstract available


  717. COIAS J, Marzuka A, Hosler GA, Chong BF, et al
    T cell polarization differs in various stages of discoid lupus erythematosus skin.
    Br J Dermatol. 2019 Nov 13. doi: 10.1111/bjd.18704.
    PubMed     Abstract available


  718. HOLLYWOOD A, O'Keeffe C, Boggs J, Feighery C, et al
    The Utility of Subcutaneous Methotrexate for Chronic Plaque Psoriasis in a Real-World Setting.
    Br J Dermatol. 2019 Nov 12. doi: 10.1111/bjd.18698.
    PubMed     Abstract available


  719. ARMSTRONG AW, Blauvelt A, Crowley JJ, Gordon KB, et al
    Defining drug-free remission of skin disease in patients with plaque psoriasis.
    Br J Dermatol. 2019 Nov 9. doi: 10.1111/bjd.18694.
    PubMed     Abstract available


  720. THAI D, Pinter A, Sebastian M, Termeer C, et al
    Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: Results from a randomised, active comparator-controlled phase 3b trial (POLARIS).
    Br J Dermatol. 2019 Nov 9. doi: 10.1111/bjd.18696.
    PubMed     Abstract available


  721. RENCZ F
    Cross-country generalizability of quality-of-life scores in atopic dermatitis.
    Br J Dermatol. 2019 Nov 8. doi: 10.1111/bjd.18601.
    PubMed    


  722. TOBIN AM
    Unravelling the microbiome in psoriasis.
    Br J Dermatol. 2019 Nov 8. doi: 10.1111/bjd.18547.
    PubMed    


  723. KLUGER N
    Recurrent headache and facial ecchymosis: a case of dermatitis artefacta?
    Br J Dermatol. 2019 Nov 8. doi: 10.1111/bjd.18691.
    PubMed     Abstract available


  724. HAYASHI A, Matsumoto K, Mitsuishi T
    Three cases of recalcitrant cutaneous warts treated with quadrivalent human papillomavirus vaccine: the HPV type may not determine the outcome.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18645.
    PubMed     Abstract available


  725. DEL REGNO L, Louveau B, Battistella M, Sadoux A, et al
    Clinical significance of BRAF/NRAS concurrent mutations in a clinic-based metastatic melanoma cohort.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18641.
    PubMed     Abstract available


  726. INAMURA E, Nishie W, Yamaguchi Y, Fujimura Y, et al
    Linear IgA/IgG bullous dermatosis with autoantibodies directing the native and processed forms of BP180.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18642.
    PubMed     Abstract available


  727. GJERSVIK P
    Why is the high risk of skin cancer in organ transplant recipients declining?
    Br J Dermatol. 2019;181:879-880.
    PubMed    


  728. DUFFY DL, Lee KJ, Jagirdar K, Pflugfelder A, et al
    Naevus count and MC1R R alleles contribute to melanoma risk.
    Br J Dermatol. 2019;181:e119-e142.
    PubMed     Abstract available


  729. ALEXANDER H, Paller AS, Traidl-Hoffmann C, Beck LA, et al
    The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18643.
    PubMed     Abstract available


    October 2019
  730. AGUILAR JA, Irurzun AL, Bayona JIY, Rodriguez MA, et al
    Image Gallery: Zosteriform metastasis from melanoma.
    Br J Dermatol. 2019 Oct 30. doi: 10.1111/bjd.18567.
    PubMed    


  731. DIELS J, Thilakarathne P, Cameron C, McElligott S, et al
    Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS Analysis.
    Br J Dermatol. 2019 Oct 25. doi: 10.1111/bjd.18634.
    PubMed     Abstract available


  732. SINGH P, Silverberg JI
    Under-screening of depression in United States outpatients with atopic dermatitis and psoriasis.
    Br J Dermatol. 2019 Oct 24. doi: 10.1111/bjd.18629.
    PubMed     Abstract available


  733. SHI KY, Kunzler E, Hynan LS, Chong BF, et al
    Autoimmune disease development before and after cutaneous lupus erythematosus diagnosis.
    Br J Dermatol. 2019 Oct 24. doi: 10.1111/bjd.18631.
    PubMed     Abstract available


  734. EGEBERG A, Griffiths CEM, Williams HC, Andersen YMF, et al
    Clinical characteristics, symptoms, and burden of psoriasis and atopic dermatitis in adults.
    Br J Dermatol. 2019 Oct 20. doi: 10.1111/bjd.18622.
    PubMed     Abstract available


  735. HOWARD M, Xie C, Wee E, Wolfe R, et al
    Acral lentiginous melanoma: differences in survival compared to other subtypes.
    Br J Dermatol. 2019 Oct 19. doi: 10.1111/bjd.18620.
    PubMed     Abstract available


  736. GRAN S
    Vitiligo and skin cancer: is it a question of ethnicity?
    Br J Dermatol. 2019 Oct 16. doi: 10.1111/bjd.18533.
    PubMed    


  737. TOLAND AE
    Developing risk prediction models for melanoma: balancing better predictive value with ease of clinical implementation.
    Br J Dermatol. 2019 Oct 13. doi: 10.1111/bjd.18531.
    PubMed    


  738. DEINLEIN T, Longo C, Schulter G, Pizzichetta MA, et al
    The prevailing dermoscopic vascular pattern in melanoma is influenced by tumor thickness and pigmentation type.
    Br J Dermatol. 2019 Oct 12. doi: 10.1111/bjd.18610.
    PubMed     Abstract available


  739. KATZMAN JA, Chavan R, Holliday A, Coman G, et al
    Mosaic Variant in ATP2C1 Presenting as Relapsing Linear Acantholytic Dermatosis: Case Report.
    Br J Dermatol. 2019 Oct 12. doi: 10.1111/bjd.18607.
    PubMed     Abstract available


  740. VAN TIGGELEN H, LeBlanc K, Campbell K, Woo K, et al
    Standardising the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel (ISTAP) Classification System in 44 countries.
    Br J Dermatol. 2019 Oct 12. doi: 10.1111/bjd.18604.
    PubMed     Abstract available


  741. CORK MJ, Thaci D, Eichenfield LF, Arkwright PD, et al
    Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension.
    Br J Dermatol. 2019 Oct 8. doi: 10.1111/bjd.18476.
    PubMed     Abstract available


  742. FREW JW, Navrazhina K
    No Evidence that Impaired Notch Signaling Differentiates Hidradenitis Suppurativa From Other Inflammatory Skin Diseases.
    Br J Dermatol. 2019 Oct 8. doi: 10.1111/bjd.18593.
    PubMed     Abstract available


  743. RUNDLE CW, Dellavalle RP
    Nonsteroidal anti-inflammatory drug associations with nonmelanoma skin cancer - the saga continues.
    Br J Dermatol. 2019;181:654-656.
    PubMed    


    September 2019
  744. STROWD LC, Feldman SR
    Overcoming poor adherence is a major hurdle to managing atopic dermatitis.
    Br J Dermatol. 2019 Sep 30. doi: 10.1111/bjd.18455.
    PubMed    


  745. ALEXEYEV O
    Psoriasis, gut and microbiome.
    Br J Dermatol. 2019 Sep 30. doi: 10.1111/bjd.18467.
    PubMed    


  746. KATOH N, Kataoka Y, Saeki H, Hide M, et al
    Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials.
    Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18565.
    PubMed     Abstract available


  747. HEETFELD AB, Schill T, Schroder SS, Forkel S, et al
    Challenging a paradigm: Skin sensitivity to sodium lauryl sulfate is independent of atopic diathesis.
    Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18564.
    PubMed     Abstract available


  748. CLAESON M, Baade P, Brown S, Soyer HP, et al
    Clinicopathological factors associated with death from thin (</=1.00mm) melanoma.
    Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18560.
    PubMed     Abstract available


  749. THYSSEN JP, Halling-Sonderby AS, Wu JJ, Egeberg A, et al
    Pain severity and use of analgesic medication in adults with atopic dermatitis: a cross-sectional study.
    Br J Dermatol. 2019 Sep 25. doi: 10.1111/bjd.18557.
    PubMed     Abstract available


  750. KOSTAKI M, Plaka M, Stergiopoulou A, Kypreou K, et al
    Trends in epidemiology of melanoma in situ in Greece: Data from a melanoma reference center during the period 2000-2018.
    Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18551.
    PubMed     Abstract available


  751. DUMMER R, Guminksi A, Gutzmer R, Lear JT, et al
    Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase 2 randomised, double-blind BOLT study.
    Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18552.
    PubMed     Abstract available


  752. LIMMER AL, Wu JH, Doan HQ, Rady PL, et al
    Acquired epidermodysplasia verruciformis: a ten-year anniversary update.
    Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18549.
    PubMed     Abstract available


  753. RITCHIE S, Qureshi I, Molloy K, Yoo J, et al
    Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T cell lymphoma at a tertiary care centre: Should we avoid chemotherapy in conditioning regimes?
    Br J Dermatol. 2019 Sep 19. doi: 10.1111/bjd.18541.
    PubMed     Abstract available


  754. GIBSON JAG, Dobbs TD, Griffiths R, Song J, et al
    The Association of Smoking and Socioeconomic status on Cutaneous Melanoma: a population based, data linkage, case-control study.
    Br J Dermatol. 2019 Sep 17. doi: 10.1111/bjd.18526.
    PubMed     Abstract available


  755. ENGELINA S, Saggu M, Yoo J, Shah F, et al
    Brentuximab a novel antibody therapy: Real-World Use Confirms Efficacy and Tolerability for CD30 positive cutaneous lymphoma.
    Br J Dermatol. 2019 Sep 16. doi: 10.1111/bjd.18535.
    PubMed     Abstract available


  756. BUSTAMANTE M, Hernandez-Ferrer C, Tewari A, Sarria Y, et al
    Dose and time effects of solar simulated ultraviolet radiation on the in vivo human skin transcriptome.
    Br J Dermatol. 2019 Sep 16. doi: 10.1111/bjd.18527.
    PubMed     Abstract available


  757. CUST AE, Badcock C, Smith J, Thomas NE, et al
    A risk prediction model for development of subsequent primary melanoma in a population-based cohort.
    Br J Dermatol. 2019 Sep 14. doi: 10.1111/bjd.18524.
    PubMed     Abstract available


  758. PARDO LM, Hamer MA, Liu F, Velthuis P, et al
    Principal component analysis of seven skin ageing features identifies three main types of skin ageing.
    Br J Dermatol. 2019 Sep 13. doi: 10.1111/bjd.18523.
    PubMed     Abstract available


  759. SOLMAZ D, Bakirci S, Al Onazi A, Al Osaimi N, et al
    Musculoskeletal ultrasound can improve referrals from dermatology to rheumatology for patients with psoriasis.
    Br J Dermatol. 2019 Sep 10. doi: 10.1111/bjd.18515.
    PubMed     Abstract available


  760. GISONDI P
    Does systemic treatment of psoriasis reduce the risk of comorbidities?
    Br J Dermatol. 2019 Sep 9. doi: 10.1111/bjd.18456.
    PubMed    


  761. KLOCZKO E, Maybury CM
    Secukinumab for treatment of nail psoriasis: results from the TRANSFIGURE trial.
    Br J Dermatol. 2019 Sep 9. doi: 10.1111/bjd.18439.
    PubMed    


  762. SILVERBERG JI
    Atopic dermatitis epidemiology: moving beyond cross-sectional studies.
    Br J Dermatol. 2019 Sep 8. doi: 10.1111/bjd.18440.
    PubMed    


  763. WANG Y, Jin H
    Image Gallery: Lichen planus pigmentosus of the tongue.
    Br J Dermatol. 2019 Sep 6. doi: 10.1111/bjd.18418.
    PubMed    


  764. COLLANTES-RODRIGUEZ C, Jimenez-Gallo D, Ossorio-Garcia L, Villegas-Romero I, et al
    Image Gallery: Cutaneous ulcers in anti-MDA5 dermatomyositis successfully treated with sildenafil.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18376.
    PubMed    


  765. KIMBALL AB, Papp KA, Reich K, Gooderham M, et al
    Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments, and switching from etanercept: results from phase 3 studies.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18484.
    PubMed     Abstract available


  766. BAILEY EE, Mayer JE, Geller AC, Johnson TM, et al
    Role of the partner/spouse in melanoma discovery and related health behaviors and practices.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18478.
    PubMed     Abstract available


  767. STILLER HT, Mikiver R, Uppugunduri S, Lindholm C, et al
    Health Related Quality of Life in Melanoma Patients - characterization of a Swedish cohort.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18486.
    PubMed     Abstract available


  768. BONSANG B, Brenaut E, Talagas M, Uguen A, et al
    Small-fiber neuropathy and pruritus: histological patterns of nerve fibers in skin biopsies.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18485.
    PubMed     Abstract available


  769. MUNTYANU A, Gulliver WP, Fleming P
    Weight Change in Patients with Psoriasis using Tumor Necrosis Factor-Alpha Inhibitors.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18483.
    PubMed     Abstract available


  770. ZHOU M, Wang H, Yang M, He C, et al
    Lipidomic analysis of facial skin surface lipid reveals the altered lipid profile in infancy acne.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18474.
    PubMed     Abstract available


  771. KOPECKI Z
    Tumour serine proteases C1r and C1s as novel biomarkers and therapeutic targets in invasive sporadic and recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma.
    Br J Dermatol. 2019 Sep 4. doi: 10.1111/bjd.18419.
    PubMed    


  772. HUANG YW, Tsai TF
    Juvenile onset Pustular Psoriasis: Case Series and Literature Review.
    Br J Dermatol. 2019 Sep 4. doi: 10.1111/bjd.18473.
    PubMed     Abstract available


  773. ROSENTHAL JM, Kim EJ
    Health-related quality of life in cutaneous T-cell lymphoma: examining all sides of the issue.
    Br J Dermatol. 2019 Sep 2. doi: 10.1111/bjd.18428.
    PubMed    


  774. RONGIOLETTI F, Mugheddu C
    Image Gallery: Green moss-like psoriasis.
    Br J Dermatol. 2019 Sep 2. doi: 10.1111/bjd.18421.
    PubMed    


    August 2019
  775. HABER RM
    Classifying primary paediatric cutaneous mucinoses.
    Br J Dermatol. 2019 Aug 29. doi: 10.1111/bjd.18431.
    PubMed    


  776. YA J, Khanna U, Havele S, Fernandez AP, et al
    Utility of Repeat Latent Tuberculosis Testing with QuantiFERON-TB Gold test in Psoriasis Patients Treated with TNF-alpha inhibitors at a Single U.S. Institution.
    Br J Dermatol. 2019 Aug 27. doi: 10.1111/bjd.18461.
    PubMed     Abstract available


  777. DI ALTOBRANDO A, Patrizi A, Vara G, Merli Y, et al
    Topical zinc oxide: an effective treatment option for erosive pustular dermatosis of the leg.
    Br J Dermatol. 2019 Aug 25. doi: 10.1111/bjd.18453.
    PubMed     Abstract available


  778. ANDERSEN L, Nyeland ME, Nyberg F
    Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the UK and the US.
    Br J Dermatol. 2019 Aug 22. doi: 10.1111/bjd.18451.
    PubMed     Abstract available


  779. GOLDINGER SM, Valeska Matter A, Urner-Bloch U, Narainsing J, et al
    Binimetinib in heavily pretreated NRAS-mutant Melanoma Patients with Brain Metastases.
    Br J Dermatol. 2019 Aug 22. doi: 10.1111/bjd.18449.
    PubMed     Abstract available


  780. ISHIDA-YAMAMOTO A
    The basket-weave pattern is present in the skin for a reason.
    Br J Dermatol. 2019 Aug 21. doi: 10.1111/bjd.18375.
    PubMed    


  781. SINGH S, Rao M, Verma A
    Image Gallery: Mutilating diffuse cutaneous leishmaniasis in AIDS.
    Br J Dermatol. 2019 Aug 20. doi: 10.1111/bjd.18367.
    PubMed    


  782. LEE KJ, Soyer HP
    Smartphones, artificial intelligence and digital histopathology take on basal cell carcinoma diagnosis.
    Br J Dermatol. 2019 Aug 19. doi: 10.1111/bjd.18374.
    PubMed    


  783. BELLONI FORTINA A, Caroppo F
    Severe childhood psoriasis: need for safety and efficacy data on long-term treatment with biologics.
    Br J Dermatol. 2019 Aug 18. doi: 10.1111/bjd.18362.
    PubMed    


  784. AICHELBURG MC, Tanew A
    Secukinumab without the initial loading dose in the treatment of plaque-type psoriasis - a simplified dosing regimen at the expense of efficacy?
    Br J Dermatol. 2019 Aug 18. doi: 10.1111/bjd.18355.
    PubMed    


  785. OLSSON M, Bajpai R, Wee LWY, Yew YW, et al
    The cost of childhood atopic dermatitis in a multi-ethnic Asian population: a cost-of-illness study.
    Br J Dermatol. 2019 Aug 17. doi: 10.1111/bjd.18442.
    PubMed     Abstract available


  786. RENCZ F, Gulacsi L, Pentek M, Szegedi A, et al
    DLQI-R scoring improves the discriminatory power of Dermatology Life Quality Index in psoriasis, pemphigus and morphea patients.
    Br J Dermatol. 2019 Aug 16. doi: 10.1111/bjd.18435.
    PubMed     Abstract available


  787. SHEEN YS, Tan KT, Tse KP, Liao YH, et al
    Genetic Alterations in Primary Melanoma in Taiwan.
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18425.
    PubMed     Abstract available


  788. WOLLENBERG A, Beck LA, Blauvelt A, Simpson EL, et al
    Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18434.
    PubMed     Abstract available


  789. DENG PH, Wang CJ, Armstrong AW
    An Association between Hidradenitis Suppurativa and HIV.
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18433.
    PubMed     Abstract available


  790. GOUIN O, Misery L
    Thymic stromal lymphopoietin, protease-activated receptor 2 and interleukin 1 are involved in the relationship between skin irritation and atopic dermatitis.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18315.
    PubMed    


  791. PUIG L
    Significant weight loss improves and prevents psoriasis and psoriatic arthritis in obese patients: a Critically Appraised Topic and a call to action.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18322.
    PubMed    


  792. HAIDARI W, Feldman SR
    Rates of psoriasis in patients with palmoplantar pustulosis.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18314.
    PubMed    


  793. CHABY G, Maldini C, Haddad C, Lebrun-Vignes B, et al
    Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-2016: a four-source capture-recapture estimate.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18424.
    PubMed     Abstract available


  794. BYRNE N, Hughes R, Murphy LA, Kirby B, et al
    Remission of severe hidradenitis suppurativa following chemotherapy for Hodgkin's lymphoma.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18423.
    PubMed     Abstract available


  795. LEBWOHL M
    A new era in the treatment of atopic dermatitis.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18349.
    PubMed    


  796. ODUM N
    Deregulated signalling and inflammation in cutaneous T-cell lymphoma.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18353.
    PubMed    


  797. DARRIGADE AS, Milpied B, Seneschal J
    Image Gallery: Jacquet papulo-erosive dermatitis in an adult.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18346.
    PubMed    


  798. GROMA G
    Oxymatrine may represent an additional therapeutic tool in severe plaque psoriasis management.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18299.
    PubMed    


  799. SOURA E, Stratigos A
    Implementing polygenic risk scores in skin cancer: a step towards personalized risk prediction.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18324.
    PubMed    


  800. CLAUSEN ML, Agner T
    The inhabitants of our skin.
    Br J Dermatol. 2019 Aug 6. doi: 10.1111/bjd.18312.
    PubMed    


  801. FEARFIELD L, Nobbs J, Petruckevitch A, Harland C, et al
    Severe vitamin D deficiency associated with BRAF mutated melanoma.
    Br J Dermatol. 2019 Aug 5. doi: 10.1111/bjd.18413.
    PubMed     Abstract available


  802. VUONG K, Armstrong BK, Drummond M, Hopper JL, et al
    Development and external validation study of a melanoma risk prediction model incorporating clinically-assessed naevi and solar lentigines.
    Br J Dermatol. 2019 Aug 4. doi: 10.1111/bjd.18411.
    PubMed     Abstract available


  803. REICH K, Augustin M, Thaci D, Pinter A, et al
    A 24-week multicentre, randomised, open-label, parallel-group study comparing the efficacy and safety of ixekizumab to fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment.
    Br J Dermatol. 2019 Aug 3. doi: 10.1111/bjd.18384.
    PubMed     Abstract available


  804. WANG X, Sun J
    Image Gallery: Acquired cutaneous lymphangiectasia secondary to rectal cancer treatment.
    Br J Dermatol. 2019;181:e36.
    PubMed    


  805. ELDER DE, Barnhill RL
    The pink papules and plaques of Spitz.
    Br J Dermatol. 2019;181:235.
    PubMed    


  806. MOTLEY R, Arron S
    Mohs micrographic surgery for cutaneous squamous cell carcinoma.
    Br J Dermatol. 2019;181:233-234.
    PubMed    


  807. FELMINGHAM C, Yip L, Tam M, Nixon RL, et al
    Allergy to sunscreen and leave-on facial products is not a likely causative mechanism in frontal fibrosing alopecia - perspective from contact allergy experts.
    Br J Dermatol. 2019 Aug 1. doi: 10.1111/bjd.18380.
    PubMed     Abstract available


    July 2019
  808. ANDERSEN YMF, Egeberg A
    Seborrhoeic dermatitis - understood or understudied?
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18307.
    PubMed    


  809. THONGPRASOM K
    Challenges in using topical calcineurin inhibitors as a treatment for recalcitrant oral lichen planus.
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18304.
    PubMed    


  810. SZEGEDI A
    Connections between atopic dermatitis and ageing.
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18306.
    PubMed    


  811. GAMBICHLER T, Schroter U, Hoxtermann S, Susok L, et al
    Decline of PD-1 positive circulating T regulatory cells predicting more favorable clinical outcome of melanoma patients under immune checkpoint blockade.
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18379.
    PubMed     Abstract available


  812. RIBERO S
    Synergy between MC1R mutations and a high naevus count in increasing melanoma risk in the general population.
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18301.
    PubMed    


  813. CHENG L
    Precision dosage of methotrexate in psoriasis.
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18273.
    PubMed    


  814. BERNIGAUD C, Chosidow O
    Are swabs an appropriate way to sample for skin microbiome research?
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18257.
    PubMed    


  815. VAN DEN REEK JMPA
    Predicting treatment success with biologics in psoriasis.
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18251.
    PubMed    


  816. NICHOLAS MN, Drucker AM
    Depression and anxiety in atopic dermatitis: increasing recognition and opportunities to intervene.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18252.
    PubMed    


  817. QIAN YT, Vano-Galvan S, Liu JW, Liu W, et al
    Image Gallery: Multiple yellowish papules and verrucous plaques on the vulva.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18243.
    PubMed    


  818. ANDERSEN YMF, Egeberg A
    Comparing apples, oranges and atopic dermatitis.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18303.
    PubMed    


  819. MAILHE M, Tissot-Dupont H, Lagier JC
    Image Gallery: Atypical rash in an HIV-infected woman.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18242.
    PubMed    


  820. LEVY M, Martin L, Bursztejn AC, Chiaverini C, et al
    Ivermectin safety in infants and children under 15 kg treated for scabies: A multicentric Observational study.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18369.
    PubMed     Abstract available


  821. RAMASAMY S, Barnard E, Dawson TL Jr, Li H, et al
    The role of the skin microbiota in acne pathophysiology.
    Br J Dermatol. 2019 Jul 24. doi: 10.1111/bjd.18230.
    PubMed     Abstract available


  822. BOTTESI G, Spoto A, Trevisson E, Zuccarello D, et al
    Dysfunctional coping is related to impaired skin-related QoL and psychological distress in Neurofibromatosis type 1 patients with major skin involvement.
    Br J Dermatol. 2019 Jul 22. doi: 10.1111/bjd.18363.
    PubMed     Abstract available


  823. NORLIN JM, Nilsson K, Persson U, Schmitt-Egenolf M, et al
    Complete Skin Clearance and PASI response rates in clinical practice- Predictors, Health Related Quality of Life improvements and implications for treatment goals.
    Br J Dermatol. 2019 Jul 20. doi: 10.1111/bjd.18361.
    PubMed     Abstract available


  824. GAMBICHLER T, Susok L, Fels M, Schneider-Gold C, et al
    Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female melanoma patient.
    Br J Dermatol. 2019 Jul 19. doi: 10.1111/bjd.18358.
    PubMed     Abstract available


  825. NAKASHIMA C, Ishida Y, Kaku Y, Epstein EH Jr, et al
    Dupilumab improved atypical fibrotic skin plaques in atopic dermatitis.
    Br J Dermatol. 2019 Jul 19. doi: 10.1111/bjd.18359.
    PubMed     Abstract available


  826. BETTUZZI T, Penso L, de Prost N, Hemery F, et al
    Trends in mortality rates for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): experience of a single center in France between 1997 and 2017.
    Br J Dermatol. 2019 Jul 19. doi: 10.1111/bjd.18360.
    PubMed     Abstract available


  827. GARDNER R, Burden AD
    How do you determine the optimal biologic treatment for psoriasis?
    Br J Dermatol. 2019 Jul 18. doi: 10.1111/bjd.13593.
    PubMed    


  828. MANOLACHE L, Finlay AY
    Why use an allergy-based quality of life measure in childhood atopic eczema?
    Br J Dermatol. 2019 Jul 17. doi: 10.1111/bjd.18157.
    PubMed    


  829. GUTIERREZ-GONZALEZ E, Descalzo-Gallego MA, Molina-Leyva A, Kueder-Pajares T, et al
    Matching burden of skin diseases, demand for dermatological consultations and clinical research activity: results from three national studies.
    Br J Dermatol. 2019 Jul 13. doi: 10.1111/bjd.18337.
    PubMed     Abstract available


  830. OLSEN CM
    Reproductive factors and risk of melanoma: still unresolved.
    Br J Dermatol. 2019 Jul 9. doi: 10.1111/bjd.18136.
    PubMed    


  831. HUANG TH, Hu SC
    Image gallery: Fluoroscopy-induced radiation dermatitis.
    Br J Dermatol. 2019 Jul 9. doi: 10.1111/bjd.18148.
    PubMed    


  832. GOTTLIEB AB, Kubanov A, van Doorn M, Sullivan J, et al
    Sustained Efficacy of Secukinumab in Subjects with Moderate-to-Severe Palmoplantar Psoriasis: 2.5-Year Results from GESTURE, a Randomized, Double-blind, Placebo-controlled Trial.
    Br J Dermatol. 2019 Jul 8. doi: 10.1111/bjd.18331.
    PubMed     Abstract available


  833. MAHIL SK, Wilson N, Dand N, Reynolds NJ, et al
    Psoriasis treat to target: defining outcomes in psoriasis using data from a real world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).
    Br J Dermatol. 2019 Jul 8. doi: 10.1111/bjd.18333.
    PubMed     Abstract available


  834. BELINCHON I
    Where does psoriasis hold out in the era of biologics?
    Br J Dermatol. 2019 Jul 7. doi: 10.1111/bjd.18159.
    PubMed    


  835. DONG W, An J, Geng P, Zeng X, et al
    Years Lost Due to Disability from Skin Diseases in China 1990-2017: Findings from the Global Burden of Disease Study 2017.
    Br J Dermatol. 2019 Jul 6. doi: 10.1111/bjd.18329.
    PubMed     Abstract available


  836. DOBOS G, Battistella M, Jouenne F, Mourah S, et al
    Challenges in the diagnosis of primary cutaneous CD30+ anaplastic large-cell lymphoma.
    Br J Dermatol. 2019 Jul 6. doi: 10.1111/bjd.18328.
    PubMed     Abstract available


  837. FROMMHERZ L, Kusel J, Zimmer A, Fischer J, et al
    Skin fragility caused by biallelic KRT10 mutations: an intriguing form of self-improving epidermolytic ichthyosis.
    Br J Dermatol. 2019 Jul 6. doi: 10.1111/bjd.18325.
    PubMed     Abstract available


  838. HSU S, Green LJ, Lebwohl MG, Wu JJ, et al
    Comparable Efficacy and Safety of Brodalumab in Obese and Non-Obese Patients With Psoriasis: Analysis of 2 Randomized Controlled Trials.
    Br J Dermatol. 2019 Jul 5. doi: 10.1111/bjd.18327.
    PubMed     Abstract available


  839. LEE H, Ko JM, Lee SH
    Generalized skin hyperpigmentation as the only manifestation of X-linked adrenoleukodystrophy.
    Br J Dermatol. 2019 Jul 3. doi: 10.1111/bjd.18310.
    PubMed     Abstract available


  840. FREW JW, Navrazhina K, Byrd AS, Garg A, et al
    Defining Lesional, Perilesional and Unaffected Skin in Hidradenitis Suppurativa: Proposed Recommendations for Clinical Trials and Translational Research Studies.
    Br J Dermatol. 2019 Jul 3. doi: 10.1111/bjd.18309.
    PubMed     Abstract available


  841. KURIZKY PS, Gomes CM, Cesetti MV, Martins GA, et al
    Cross-sectional screening study for leishmania DNA and antibodies in biologic-treated psoriasis patients living in an area endemic for leishmaniasis.
    Br J Dermatol. 2019 Jul 1. doi: 10.1111/bjd.18262.
    PubMed     Abstract available


  842. HAO-ZE S, Liu YX, Jiang YQ, Chen SL, et al
    Clinical characteristics of primary cutaneous lymphoma: two centers analysis in China.
    Br J Dermatol. 2019 Jul 1. doi: 10.1111/bjd.18266.
    PubMed     Abstract available


  843. COLE D, Mohammed T, Lim H
    Rapid Response of Pityriasis Rubra Pilaris with Psoriasis Overlap to Secukinumab.
    Br J Dermatol. 2019 Jul 1. doi: 10.1111/bjd.18263.
    PubMed     Abstract available


  844. BALAKIRSKI G, Grothaus J, Altengarten J, Ott H, et al
    Pediatric lichen sclerosus: A systematic review of 4516 cases.
    Br J Dermatol. 2019 Jul 1. doi: 10.1111/bjd.18267.
    PubMed     Abstract available


  845. ANDERSEN L, Nyeland ME, Nyberg F
    Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the UK and the US.
    Br J Dermatol. 2019 Jul 1. doi: 10.1111/bjd.18296.
    PubMed     Abstract available


  846. LEE HY
    How different is Stevens-Johnson syndrome/toxic epidermal necrolysis in children?
    Br J Dermatol. 2019;181:10-11.
    PubMed    


  847. ARMSTRONG J
    Bioenergetic cellular index: a clinical biomarker to identify metabolic adaption in melanoma?
    Br J Dermatol. 2019;181:15-16.
    PubMed    


  848. DE BRUIN-WELLER M
    Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?
    Br J Dermatol. 2019;181:12-13.
    PubMed    


  849. FRANKE V
    Talimogene laherparepvec monotherapy, an elegant alternative to systemic immunotherapy for the treatment of early metastatic melanoma.
    Br J Dermatol. 2019;181:20-21.
    PubMed    


  850. TOLAND AE
    POT1 pathogenic variants: not all telomere pathway genes are equal in risk of hereditary cutaneous melanoma.
    Br J Dermatol. 2019;181:14-15.
    PubMed    


  851. DELLATORRE G, Gadens GA
    Image Gallery: Wide area digital dermoscopy for congenital melanocytic naevi.
    Br J Dermatol. 2019;181:e3.
    PubMed    


  852. DODIUK-GAD RP
    International and multidisciplinary scientific collaborations and networks are advancing knowledge about Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2019;181:18-19.
    PubMed    


  853. SILPA-ARCHA N, Lim HW, Wongpraparut C
    Excimer laser in vitiligo: where there is light, there is hope.
    Br J Dermatol. 2019;181:21-22.
    PubMed    


  854. LE CLEACH L, Cribier B
    New evidence but still unmet medical needs in rosacea treatment.
    Br J Dermatol. 2019;181:11-12.
    PubMed    


  855. DE BERKER D, Pasch MC
    Primary care and actinic keratosis.
    Br J Dermatol. 2019;181:13-14.
    PubMed    


  856. ZOUBOULIS CC
    The socioeconomic burden of hidradenitis suppurativa/acne inversa.
    Br J Dermatol. 2019;181:7-8.
    PubMed    


  857. OOSTERHAVEN JAF
    Anatomical location differences in sodium lauryl sulfate-induced irritation.
    Br J Dermatol. 2019;181:19-20.
    PubMed    


    June 2019
  858. CHOI JY, Dawe R, Ibbotson S, Fleming C, et al
    Topical treatments in atopic dermatitis: unexpectedly low use of emollients; use of topical corticosteroid is higher in juvenile patients, higher in male vs females, and shows independent associations with asthma and depression.
    Br J Dermatol. 2019 Jun 30. doi: 10.1111/bjd.18265.
    PubMed     Abstract available


  859. GARCIA-DOVAL I, Sbidian E
    Effectiveness of classic drugs in psoriasis: still alive.
    Br J Dermatol. 2019 Jun 28. doi: 10.1111/bjd.17876.
    PubMed    


  860. HUNTER HJA
    What's the point in checking the skin?
    Br J Dermatol. 2019 Jun 25. doi: 10.1111/bjd.17829.
    PubMed    


  861. LIU C, Ko MJ
    Image Gallery: Benign lymphangiomatous papules of the skin after radiotherapy.
    Br J Dermatol. 2019 Jun 25. doi: 10.1111/bjd.17844.
    PubMed    


  862. GUPTA GK, Pittaluga S, Cowen EW
    Image Gallery: Primary cutaneous Rosai-Dorfman disease.
    Br J Dermatol. 2019 Jun 25. doi: 10.1111/bjd.17999.
    PubMed    


  863. KIM HS, Kim HJ, Hong ES, Kim KB, et al
    The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
    Br J Dermatol. 2019 Jun 24. doi: 10.1111/bjd.18247.
    PubMed     Abstract available


  864. KORMAN NJ
    Management of psoriasis as a systemic disease: What is the evidence?
    Br J Dermatol. 2019 Jun 21. doi: 10.1111/bjd.18245.
    PubMed     Abstract available


  865. ANKER JP, Ribero S, Yelamos O, Garcia A, et al
    Basal Cell Carcinoma Characterisation Using Fusion Ex Vivo Confocal Microscopy: A Promising Change In Conventional Skin Histopathology.
    Br J Dermatol. 2019 Jun 20. doi: 10.1111/bjd.18239.
    PubMed     Abstract available


  866. LIYANAGE UE, Law MH, Barrett JH, Iles MM, et al
    Is there a causal relationship between vitamin D and melanoma risk? : A Mendelian randomization study.
    Br J Dermatol. 2019 Jun 19. doi: 10.1111/bjd.18238.
    PubMed     Abstract available


  867. REICH K, Warren RB, Iversen L, Puig L, et al
    Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomised phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks.
    Br J Dermatol. 2019 Jun 19. doi: 10.1111/bjd.18232.
    PubMed     Abstract available


  868. BELLINATO F, Girolomoni G, Gisondi P
    Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission.
    Br J Dermatol. 2019 Jun 18. doi: 10.1111/bjd.18225.
    PubMed     Abstract available


  869. SHIBATA Y, Serada S, Fujimoto M, Oishi T, et al
    Myosin heavy chain, a novel allergen for fish allergy in patients with atopic dermatitis.
    Br J Dermatol. 2019 Jun 18. doi: 10.1111/bjd.18226.
    PubMed     Abstract available


  870. GREEN A, Shaddick G, Charlton R, Snowball J, et al
    Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis.
    Br J Dermatol. 2019 Jun 18. doi: 10.1111/bjd.18227.
    PubMed     Abstract available


  871. AHMED S, Chakka S, Concha J, Krain R, et al
    Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis.
    Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18223.
    PubMed     Abstract available


  872. HERCOGOVA J, Papp KA, Chyrok V, Ullmann M, et al
    AURIEL-PsO: A randomised, double-blind Phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB110222 to reference adalimumab in patients with moderate-to-severe chronic plaque-type psoriasis.
    Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18220.
    PubMed     Abstract available


  873. DUMONT M, Ram-Wolff C, Roelens M, Brice P, et al
    Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas.
    Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18215.
    PubMed     Abstract available


  874. MOLLANAZAR NK, Qiu CC, Aldrich JL, Tedaldi E, et al
    Use of Dupilumab in HIV-positive Patients: Report of Four Cases.
    Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18222.
    PubMed     Abstract available


  875. VAN LEERSUM FS, Seyger MMB, Theunissen TEJ, Bongers EMHF, et al
    Recessive mosaicism in ABCA12 causes blaschkoid congenital ichthyosiform erythroderma.
    Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18216.
    PubMed     Abstract available


  876. BEATSON M, Misitzis A, Lew RA, Weinstock MA, et al
    Trends in usage of the terms keratinocyte carcinoma and nonmelanoma skin cancer in the medical literature.
    Br J Dermatol. 2019 Jun 7. doi: 10.1111/bjd.18213.
    PubMed     Abstract available


  877. SIMPSON JK, Martinez-Quiepo M, Onoufriadis A, Tso S, et al
    Genotype-phenotype correlation in a large English cohort of autosomal recessive ichthyosis.
    Br J Dermatol. 2019 Jun 6. doi: 10.1111/bjd.18211.
    PubMed     Abstract available


  878. MAJEED-ARISS R, McPhee M, McAteer H, Griffiths C, et al
    The top ten research priorities for psoriasis in the UK; results of a James Lind Alliance psoriasis priority setting partnership.
    Br J Dermatol. 2019 Jun 4. doi: 10.1111/bjd.18209.
    PubMed     Abstract available


  879. LUI H, Bolognia J, Pellacani G, Griffiths CEM, et al
    How does the International League of Dermatological Societies promote skin health for the world?
    Br J Dermatol. 2019;180:1281-1283.
    PubMed    


  880. CROWLEY J
    Targeting granulocyte-monocyte colony-stimulating factor in psoriasis. What a negative study can teach us.
    Br J Dermatol. 2019;180:1286-1287.
    PubMed    


  881. SHOJI R, Osada SI, Noto M, Maki N, et al
    Image Gallery: Basal cell carcinoma on the fingertip pad.
    Br J Dermatol. 2019;180:e181.
    PubMed    


  882. JANDA M
    Is there a role for digital technology in measuring the value of skin self-examination?
    Br J Dermatol. 2019;180:1285.
    PubMed    


  883. NEWTON P, Smith D
    Learning from patients' experiences: the case of Travellers and their experiences of using health services for skin complaints.
    Br J Dermatol. 2019;180:1290-1291.
    PubMed    


  884. MCINERNEY-LEO AM, Finnane A
    The personal touch: does the communication method affect response to melanoma genetic risk?
    Br J Dermatol. 2019;180:1288-1289.
    PubMed    


  885. POYNER EFM, Dubois A, Haniffa M
    Are regulatory T cells associated with cutaneous viral infections?
    Br J Dermatol. 2019;180:1294.
    PubMed    


  886. ROWLANDS G
    Health literacy and psoriasis: putting the patient at the centre of care.
    Br J Dermatol. 2019;180:1299-1300.
    PubMed    


  887. ALBRECHT J, Werth VP
    Understanding cutaneous lupus erythematosus: a step forward.
    Br J Dermatol. 2019;180:1292-1293.
    PubMed    


  888. LESTER JC, Taylor SC, Chren MM
    Under-representation of skin of colour in dermatology images: not just an educational issue.
    Br J Dermatol. 2019;180:1521-1522.
    PubMed    


  889. KINOUCHI M, Iwasaki T, Koyama M, Obata M, et al
    Image Gallery: Cutaneous hydrophilic polymer emboli following thoracic endovascular aortic repair.
    Br J Dermatol. 2019;180:e182.
    PubMed    


  890. STROWD LC, Feldman SR
    Lead with your gut: research-implicated infant gut staphylococcal strains may predict development of atopic dermatitis.
    Br J Dermatol. 2019;180:1296-1297.
    PubMed    


  891. MAGIN P
    Psoriasis and sleep: unravelling the relationship.
    Br J Dermatol. 2019;180:1289-1290.
    PubMed    


  892. MONTGOMERY K
    Acknowledging the impact of hair loss.
    Br J Dermatol. 2019;180:1287.
    PubMed    


  893. SUN J, Wang Y
    Brentuximab vedotin: unexpectedly good response in CD30(-) mycosis fungoides.
    Br J Dermatol. 2019;180:1300-1301.
    PubMed    


  894. SAUNTE DML
    High speed and reproducibility in routine diagnostics of superficial fungal infections.
    Br J Dermatol. 2019;180:1298-1299.
    PubMed    


  895. APFELBACHER CJ
    Working in the dirt and heat: Bavarian farmers' insights into barriers to implementing sun protection related to the demands of their agricultural work.
    Br J Dermatol. 2019;180:1291-1292.
    PubMed    


  896. NOTINGHER I
    Can fluorescence confocal microscopy replace frozen sections for margin assessment in Mohs micrographic surgery?
    Br J Dermatol. 2019;180:1295-1296.
    PubMed    


  897. CONTASSOT E, French LE
    A new link between autoinflammation and hidradenitis suppurativa?
    Br J Dermatol. 2019;180:1294-1295.
    PubMed    


  898. YAMAGAMI J
    Prediction of relapse in the treatment of pemphigus.
    Br J Dermatol. 2019;180:1299.
    PubMed    


  899. LONGO C, Pampena R, Piana S, Pellacani G, et al
    When follow-up is telling you the truth.
    Br J Dermatol. 2019;180:1559-1560.
    PubMed    


  900. CHAWLA S
    A novel approach to outpatient clinic management.
    Br J Dermatol. 2019;180:1560-1561.
    PubMed    


    May 2019
  901. GABES M, Chamlin SL, Lai JS, Cella D, et al
    Evaluation of responsiveness and estimation of smallest detectable change (SDC) and minimal important change (MIC) scores for the Childhood Atopic Dermatitis Impact Scale.
    Br J Dermatol. 2019 May 31. doi: 10.1111/bjd.18204.
    PubMed     Abstract available


  902. SBIDIAN E, Madrange M, Viguier M, Salmona M, et al
    Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds.
    Br J Dermatol. 2019 May 31. doi: 10.1111/bjd.18203.
    PubMed     Abstract available


  903. PRESLEY C, Rundle CW, Kolodziejczyk T, Andrews S, et al
    Prioritisation of Cochrane Skin Systematic Reviews.
    Br J Dermatol. 2019 May 30. doi: 10.1111/bjd.18180.
    PubMed     Abstract available


  904. DE WIJS LEM, Bosma AL, Erler NS, Hollestein LM, et al
    Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data.
    Br J Dermatol. 2019 May 30. doi: 10.1111/bjd.18179.
    PubMed     Abstract available


  905. HENRI P, Prevel C, Pellerano M, Lacote J, et al
    Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity.
    Br J Dermatol. 2019 May 30. doi: 10.1111/bjd.18178.
    PubMed     Abstract available


  906. LAGHA IB, Jaber K, Rabhi F, Slimane B, et al
    Psoriasis and liver fibrosis: an investigation using transient elastography in Tunisian patients with psoriasis.
    Br J Dermatol. 2019 May 30. doi: 10.1111/bjd.18177.
    PubMed     Abstract available


  907. LO Y, Tsai TF
    Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case series.
    Br J Dermatol. 2019 May 30. doi: 10.1111/bjd.18174.
    PubMed     Abstract available


  908. BRONCKERS IMGJ, Maatkamp M, Kievit W, van de Kerkhof PCM, et al
    The association of scalp psoriasis with overall psoriasis severity and koebnerization in children: cross-sectional findings from the Dutch ChildCAPTURE registry.
    Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18168.
    PubMed     Abstract available


  909. UCHIDA H, Kamata M, Mizukawa I, Watanabe A, et al
    Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: A single-centre retrospective study.
    Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18163.
    PubMed     Abstract available


  910. GONZALEZ-CANTERO A, Carretero G, Rivera R, Ferrandiz C, et al
    Women with moderate-severe psoriasis in Spain (Biobadaderm registry) show over a 50% reduction in age-adjusted fertility rate when compared with the general population.
    Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18164.
    PubMed     Abstract available


  911. DESCHAMPS O, Ortonne N, Hue S, Rodriguez C, et al
    Acute exanthemas: a prospective study of 98 adult patients with emphasis of cytokinic and metagenomic investigation.
    Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18166.
    PubMed     Abstract available


  912. POLUBOTHU S, Kinsler VA
    Longitudinal study of congenital melanocytic naevi reveals that final colour is determined by normal skin colour, and is unaltered by superficial removal techniques.
    Br J Dermatol. 2019 May 23. doi: 10.1111/bjd.18149.
    PubMed     Abstract available


  913. KOBIC A, Shah KK, Schmitt AR, Goyal G, et al
    Erdheim-Chester Disease: Expanding the spectrum of cutaneous manifestations.
    Br J Dermatol. 2019 May 23. doi: 10.1111/bjd.18153.
    PubMed     Abstract available


  914. LOGGER JGM, de Vries FMC, van Erp PEJ, de Jong EMGJ, et al
    Non-invasive objective skin measurement methods for rosacea assessment: a systematic review.
    Br J Dermatol. 2019 May 23. doi: 10.1111/bjd.18151.
    PubMed     Abstract available


  915. POLUBOTHU S, McGuire N, Al-Olabi L, Baird W, et al
    Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
    Br J Dermatol. 2019 May 21. doi: 10.1111/bjd.18106.
    PubMed     Abstract available


  916. AMERI AH, Mooradian MJ, Emerick KS, Park JC, et al
    Immunotherapeutic Strategies for Cutaneous Squamous Cell Carcinoma Prevention in Xeroderma Pigmentosum.
    Br J Dermatol. 2019 May 18. doi: 10.1111/bjd.18144.
    PubMed     Abstract available


  917. CALBET-LLOPART N, Potrony M, Tell-Marti G, Carrera C, et al
    Detection of cell-free circulating BRAF(V) (600E) by droplet digital PCR in melanoma and non-melanoma patients under dermatological surveillance.
    Br J Dermatol. 2019 May 18. doi: 10.1111/bjd.18147.
    PubMed     Abstract available


  918. BARBIERI J, Gelfand JM
    Responsiveness of the EQ-5D-3L, DLQI, and DLQI-R for Patients With Psoriasis in the United States.
    Br J Dermatol. 2019 May 17. doi: 10.1111/bjd.18142.
    PubMed     Abstract available


  919. REICH K, Puig L, Szepietowski JC, Paul C, et al
    Secukinumab dosing optimization in patients with moderate to severe plaque psoriasis: Results from the randomised, open-label OPTIMISE study.
    Br J Dermatol. 2019 May 17. doi: 10.1111/bjd.18143.
    PubMed     Abstract available


  920. ERSSER SJ, Dyson J, Muinonen-Martin A
    Significant Limitations of a Systematic Review and Meta-Analysis of Interventions to Promote Skin Self-Examination: Reply from Authors.
    Br J Dermatol. 2019 May 15. doi: 10.1111/bjd.18131.
    PubMed     Abstract available


  921. COUPS EJ
    Significant Limitations of a Systematic Review and Meta-Analysis of Interventions to Promote Skin Self-Examination.
    Br J Dermatol. 2019 May 15. doi: 10.1111/bjd.18130.
    PubMed     Abstract available


  922. JIAO Q, Qian Q, Liu C, Luo Y, et al
    TH 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of ICOS.
    Br J Dermatol. 2019 May 15. doi: 10.1111/bjd.18040.
    PubMed     Abstract available


  923. GOTO H, Tada A, Ibe A, Kitajima Y, et al
    Basket-weave structure in the stratum corneum is an important factor for maintaining physiological properties of human skin as studied using reconstructed human epidermis and tape-stripping of human cheek skin.
    Br J Dermatol. 2019 May 11. doi: 10.1111/bjd.18123.
    PubMed     Abstract available


  924. RUSSELL-JONES R
    A Brighter Future for Melanoma.
    Br J Dermatol. 2019 May 11. doi: 10.1111/bjd.18122.
    PubMed     Abstract available


  925. KIM TH, Kim HJ, Seo JW, Song KH, et al
    Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities.
    Br J Dermatol. 2019 May 11. doi: 10.1111/bjd.18121.
    PubMed     Abstract available


  926. MATTERNE U, Baumeister SE, Apfelbacher C
    Suicidality and risk of suicidality in psoriasis: A critical appraisal of two systematic reviews and meta-analyses.
    Br J Dermatol. 2019 May 10. doi: 10.1111/bjd.18108.
    PubMed     Abstract available


  927. CLAYTON RW, Gobel K, Niessen CM, Paus R, et al
    Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis.
    Br J Dermatol. 2019 May 6. doi: 10.1111/bjd.17981.
    PubMed     Abstract available


  928. ELLIS R, Tang D, Nasr B, Greenwood A, et al
    Epidermal AMBRA1 and Loricrin; a paradigm shift in the prognostication and stratification of AJCC stage I melanomas.
    Br J Dermatol. 2019 May 6. doi: 10.1111/bjd.18086.
    PubMed     Abstract available


  929. GIUNTA A, Manfreda V, Esposito M, Duca ED, et al
    Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis: a single-center, observational, retrospective, real-life study.
    Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18090.
    PubMed     Abstract available


  930. RIIHILA P, Viiklepp K, Nissinen L, Farshchian M, et al
    Tumor cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
    Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18095.
    PubMed     Abstract available


  931. CONCHA JSS, Pena S, Gaffney RG, Patel B, et al
    Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.
    Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18096.
    PubMed     Abstract available


  932. TESKE NM, Jacobe HT
    Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphea by severity and identify clinically significant change.
    Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18097.
    PubMed     Abstract available


  933. MASLIN D, Veitch D, Williams HC
    Direct infant UV light exposure is associated with eczema and immune development: A Critical Appraisal.
    Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18087.
    PubMed     Abstract available


  934. MOLLOY K, Jonak C, Sherida FJ, Woei-A-Jin H, et al
    Characteristics associated with significantly worse quality of life in mycosis fungoides/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
    Br J Dermatol. 2019 May 2. doi: 10.1111/bjd.18089.
    PubMed     Abstract available


  935. LEE HH, Patel KR, Singam V, Rastogi S, et al
    Associations of cutaneous and extra-cutaneous infections with Hidradenitis Suppurativa in US children and adults.
    Br J Dermatol. 2019 May 2. doi: 10.1111/bjd.18093.
    PubMed     Abstract available


  936. WERTH VP, Merrill JT
    A double-blind, randomized, placebo-controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus.
    Br J Dermatol. 2019;180:964-965.
    PubMed    


  937. VENTURA A, Pitocco R, Di Stefani A, Cota C, et al
    Image Gallery: Peculiar subungual localization of a second primary melanoma during BRAF inhibitors treatment for metastatic melanoma: case report.
    Br J Dermatol. 2019;180:e142.
    PubMed    


  938. SONG PI, Armstrong CA
    Novel therapeutic approach with PAC-14028 cream, a TRPV1 antagonist, for patients with mild-to-moderate atopic dermatitis.
    Br J Dermatol. 2019;180:971-972.
    PubMed    


  939. LEE EB, Wu JJ
    Safety of long-term interleukin-23 inhibition in patients with psoriasis.
    Br J Dermatol. 2019;180:977-978.
    PubMed    


  940. STROWD LC
    Inpatient dermatology: a paradigm shift in the management of skin disease in the hospital.
    Br J Dermatol. 2019;180:966-967.
    PubMed    


  941. LIU W, Zhao Y, Liu JW, Qian YT, et al
    Image Gallery: Cutaneous Phialophora verrucosa infection in a 28-year-old farmer.
    Br J Dermatol. 2019;180:e143.
    PubMed    


  942. INGRAM JR
    Refining the hidradenitis suppurativa Hurley staging system for mild, moderate and severe disease.
    Br J Dermatol. 2019;180:991-992.
    PubMed    


  943. MICHELETTI RG
    The potential cost-savings of tumour necrosis factor inhibitors for hidradenitis suppurativa.
    Br J Dermatol. 2019;180:988-989.
    PubMed    


  944. TANGHETTI E
    The importance of good photography in clinical trials and in the clinic.
    Br J Dermatol. 2019;180:978.
    PubMed    


  945. APFELBACHER CJ, Ofenloch R
    Good evidence on measurement properties of the Dermatology Life Quality Index, Itchy Quality of Life and 5-dimensions itch scales in atopic eczema, but problems with structural validity remain.
    Br J Dermatol. 2019;180:979-980.
    PubMed    


  946. EDWARDS C
    Measurement of vitiligo: human vs. machine.
    Br J Dermatol. 2019;180:991.
    PubMed    


  947. PAIN CE
    Juvenile localized scleroderma: can we modify treatment strategies based on predictors of relapse?
    Br J Dermatol. 2019;180:990-991.
    PubMed    


  948. NISHIDA H
    Genetic analysis of digital papillary adenocarcinoma.
    Br J Dermatol. 2019;180:987.
    PubMed    


  949. JEMEC GBE
    Evidence-based hidradenitis suppurativa guidelines - and now all together please.
    Br J Dermatol. 2019;180:975.
    PubMed    


  950. FERNANDEZ AP
    Amyopathic dermatomyositis - a 'feel-good' dermatology story.
    Br J Dermatol. 2019;180:974.
    PubMed    


  951. LUDWIG RJ
    Type VII collagen IgE autoantibodies in epidermolysis bullosa acquisita: more common than suspected.
    Br J Dermatol. 2019;180:981-983.
    PubMed    


  952. RAMOT Y
    Keratoderma and woolly hair: an important clue for the presence of cardiac pathology.
    Br J Dermatol. 2019;180:983-984.
    PubMed    


  953. QUERFELD C
    The emerging role of microRNAs in the molecular diagnosis of mycosis fungoides.
    Br J Dermatol. 2019;180:984-985.
    PubMed    


  954. RODRIGUES JN
    Validated or not validated? Is that the question?
    Br J Dermatol. 2019;180:976.
    PubMed    


  955. MELLODY KT, Ozols M, Watson REB
    The role of fibroblasts in the pathogenesis of linear morphoea: targeting the secretome.
    Br J Dermatol. 2019;180:985-987.
    PubMed    


  956. YAMAGAMI J
    Reorganization of serum analysis tools for the diagnosis of bullous pemphigoid.
    Br J Dermatol. 2019;180:980-981.
    PubMed    


  957. EGEBERG A
    Chronic urticaria - bad to the bone?
    Br J Dermatol. 2019;180:979.
    PubMed    


  958. GELLER S, Lebowitz E, Pulitzer M, Myskowski PL, et al
    Understanding racial disparities in mycosis fungoides through international collaborative studies.
    Br J Dermatol. 2019;180:1263-1264.
    PubMed    


  959. HORTON E, Lee N, Layton AM, Eady EA, et al
    Response to 'Views of oral antibiotics and advice seeking about acne: a qualitative study of online discussion forums' based on evidence obtained from The Acne Priority Setting Partnership.
    Br J Dermatol. 2019;180:1265-1266.
    PubMed    


  960. ALBRECHT J, Barbaric J, Nast A
    Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa? Reply from the authors.
    Br J Dermatol. 2019;180:1262-1263.
    PubMed    


  961. SCARISBRICK JJ, Quaglino P, Prince HM, Kim YH, et al
    Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease.
    Br J Dermatol. 2019;180:1264-1265.
    PubMed    


  962. CAPOSIENA CARO RD, Bianchi L
    Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa?
    Br J Dermatol. 2019;180:1262.
    PubMed    


    April 2019
  963. SBIDIAN E, Billionnet C, Weill A, Maura G, et al
    Persistence of apremilast in moderate-to-severe psoriasis. A real-world analysis of 14,147 apremilast- and methotrexate-naive patients in the French national health insurance database.
    Br J Dermatol. 2019 Apr 25. doi: 10.1111/bjd.18047.
    PubMed     Abstract available


  964. CENZER I, Nkansah-Mahaney N, Wehner M, Chren MM, et al
    A Multi Year Cross Sectional Study of US National Prescribing Patterns of First Generation Sedating Antihistamines in Older Adults with Skin Disease.
    Br J Dermatol. 2019 Apr 25. doi: 10.1111/bjd.18042.
    PubMed     Abstract available


  965. ARMARIO-HITA JC, Pereyra-Rodriguez J, Silvestre JF, Ruiz-Villaverde R, et al
    Treatment of moderate-to-severe Atopic dermatitis with dupilumab in real clinical practice. A multicentre, retrospective case series.
    Br J Dermatol. 2019 Apr 25. doi: 10.1111/bjd.18041.
    PubMed     Abstract available


  966. ZIEMAN AG, Coulombe PA
    Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: New insight into skin epithelial homeostasis and avenues for treatment.
    Br J Dermatol. 2019 Apr 25. doi: 10.1111/bjd.18033.
    PubMed     Abstract available


  967. BLANCHARD SK, Sullivan KM, Hooten JN, Holcomb ZE, et al
    High dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft versus host disease.
    Br J Dermatol. 2019 Apr 24. doi: 10.1111/bjd.18028.
    PubMed     Abstract available


  968. THACI D, Papp K, Marcoux D, Weibel L, et al
    Sustained Long-Term Efficacy and Safety of Adalimumab in Pediatric Patients with Severe Chronic Plaque Psoriasis from a Randomised, Double-Blind, Phase 3 Study.
    Br J Dermatol. 2019 Apr 24. doi: 10.1111/bjd.18029.
    PubMed     Abstract available


  969. JIANG YQ, Xiong JH, Li HY, Yang XH, et al
    Recognizing Basal Cell Carcinoma on Smartphone-Captured Digital Histopathology Images with Deep Neural Network.
    Br J Dermatol. 2019 Apr 24. doi: 10.1111/bjd.18026.
    PubMed     Abstract available


  970. ELEN-LIRA F, Podlipnik S, Potrony M, Tell-Marti G, et al
    Inherited MC1R variants in melanoma patients are associated with better survival in females.
    Br J Dermatol. 2019 Apr 23. doi: 10.1111/bjd.18024.
    PubMed     Abstract available


  971. VAN DEN BERGHE N, De Keyser E, Soenen R, Meuleman L, et al
    Clinical response correlates with 4-week post injection ustekinumab concentrations in moderate-to-severe psoriasis patients.
    Br J Dermatol. 2019 Apr 20. doi: 10.1111/bjd.18016.
    PubMed     Abstract available


  972. GISONDI P, Rovaris M, Piaserico S, Girolomoni G, et al
    Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis.
    Br J Dermatol. 2019 Apr 20. doi: 10.1111/bjd.18015.
    PubMed     Abstract available


  973. RICHER V, AlObaida S, Kharazmi P, Lee T, et al
    Old is gold? Retrospective evaluation of efficacy and safety of topical psoralen-UVA phototherapy for palmoplantar psoriasis and dermatitis.
    Br J Dermatol. 2019 Apr 18. doi: 10.1111/bjd.18012.
    PubMed     Abstract available


  974. PAPINI M, Cusano F, Romanelli M, Burlando M, et al
    Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate to severe plaque-type psoriasis: Results from extension phase of the SUPREME study.
    Br J Dermatol. 2019 Apr 18. doi: 10.1111/bjd.18013.
    PubMed     Abstract available


  975. LANGAN EA, Kunstner A, Miodovnik M, Zillikens D, et al
    Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis.
    Br J Dermatol. 2019 Apr 15. doi: 10.1111/bjd.17989.
    PubMed     Abstract available


  976. GASPARINI G, Madjlessi N, Delyon J, Carmisciano L, et al
    Usefulness of the "two-step method" of digital follow-up in early stage melanoma detection in at high risk French patients - A retrospective 4-year study.
    Br J Dermatol. 2019 Apr 12. doi: 10.1111/bjd.18006.
    PubMed     Abstract available


  977. RONGIOLETTI F
    Primary pediatric cutaneous mucinoses.
    Br J Dermatol. 2019 Apr 12. doi: 10.1111/bjd.18004.
    PubMed     Abstract available


  978. BURDEN-TEH E, Thomas KS, Gran S, Murphy R, et al
    Development of clinical diagnostic criteria for plaque psoriasis in children: An eDelphi consensus study with the International Psoriasis Council.
    Br J Dermatol. 2019 Apr 10. doi: 10.1111/bjd.17994.
    PubMed     Abstract available


  979. SILVERBERG JI, Margolis DJ, Boguniewicz M, Fonacier L, et al
    Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Br J Dermatol. 2019 Apr 10. doi: 10.1111/bjd.18002.
    PubMed     Abstract available


  980. REICH K, Reich JLK, Falk TM, Blodorn-Schlicht N, et al
    Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous Th1- and Th17-inflammatory pathways.
    Br J Dermatol. 2019 Apr 10. doi: 10.1111/bjd.18001.
    PubMed     Abstract available


  981. VAND-RAJABPOUR F, Noormohammadpour P, Ahmadifard MR, Panjeshahi S, et al
    Upregulation of SNAI2 and SOX9 mRNA versus downregulation of eight other EMT/stemness related genes in Basal Cell Carcinoma.
    Br J Dermatol. 2019 Apr 10. doi: 10.1111/bjd.17995.
    PubMed     Abstract available


  982. DIENG M, Morton RL, Costa DSJ, Butow PN, et al
    Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomised controlled trial.
    Br J Dermatol. 2019 Apr 9. doi: 10.1111/bjd.17990.
    PubMed     Abstract available


  983. GOYAL A, Goyal K, Bohjanen K, Pearson D, et al
    Epidemiology of primary cutaneous gamma/delta T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the United States from 2006-2015: A Surveillance, Epidemiology, and End Results-18 analysis.
    Br J Dermatol. 2019 Apr 5. doi: 10.1111/bjd.17985.
    PubMed     Abstract available


  984. EL-KHAYAT RH, Salmon PJ, Mortimer NJ
    A retrospective review of conchal bowl full-thickness skin grafts for reconstruction of nasal ala defects.
    Br J Dermatol. 2019 Apr 4. doi: 10.1111/bjd.17988.
    PubMed     Abstract available


  985. BORDA LJ, Jaller JA, Kirsner RS
    Absence of donor-site pathergy following fractional autologous full-thickness skin grafting in pyoderma gangrenosum.
    Br J Dermatol. 2019 Apr 4. doi: 10.1111/bjd.17987.
    PubMed     Abstract available


  986. SCARFI F, Gori A, Topa A, Trane L, et al
    Image Gallery: In vivo fluorescence-advanced videodermatoscopy for the characterization of skin melanocytic pigmented lesions.
    Br J Dermatol. 2019;180:e104.
    PubMed    


  987. OCAMPO-CANDIANI J, Ocampo-Garza SS, Franco-Marquez R, Villarreal-Villarreal CD, et al
    Image Gallery: Primary cutaneous chest-wall osteosarcoma, an extraordinary entity.
    Br J Dermatol. 2019;180:e105.
    PubMed    


  988. STANDER S
    How acute stress impacts the itch-scratch cycle in atopic dermatitis: a clinical lesson.
    Br J Dermatol. 2019;180:689-690.
    PubMed    


  989. FIORENTINO D
    Dermatomyositis antibodies continue to mysTIFy.
    Br J Dermatol. 2019;180:709-710.
    PubMed    


  990. MARTINEZ AE
    Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa.
    Br J Dermatol. 2019;180:711-712.
    PubMed    


  991. WELZEL J
    From actinic keratosis to squamous cell carcinoma - answers to some open questions.
    Br J Dermatol. 2019;180:699-700.
    PubMed    


  992. HAMBLY R, Kirby B
    Prolonged clindamycin and rifampicin for hidradenitis suppurativa: resist to prevent resistance.
    Br J Dermatol. 2019;180:702-703.
    PubMed    


  993. SHALOM G, Cohen AD
    The epidemiology of hidradenitis suppurativa: what do we know?
    Br J Dermatol. 2019;180:712-713.
    PubMed    


  994. SITARU C
    Measuring the quality of life in pemphigus.
    Br J Dermatol. 2019;180:705.
    PubMed    


  995. WILLIAMS C, Fuller LC
    Why does scabies treatment fail?
    Br J Dermatol. 2019;180:710-711.
    PubMed    


  996. WOLF P
    Ablative fractional laser-fortified daylight photodynamic therapy may be the patient's preferred choice for the treatment of field cancerization.
    Br J Dermatol. 2019;180:697-698.
    PubMed    


  997. GOLDENBERG A, Jacob SE
    The atopic paradox.
    Br J Dermatol. 2019;180:704-705.
    PubMed    


  998. DE BERKER D
    A discrete-choice experiment and actinic keratosis: what is the answer?
    Br J Dermatol. 2019;180:691-692.
    PubMed    


  999. MORTON CA
    Come in from the cold - laser fabric photodynamic therapy offers an alternative to seasonal daylight therapy.
    Br J Dermatol. 2019;180:703-704.
    PubMed    


  1000. DIRSCHKA T, Gupta G
    Treatments for actinic keratoses - still a challenge for clinicians.
    Br J Dermatol. 2019;180:701.
    PubMed    


  1001. GELLER S
    Unfolding the genetic basis of pemphigus.
    Br J Dermatol. 2019;180:713-714.
    PubMed    


  1002. BESSIS D, Petit A, Battistella M, Bourrat E, et al
    Naevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal naevus) and mosaic FGFR3 and FGFR2 mutations.
    Br J Dermatol. 2019;180:955-957.
    PubMed    


  1003. MELNIK BC, John SM, Agamia NF, Chen W, et al
    Isotretinoin's paradoxical effects in immortalized sebocytes.
    Br J Dermatol. 2019;180:957-958.
    PubMed    


  1004. MARASCA C, Scala E, Di Caprio R, Raimondo A, et al
    Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb.
    Br J Dermatol. 2019;180:950-951.
    PubMed    


  1005. ALBRECHT J, Barbaric J, Nast A
    Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin-rifampicin combination for hidradenitis suppurativa?
    Br J Dermatol. 2019;180:949-950.
    PubMed    


  1006. MARASCA C, Masara A, Annunziata MC, Bettoli V, et al
    Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.
    Br J Dermatol. 2019;180:949.
    PubMed    


    March 2019
  1007. REDHU D, Franke K, Kumari V, Francuzik W, et al
    TSLP production induced by skin irritation results from the concomitant activation of PAR-2 and IL-1 pathways.
    Br J Dermatol. 2019 Mar 29. doi: 10.1111/bjd.17940.
    PubMed     Abstract available


  1008. SAKNITE I, Gill M, Alessi-Fox C, Byrne M, et al
    Features of cutaneous acute graft-versus-host disease by reflectance confocal microscopy.
    Br J Dermatol. 2019 Mar 29. doi: 10.1111/bjd.17921.
    PubMed     Abstract available


  1009. TARAZI M, Gaffney RG, Feng R, Werth VP, et al
    Evaluating cutaneous lupus disease activity endpoints and their effects on quality of life as an outcome measure for clinical trials.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17926.
    PubMed     Abstract available


  1010. KINSLER VA, Boccara O, Fraitag S, Torrelo A, et al
    Mosaic abnormalities of the skin - review and guidelines from the European Reference Network for rare skin diseases (ERN-Skin).
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17924.
    PubMed     Abstract available


  1011. HIDALGO-CANTABRANA C, Gomez J, Delgado S, Requena-Lopez S, et al
    Gut microbiota dysbiosis in a cohort of psoriasis patients.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17931.
    PubMed     Abstract available


  1012. ZHANG Y, Chen H, Jiang Y, Xu X, et al
    Clinicopathological features of cutaneous Rosai-Dorfman disease and its relationship to IgG4-related disease:a retrospective study.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17939.
    PubMed     Abstract available


  1013. SEMENOV YR, Rosenberg AR, Herbosa C, Mehta-Shah N, et al
    Health-related quality of life and economic implications of cutaneous T-cell lymphoma.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17941.
    PubMed     Abstract available


  1014. PANDEYA N, Olsen CM, Thompson BS, Dusingize JC, et al
    Aspirin and non-steroidal anti-inflammatory drug use and keratinocyte cancers: A large population-based cohort study of skin cancer in Australia.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17938.
    PubMed     Abstract available


  1015. BISSONNETTE R, Maari C, Forman S, Bhatia N, et al
    The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17932.
    PubMed     Abstract available


  1016. MORO R, Fabiano A, Mangeri F, Di Buduo A, et al
    Objective evaluation of infantile hemangiomas response to propanolol treatment using a 3D imaging system.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17925.
    PubMed     Abstract available


  1017. MAGHEN P, Unrue EL, Oussedik E, Cline A, et al
    Regardless of How Risks Are Framed, Patients Seem Hesitant to Use Topical Steroids for Atopic Dermatitis.
    Br J Dermatol. 2019 Mar 27. doi: 10.1111/bjd.17929.
    PubMed     Abstract available


  1018. ROBERTS MR, Asgari MM, Toland AE
    Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
    Br J Dermatol. 2019 Mar 25. doi: 10.1111/bjd.17917.
    PubMed     Abstract available


  1019. ELIAS ML, Lambert WC
    Surgical Management of Localized Melanoma: A National Cancer Database Retrospective Review.
    Br J Dermatol. 2019 Mar 25. doi: 10.1111/bjd.17901.
    PubMed     Abstract available


  1020. SUN SL, Liu JJ, Zhong B, Wang JK, et al
    Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis.
    Br J Dermatol. 2019 Mar 22. doi: 10.1111/bjd.17898.
    PubMed     Abstract available


  1021. WILLIAMSON S, Merritt J, De Benedetto A
    Atopic Dermatitis in the Elderly: A review of clinical and pathophysiology hallmarks.
    Br J Dermatol. 2019 Mar 21. doi: 10.1111/bjd.17896.
    PubMed     Abstract available


  1022. VENABLES ZC, Nijsten T, Wong KF, Autier P, et al
    Epidemiology of basal and cutaneous squamous cell carcinoma in the United Kingdom 2013-2015: a cohort study.
    Br J Dermatol. 2019 Mar 12. doi: 10.1111/bjd.17873.
    PubMed     Abstract available


  1023. ZINK A, Schielein M, Wildner M, Rehfuess EA, et al
    "Try to make good hay in the shade, it won't work!" - A qualitative interview study on the perspectives of Bavarian farmers regarding primary prevention of skin cancer.
    Br J Dermatol. 2019 Mar 12. doi: 10.1111/bjd.17872.
    PubMed     Abstract available


  1024. BHOYRUL B, Ondhia D, Lyon C
    Botulinum neurotoxin A is an effective treatment for irritant dermatitis caused by ostomy leaks in patients with retractile stomas.
    Br J Dermatol. 2019 Mar 6. doi: 10.1111/bjd.17856.
    PubMed     Abstract available


  1025. WANG CH, Chi MH, Lin JY, Chung WH, et al
    NUDT15 Polymorphism identified in an Azathioprine Hypersensitivity Syndrome Presenting as Erythema Nodosum and Hepatotoxicity.
    Br J Dermatol. 2019 Mar 6. doi: 10.1111/bjd.17859.
    PubMed     Abstract available


  1026. SILVERBERG JI, Gelfand JM, Margolis DJ, Boguniewicz M, et al
    Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.
    Br J Dermatol. 2019 Mar 5. doi: 10.1111/bjd.17683.
    PubMed     Abstract available


  1027. DEQUIDT L, Franck N, Sanchez-Pena P, Dalle S, et al
    Cutaneous lymphomas appearing under biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.
    Br J Dermatol. 2019 Mar 5. doi: 10.1111/bjd.17834.
    PubMed     Abstract available


  1028. MCPHERSON T, Exton LS, Biswas S, Creamer D, et al
    British Association of Dermatologists guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people 2018.
    Br J Dermatol. 2019 Mar 4. doi: 10.1111/bjd.17841.
    PubMed     Abstract available


  1029. CASSIUS C, Davis CJ, Bravard P, Carre-Gislard D, et al
    Look-alike and sound-alike drugs: A potential cause of cutaneous adverse reactions to drugs.
    Br J Dermatol. 2019 Mar 3. doi: 10.1111/bjd.17842.
    PubMed     Abstract available


  1030. VAN BEUGEN S, Ferwerda M, van Middendorp H, Smit JV, et al
    Economic evaluation of a tailored therapist-guided internet-based cognitive behavioral treatment (ICBT) for patients with psoriasis: a randomized controlled trial.
    Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17848.
    PubMed     Abstract available


  1031. NAKAMURA T, Haider S, Colicino S, Murray CS, et al
    Different definitions of atopic dermatitis: Impact on prevalence estimates and associated risk factors.
    Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17853.
    PubMed     Abstract available


  1032. OH ST, Yang KJ, Lee JU, Bae JM, et al
    Differential expression of PD-1 according to the histologic differentiation of cutaneous squamous cell carcinoma.
    Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17850.
    PubMed     Abstract available


  1033. SHI HJ, Zhou H, Ma AL, Wang L, et al
    Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis.
    Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17852.
    PubMed     Abstract available


  1034. YIU ZZN, Mason KJ, Barker JNWN, Hampton PJ, et al
    A Standardisation Approach to Compare Treatment Safety and Effectiveness Outcomes between Clinical Trials and Real World Populations in Psoriasis.
    Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17849.
    PubMed     Abstract available


  1035. PRADHAN S, Ran X, Xu X, Yang Y, et al
    Image Gallery: Dermoscopy of perianal molluscum contagiosum in a child caused by molluscum contagiosum virus subtype I.
    Br J Dermatol. 2019;180:e68.
    PubMed    


  1036. NAVARRETE-DECHENT C, Rajadhyaksha M, Nehal KS
    Can optical coherence tomography improve the management of basal cell carcinoma?
    Br J Dermatol. 2019;180:448-449.
    PubMed    


  1037. RYAN C
    Genital psoriasis: the failure of dermatologists to identify genital involvement.
    Br J Dermatol. 2019;180:460-461.
    PubMed    


  1038. WANG Y, Bagot M
    Updates in cutaneous lymphoma: evidence-based guidelines for the management of cutaneous lymphoma 2018.
    Br J Dermatol. 2019;180:443-444.
    PubMed    


  1039. FURUE M
    Useful components in the stratum corneum for assessment of atopic dermatitis.
    Br J Dermatol. 2019;180:457-458.
    PubMed    


  1040. GJERSVIK P
    How to organize skin cancer care for organ transplant recipients.
    Br J Dermatol. 2019;180:458-459.
    PubMed    


  1041. YOUNG AR
    Shining light on darker skins.
    Br J Dermatol. 2019;180:456-457.
    PubMed    


  1042. ANDERSEN YMF
    Cutaneous adnexal carcinomas, the forgotten skin cancers?
    Br J Dermatol. 2019;180:453-454.
    PubMed    


  1043. SILVERBERG JI
    Atopic dermatitis: it's not just barrier dysfunction.
    Br J Dermatol. 2019;180:447-448.
    PubMed    


  1044. VITTRUP I, Thyssen JP
    Atopic dermatitis and educational achievements - what have we learned?
    Br J Dermatol. 2019;180:452-453.
    PubMed    


  1045. DUFFY DL, Lee KJ, Jagirdar K, Pflugfelder A, et al
    High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17833.
    PubMed     Abstract available


  1046. DONA MG, Chiantore MV, Gheit T, Fiorucci G, et al
    Comprehensive analysis of beta and gamma Human Papillomaviruses in actinic keratosis and apparently healthy skin of elderly patients.
    Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17836.
    PubMed     Abstract available


  1047. TRAUPE H
    A rose is a rose: naevoid manifestations blur the boundary between naevus and classical gene defect in focal dermal hypoplasia.
    Br J Dermatol. 2019;180:461-462.
    PubMed    


  1048. AKIYAMA M
    Congenital ichthyoses: there is always more to learn about managing these rare and complex diseases.
    Br J Dermatol. 2019;180:449-450.
    PubMed    


  1049. SCHREML S
    Scoring pyoderma gangrenosum.
    Br J Dermatol. 2019;180:438-439.
    PubMed    


  1050. HART PH
    The case for greater vigilance in applying sunscreen during real-life sun exposure.
    Br J Dermatol. 2019;180:462-463.
    PubMed    


  1051. KUMAR S
    Infrared spectroscopy could be a diagnostic tool in dermatology.
    Br J Dermatol. 2019;180:459-460.
    PubMed    


  1052. HIJNEN DJ
    'En route' to precision medicine.
    Br J Dermatol. 2019;180:455-456.
    PubMed    


  1053. WOLKERSTORFER A
    The long road to valid outcomes in vitiligo.
    Br J Dermatol. 2019;180:454-455.
    PubMed    


  1054. HAMMERS CM, Konig IR
    Bullous pemphigoid and cancer in Taiwan.
    Br J Dermatol. 2019;180:451-452.
    PubMed    


  1055. FREW JW
    Complement, hidradenitis suppurativa and pathogen-driven positive selection.
    Br J Dermatol. 2019;180:685-686.
    PubMed    


    February 2019
  1056. GISONDI P, Geat D, Idolazzi L, Girolomoni G, et al
    Relapse of psoriatic arthritis in patients with active psoriasis swapped from TNF-alpha to IL-17A inhibitor.
    Br J Dermatol. 2019 Feb 28. doi: 10.1111/bjd.17837.
    PubMed     Abstract available


  1057. CONDORELLI AG, Logli E, Cianfarani F, Teson M, et al
    miR-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Br J Dermatol. 2019 Feb 28. doi: 10.1111/bjd.17840.
    PubMed     Abstract available


  1058. ANDERSEN YMF, Augustin M, Petersen J, Hagenstrom K, et al
    Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
    Br J Dermatol. 2019 Feb 28. doi: 10.1111/bjd.17832.
    PubMed     Abstract available


  1059. ZANDER N, Sommer R, Schafer I, Reinert R, et al
    Epidemiology and Dermatological Comorbidity of Seborrhoeic Dermatitis - Population-based Study in 161,000 Employees.
    Br J Dermatol. 2019 Feb 25. doi: 10.1111/bjd.17826.
    PubMed     Abstract available


  1060. DANGIEN A, Beylot-Barry M, Battistella M, Ram-Wolff C, et al
    Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B-cell lymphoma presenting as AL amyloidoma of the skin.
    Br J Dermatol. 2019 Feb 22. doi: 10.1111/bjd.17821.
    PubMed     Abstract available


  1061. SILVERBERG JI, Simpson EL, Ardeleanu M, Thaci D, et al
    Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from 2 phase III trials.
    Br J Dermatol. 2019 Feb 21. doi: 10.1111/bjd.17791.
    PubMed     Abstract available


  1062. REES S, Kirby L, Simpson RC
    Living with vulval lichen sclerosus: a systematic review.
    Br J Dermatol. 2019 Feb 21. doi: 10.1111/bjd.17790.
    PubMed     Abstract available


  1063. HIURA A, Yoshino K, Maeda T, Nagai K, et al
    Chemoradiotherapy could improve overall survival of patients with stage IV cutaneous squamous cell carcinoma: analysis of 34 cases.
    Br J Dermatol. 2019 Feb 21. doi: 10.1111/bjd.17792.
    PubMed     Abstract available


  1064. RESSLER J, Silmbrod R, Stepan A, Tuchmann F, et al
    T-VEC in advanced Melanoma - Complete response in a heart and kidney transplant patient: A case report.
    Br J Dermatol. 2019 Feb 18. doi: 10.1111/bjd.17783.
    PubMed     Abstract available


  1065. NAPOLITANO M, Megna M, Fabbrocini G, Nistico SP, et al
    Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.
    Br J Dermatol. 2019 Feb 15. doi: 10.1111/bjd.17779.
    PubMed     Abstract available


  1066. IRVINE AD, Mina-Osorio P
    Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide.
    Br J Dermatol. 2019 Feb 13. doi: 10.1111/bjd.17766.
    PubMed     Abstract available


  1067. MASHAYEKHI S, Nast A, Gaskins M, Ahmed S, et al
    Hidden treasures: Exploring selective publication of trials and trial outcomes in biologic treatment for plaque psoriasis.
    Br J Dermatol. 2019 Feb 13. doi: 10.1111/bjd.17773.
    PubMed     Abstract available


  1068. STOER NC, Botteri E, Ghiasvand R, Busund M, et al
    Reproductive factors and risk of melanoma: a population-based cohort study.
    Br J Dermatol. 2019 Feb 12. doi: 10.1111/bjd.17771.
    PubMed     Abstract available


  1069. HALK AB, Potjer TP, Kukutsch NA, Vasen HFA, et al
    Surveillance for familial melanoma: recommendations from a national centre of expertise.
    Br J Dermatol. 2019 Feb 11. doi: 10.1111/bjd.17767.
    PubMed     Abstract available


  1070. MERCIECA L, Lavery D, Warren RB, Griffiths CEM, et al
    Long-term, real world, efficacy of biologics for psoriasis: a single centre's experience.
    Br J Dermatol. 2019 Feb 9. doi: 10.1111/bjd.17756.
    PubMed     Abstract available


  1071. TOTTE JEE, Pardo LM, Fieten KB, Vos MC, et al
    The nasal and skin microbiome are associated with disease severity in pediatric atopic dermatitis.
    Br J Dermatol. 2019 Feb 9. doi: 10.1111/bjd.17755.
    PubMed     Abstract available


  1072. GUALDI G, Moro R, Regina V, Caravello S, et al
    PRISModegib: the use of the PRISM test to assess the Health-Related Quality of Life of patients with Locally Advanced Basal Cell Carcinoma undergoing Hedgehog Pathway Inhibitor Therapy.
    Br J Dermatol. 2019 Feb 9. doi: 10.1111/bjd.17754.
    PubMed     Abstract available


  1073. RAN D, Cai M, Huang H, Zhou Y, et al
    Association analysis within MHC region of psoriasis vulgaris accounting for familial history.
    Br J Dermatol. 2019 Feb 8. doi: 10.1111/bjd.17747.
    PubMed     Abstract available


  1074. VO S, Watanabe R, Koguchi-Yoshioka H, Matsumura Y, et al
    CD8 resident memory T cells with IL-17A-producing potential are accumulated in disease-naive non-lesional sites of psoriasis possibly in correlation with disease duration.
    Br J Dermatol. 2019 Feb 8. doi: 10.1111/bjd.17748.
    PubMed     Abstract available


  1075. REICH K, Rich P, Maari C, Bissonnette R, et al
    Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Randomised Phase 2 Study.
    Br J Dermatol. 2019 Feb 7. doi: 10.1111/bjd.17628.
    PubMed     Abstract available


  1076. MAHIL SK, McSweeney SM, Kloczko E, McGowan B, et al
    Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically-appraised topic.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17741.
    PubMed     Abstract available


  1077. UD-DIN S, Foden P, Stocking K, Mazhari M, et al
    Objective assessment of dermal fibrosis in cutaneous scarring: using optical coherence tomography, high frequency ultrasound and immuno-histo-morphometry of human skin.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17739.
    PubMed     Abstract available


  1078. SANCLEMENTE G, Vasquez D, Aguirre D
    Construct validity and responsiveness of the Colombian version of Skindex-29.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17742.
    PubMed     Abstract available


  1079. SHARMA A, Adarsh MB, Dogra S, Vaiphei K, et al
    Evaluation of subclinical gut inflammation using fecal calprotectin levels and colonic mucosal biopsy in psoriasis and psoriatic arthritis patients.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17745.
    PubMed     Abstract available


  1080. MOURAD A, Straube S, Armijo-Olivo S, Gniadecki R, et al
    Factors Predicting Persistence of Biologic Drugs in Psoriasis: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17738.
    PubMed     Abstract available


  1081. YOSIPOVITCH G, Reaney M, Mastey V, Eckert L, et al
    Peak Pruritus Numerical Rating Scale: Psychometric Validation and Responder Definition for Assessing Itch in Moderate-To-Severe Atopic Dermatitis.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17744.
    PubMed     Abstract available


  1082. PETERS N, Schubert M, Geppert JP, Moehrle M, et al
    Micrographic controlled surgery of basal cell carcinomas - Rapid Lump Examination (RLE) in comparison to H&E-stained paraffin sections.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17740.
    PubMed     Abstract available


  1083. STORAN ER, Woolf RT, Smith CH, Pink A, et al
    Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17712.
    PubMed     Abstract available


  1084. BLAUVELT A, Rosmarin D, Bieber T, Simpson EL, et al
    Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomic regions: data from phase 3 clinical trials.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17703.
    PubMed     Abstract available


  1085. ZOUTENDIJK J, Tio D, Koljenovic S, van den Bos RR, et al
    Nine percent of biopsy proven lentigo maligna are reclassified as lentigo maligna melanoma after surgery.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17714.
    PubMed     Abstract available


  1086. WELFRINGER-MORIN A, Fraitag S, Balguerie X, Laaengh-Massoni C, et al
    Late ulceration of residual abortive infantile hemangioma: a rare complication.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17717.
    PubMed     Abstract available


  1087. CHAN MP
    Refining the ever-evolving molecular landscape of spitzoid melanocytic neoplasms.
    Br J Dermatol. 2019;180:262.
    PubMed    


  1088. GISONDI P
    Is the routine screening for hyperhomocysteinaemia recommended in patients with chronic plaque psoriasis?
    Br J Dermatol. 2019;180:262-263.
    PubMed    


  1089. MISERY L
    Alexithymia and psoriasis: what is the link?
    Br J Dermatol. 2019;180:261.
    PubMed    


  1090. GARCIA-DOVAL I, Albrecht J
    Who likes to perform the Psoriasis Area and Severity Index?
    Br J Dermatol. 2019;180:260-261.
    PubMed    


  1091. ERFURT-BERGE C
    Influence on contact allergy of immune-mediated skin diseases such as psoriasis.
    Br J Dermatol. 2019;180:256-257.
    PubMed    


  1092. MAGDALENO-TAPIAL J, Valenzuela-Onate C, Giacaman von der Weth MM, Ferrer-Guillen B, et al
    Image Gallery: Painful skin rash on the face after a 'chemsex' party.
    Br J Dermatol. 2019;180:e33.
    PubMed    


  1093. XU Z, Lin Z
    Image Gallery: Cutaneous findings in an adult with X-linked reticulate pigmentary disorder.
    Br J Dermatol. 2019;180:e37.
    PubMed    


  1094. ZHANG Y, Chen H
    Image Gallery: Generalized cutaneous Rosai-Dorfman disease presenting as acneiform lesions.
    Br J Dermatol. 2019;180:e36.
    PubMed    


  1095. LEVY ML
    Consensus, collaboration and care coordination.
    Br J Dermatol. 2019;180:253.
    PubMed    


  1096. MELLERIO JE
    Potential therapeutic targeting of inflammation in epidermolysis bullosa simplex.
    Br J Dermatol. 2019;180:258-260.
    PubMed    


  1097. RAJARATNAM R
    Resiquimod for actinic keratosis: is this a new treatment option?
    Br J Dermatol. 2019;180:254-255.
    PubMed    


  1098. JANDA M, Soyer HP
    Can clinical decision making be enhanced by artificial intelligence?
    Br J Dermatol. 2019;180:247-248.
    PubMed    


  1099. PUIG L
    British Association of Dermatologists Biologic Interventions Register delivers: infliximab increases risk of serious infections.
    Br J Dermatol. 2019;180:257-258.
    PubMed    


  1100. MONTAUDIE H
    Is an anti-interleukin-17 receptor able to do the job when an anti-interleukin-12/23 has failed?
    Br J Dermatol. 2019;180:255-256.
    PubMed    


  1101. HON KL, Ng WGG, Kung JSC, Cheng NS, et al
    Utility of Pediatric Allergic Disease Quality of Life Questionnaire for childhood eczema.
    Br J Dermatol. 2019 Feb 1. doi: 10.1111/bjd.17710.
    PubMed     Abstract available


    January 2019
  1102. JEONG D, Aralis H, Bruhn KW, Cotliar J, et al
    A Reliability Study Using Network Oriented Research Assistant (NORA((R)) ) Examining the Use of Digital Photographs in the Assessment of Psoriasis.
    Br J Dermatol. 2019 Jan 31. doi: 10.1111/bjd.17702.
    PubMed     Abstract available


  1103. SVENDSEN MT, Moller S, Feldman SR, Andersen KE, et al
    Socio-demographic factors do not have a large influence on psoriasis patients' adherence to topical treatment.
    Br J Dermatol. 2019 Jan 31. doi: 10.1111/bjd.17707.
    PubMed     Abstract available


  1104. JOHNSON CM, Fitch K, Merola JF, Han J, et al
    Plasma TNF-alpha and adiponectin levels differentiate psoriatic arthritis from psoriasis patients.
    Br J Dermatol. 2019 Jan 29. doi: 10.1111/bjd.17700.
    PubMed     Abstract available


  1105. SHAUB AR, Lewis ET, Nevedal AL, Swetter SM, et al
    Physician Perceptions of Primary Care-based Skin Cancer Screening in a Veterans Affairs Pilot Study.
    Br J Dermatol. 2019 Jan 29. doi: 10.1111/bjd.17699.
    PubMed     Abstract available


  1106. SUN XL, Li LF
    Screening for hepatitis B virus and tuberculosis infection in patients with moderate-to-severe psoriasis recruiting for biologic therapy in China.
    Br J Dermatol. 2019 Jan 28. doi: 10.1111/bjd.17693.
    PubMed     Abstract available


  1107. GILHOOLEY E, Daly S, Gallagher O, Glacken M, et al
    Experience of skin disease and relationships with healthcare providers: a qualitative study of Traveller women in Ireland.
    Br J Dermatol. 2019 Jan 28. doi: 10.1111/bjd.17697.
    PubMed     Abstract available


  1108. PRAST-NIELSEN S, Tobin AM, Adamzik K, Powles A, et al
    Investigation of the Skin Microbiome: Swabs vs Biopsies.
    Br J Dermatol. 2019 Jan 28. doi: 10.1111/bjd.17691.
    PubMed     Abstract available


  1109. HENRY AL, Bundy C, Kyle SD, Griffiths CEM, et al
    Understanding the experience of sleep disturbance in psoriasis: A qualitative exploration using the Common Sense, Self-Regulation Model.
    Br J Dermatol. 2019 Jan 23. doi: 10.1111/bjd.17685.
    PubMed     Abstract available


  1110. DIKA E, Patrizi A, Lambertini M, Scarfi F, et al
    Comment on "Diagnostic accuracy of ex vivo fluorescence confocal microscopy for Mohs surgery of basal cell carcinomas: A prospective study on 753 margins".
    Br J Dermatol. 2019 Jan 23. doi: 10.1111/bjd.17686.
    PubMed     Abstract available


  1111. MARTINEZ-DOMENECH A, Garcia-Legaz-Martinez M, Magdaleno-Tapial J, Torrecillas M, et al
    Anti-TNF-associated cutaneous leishmaniasis: a single-institution experience.
    Br J Dermatol. 2019 Jan 19. doi: 10.1111/bjd.17644.
    PubMed     Abstract available


  1112. PASTERFIELD M, Clarke SA, R Thompson A
    A qualitative examination of the experience of skin camouflage by people living with visible skin conditions.
    Br J Dermatol. 2019 Jan 18. doi: 10.1111/bjd.17646.
    PubMed     Abstract available


  1113. COUTURE-COSSETTE A, Morand M, Vinh DC, Gratton M, et al
    Severe disseminated Nocardia infection associated with ustekinumab treatment for psoriasis.
    Br J Dermatol. 2019 Jan 18. doi: 10.1111/bjd.17642.
    PubMed     Abstract available


  1114. REHBINDER EM, Winger AJ, Landro L, Asarnoj A, et al
    Dry skin and skin barrier in early infancy.
    Br J Dermatol. 2019 Jan 13. doi: 10.1111/bjd.17626.
    PubMed     Abstract available


  1115. OGUNSANYA ME, Cho SK, Hudson A, Chong BF, et al
    Validation and Reliability of a Disease-Specific Quality of Life Measure in Patients with Cutaneous Lupus Erythematosus: CLEQoL.
    Br J Dermatol. 2019 Jan 13. doi: 10.1111/bjd.17636.
    PubMed     Abstract available


  1116. TAUBER M, Apoil PA, Richet C, Laurent J, et al
    Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real life practice.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17629.
    PubMed     Abstract available


  1117. THOREL D, Delcampe A, Ingen-Housz-Oro S, Hajj C, et al
    Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17627.
    PubMed     Abstract available


  1118. MCKENZIE S, Zang P, Blackcloud P, Cohen B, et al
    Case Series of Cutaneous Mucormycosis in Setting of Herpesviridae Infection.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17631.
    PubMed     Abstract available


  1119. AL-JANABI A, Jabbar-Lopez ZK, Griffiths CEM, Yiu ZZN, et al
    Risankizumab versus ustekinumab for plaque psoriasis: a critical appraisal.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17624.
    PubMed     Abstract available


  1120. HANSEN PR, Isaksen JL, Borut Jemec G, Ellervik C, et al
    Thyroid function in psoriasis.
    Br J Dermatol. 2019 Jan 10. doi: 10.1111/bjd.17622.
    PubMed     Abstract available


  1121. MASON KJ, Williams S, Yiu ZZN, McElhone K, et al
    Persistence and Effectiveness of Non-Biologic Systemic Therapies for Moderate-Severe Psoriasis in Adults: a Systematic Review.
    Br J Dermatol. 2019 Jan 10. doi: 10.1111/bjd.17625.
    PubMed     Abstract available


  1122. SOON SL, Ibrahim SF, Arron ST
    A randomised phase II study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned.
    Br J Dermatol. 2019 Jan 9. doi: 10.1111/bjd.17623.
    PubMed     Abstract available


  1123. LEE YW, Won CH, Jung K, Nam HJ, et al
    Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
    Br J Dermatol. 2019 Jan 8. doi: 10.1111/bjd.17455.
    PubMed     Abstract available


  1124. VAN DELFT LCJ, Essers BAB, Harnas S, Kelleners-Smeets NWJ, et al
    Quantitative survey into value clarification of discussed treatment options among patients treated for basal-cell carcinoma.
    Br J Dermatol. 2019 Jan 5. doi: 10.1111/bjd.17609.
    PubMed     Abstract available


  1125. CARR DF, Wang CW, Bellon T, Ressel L, et al
    Serum and blister-fluid elevation and decreased epidermal content of HMGB1 protein in drug-induced Stevens Johnson syndrome/toxic epidermal necrolysis.
    Br J Dermatol. 2019 Jan 5. doi: 10.1111/bjd.17610.
    PubMed     Abstract available


  1126. JIYAD Z, Akhras V
    Incidence of melanoma and outcomes of longitudinal melanonychia in a cohort of cases referred to a London dermatology department.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17607.
    PubMed     Abstract available


  1127. ENZAN N, Kitadate A, Tanaka A, Matsue K, et al
    Incisional random skin biopsy, not punch biopsy, is an appropriate method for diagnosis of intravascular large B-cell lymphoma: A clinicopathological study of 25 patients.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17603.
    PubMed     Abstract available


  1128. ROMITI R, Valenzuela F, Chouela EN, Xu W, et al
    Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: Integrated safety analysis from 11 clinical trials of patients with plaque psoriasis.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17604.
    PubMed     Abstract available


  1129. GARCIA-DOVAL I, Davila-Seijo P
    How real are 'real-life studies' in psoriasis, and the uncertain meaning of drug persistence.
    Br J Dermatol. 2019;180:15-16.
    PubMed    


  1130. GISONDI P, Girolomoni G
    The multifaceted association between psoriasis and obesity.
    Br J Dermatol. 2019;180:24.
    PubMed    


  1131. CHONG BF
    Applying the Cutaneous Lupus Erythematosus Disease Area and Severity Index to paediatric cutaneous lupus erythematosus.
    Br J Dermatol. 2019;180:20-21.
    PubMed    


  1132. MAGIN P
    Patient preferences and patient-centredness in skin cancer care: implications for clinicians and patient management.
    Br J Dermatol. 2019;180:22-23.
    PubMed    


  1133. SCHILLING B, Wiesner T
    Tackling melanoma by adjuvant therapy: why, whom and how?
    Br J Dermatol. 2019;180:1-2.
    PubMed    


  1134. DANIELSEN K
    Increased risk of death in patients with psoriasis: disease or lifestyle?
    Br J Dermatol. 2019;180:3-4.
    PubMed    


  1135. MOSS C
    RASopathies and the skin.
    Br J Dermatol. 2019;180:21.
    PubMed    


  1136. ORMEROD AD
    Dutch guidelines for psoriasis treatment.
    Br J Dermatol. 2019;180:11.
    PubMed    


  1137. CRIADO PR
    What lessons can we learn from an apparent decrease in the use of topical drugs for psoriasis?
    Br J Dermatol. 2019;180:19.
    PubMed    


  1138. RYAN C
    Adalimumab treatment for psoriasis - safety in numbers.
    Br J Dermatol. 2019;180:14-15.
    PubMed    


  1139. VAN DER KRAAIJ GE, Balak DMW, Busard CI, van Cranenburgh OD, et al
    Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.
    Br J Dermatol. 2019;180:31-42.
    PubMed    


  1140. VAN AKKOOI ACJ, Hayes A
    Recent developments in lymph node surgery for melanoma.
    Br J Dermatol. 2019;180:5-7.
    PubMed    


  1141. GRANTHAM HJ, Reynolds NJ
    The devil is in the data: differences in drug persistence between SNIIRAM, the French national health insurance database, and psoriasis biologics intervention registers.
    Br J Dermatol. 2019;180:8-10.
    PubMed    


  1142. O'SHAUGHNESSY RFL
    Targeting tryptophan transport and breakdown in basal cell carcinoma.
    Br J Dermatol. 2019;180:16-17.
    PubMed    


  1143. FLEMING P
    Tofacitinib: a new oral Janus kinase inhibitor for psoriasis.
    Br J Dermatol. 2019;180:13-14.
    PubMed    


  1144. BREMER J, van den Akker PC
    Therapies for epidermolysis bullosa: delivery is key.
    Br J Dermatol. 2019;180:17-19.
    PubMed    


  1145. GIMENEZ-ARNAU AM
    Omalizumab: living up to PROMises.
    Br J Dermatol. 2019;180:12-13.
    PubMed    


  1146. WERNER RN, Nast A
    'Surprisingly little evidence' on how best to treat actinic keratosis in organ transplant recipients.
    Br J Dermatol. 2019;180:11-12.
    PubMed    


  1147. YUAN H, Pan M
    Antibody reactive to a novel autoantigen on the nondesmosomal keratinocyte surfaces leads to herpetiform pemphigus.
    Br J Dermatol. 2019;180:22.
    PubMed    


  1148. WEISS KT, Zeman F, Schreml S
    A randomized trial of early endovenous ablation in venous ulceration: a critical appraisal: Original Article: Gohel MS, Heatly F, Liu X et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med 2018; 378:2105-114.
    Br J Dermatol. 2019;180:51-55.
    PubMed     Abstract available


  1149. ARAGON-MIGUEL R, Prieto-Barrios M, Calleja-Algarra A, Pinilla-Martin B, et al
    Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Br J Dermatol. 2019;180:e1.
    PubMed    


  1150. LOBATO-BEREZO A, Vidal Navarro A, Pujol RM
    Image Gallery: Red coral vascular pattern as a new dermoscopic clue for clear cell acanthoma.
    Br J Dermatol. 2019;180:e4.
    PubMed    


  1151. SUN JR, Li YR, Tu P, Chen XX, et al
    Image Gallery: A case of porokeratosis ptychotropica.
    Br J Dermatol. 2019;180:e2.
    PubMed    


  1152. KJERKEGAARD U, Bygum A
    Image Gallery: Scabies incognito.
    Br J Dermatol. 2019;180:e5.
    PubMed    


  1153. CHEN X, Yang Y, Lin Z
    Image Gallery: Poikiloderma with neutropenia.
    Br J Dermatol. 2019;180:e6.
    PubMed    


    December 2018
  1154. LARSEN MH, Strumse YAS, Borge CR, Osborne R, et al
    Health literacy - a new piece of the puzzle in psoriasis care?
    Br J Dermatol. 2018 Dec 31. doi: 10.1111/bjd.17595.
    PubMed     Abstract available


  1155. VAN EGMOND S, Wakkee M, van Rengen A, Bastiaens MT, et al
    Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.
    Br J Dermatol. 2018 Dec 30. doi: 10.1111/bjd.17594.
    PubMed     Abstract available


  1156. BAKKER DS, Ariens LFM, van Luijk C, van der Schaft J, et al
    Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis.
    Br J Dermatol. 2018 Dec 30. doi: 10.1111/bjd.17538.
    PubMed     Abstract available


  1157. SHEU JC, Tran J, Rady PL, Dao H Jr, et al
    Polyomaviruses of the Skin: Integrating Molecular and Clinical Advances in an Emerging Class of Viruses.
    Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17592.
    PubMed     Abstract available


  1158. MIURA K, Olsen CM, Rea S, Marsden J, et al
    Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta-analysis.
    Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17586.
    PubMed     Abstract available


  1159. KHOURY LR, Moller T, Zachariae C, Correll H, et al
    A prospective, clinical non-randomised controlled trial of individualised, nurse-led patient-centred intervention of patients with psoriasis.
    Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17585.
    PubMed     Abstract available


  1160. FENTON GL, Smit AK, Keogh L, Cust AE, et al
    Exploring the Emotional and Behavioural Reactions to Receiving Personalised Melanoma Genomic Risk Information: A Qualitative Study.
    Br J Dermatol. 2018 Dec 22. doi: 10.1111/bjd.17582.
    PubMed     Abstract available


  1161. RIJSBERGEN M, van der Kolk TN, Hogendoorn G, Kouwenhoven S, et al
    A randomised controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts.
    Br J Dermatol. 2018 Dec 22. doi: 10.1111/bjd.17583.
    PubMed     Abstract available


  1162. LEE EH, Pusic AL, Cano SJ, Klassen AF, et al
    The FACE-Q Skin Cancer Module Addresses Post-Resection Aesthetic and Quality of Life Outcomes.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17525.
    PubMed     Abstract available


  1163. ERSSER SJ, Effah A, Dyson J, Kellar I, et al
    Effectiveness of interventions to support the early detection of skin-cancer through skin self-examination: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17529.
    PubMed     Abstract available


  1164. DOBBS TD, Samarendra H, Hughes S, Hutchings HA, et al
    The FACE-Q Skin Cancer Module Addresses Post-Resection Aesthetic and Quality of Life Outcomes: Reply from Authors.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17526.
    PubMed     Abstract available


  1165. FICHMAN V, do Valle ACF, Freitas DFS, Sampaio FMS, et al
    Cryosurgery for the treatment of cutaneous sporotrichosis: Experience with 199 cases.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17532.
    PubMed     Abstract available


  1166. ZHU PQ, Yan HM, Zhao HJ, Guo DY, et al
    A novel premature termination mutation in FDPS in a Chinese family with disseminated superficial actinic porokeratosis.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17531.
    PubMed     Abstract available


  1167. GILSON D, Whittaker SJ, Child FJ, Scarisbrick JJ, et al
    British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.
    Br J Dermatol. 2018 Dec 17. doi: 10.1111/bjd.17240.
    PubMed    


  1168. PALMGREN J, Paoli J, Schmidtchen A, Saleh K, et al
    Variability in the Diagnosis of Surgical Site Infections After Full-Thickness Skin Grafting: An International Survey.
    Br J Dermatol. 2018 Dec 10. doi: 10.1111/bjd.17517.
    PubMed     Abstract available


  1169. NAJERA L, Alonso-Juarranz M, Garrido M, Ballestin C, et al
    Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma.
    Br J Dermatol. 2018 Dec 7. doi: 10.1111/bjd.17513.
    PubMed     Abstract available


  1170. REINDERS MGHC, Cosgun B, Gijezen LMC, van Oosterhoud CN, et al
    Genetic profiling of basal cell carcinomas detects postzygotic mosaicism in basal cell naevus syndrome.
    Br J Dermatol. 2018 Dec 5. doi: 10.1111/bjd.17337.
    PubMed     Abstract available


  1171. FOX JA, Langbecker D, Rosenberg J, Ekberg S, et al
    Uncertain diagnosis and prognosis in advanced melanoma: A qualitative study of the experiences of bereaved carers in a time of immune and targeted therapies.
    Br J Dermatol. 2018 Dec 4. doi: 10.1111/bjd.17511.
    PubMed     Abstract available


  1172. LONGO C, Pampena R, Bombonato C, Gardini S, et al
    Diagnostic accuracy of ex vivo fluorescence confocal microscopy for Mohs surgery of basal cell carcinomas: a prospective study on 753 margins.
    Br J Dermatol. 2018 Dec 4. doi: 10.1111/bjd.17507.
    PubMed     Abstract available


  1173. MOSCARELLA E, Ronchi A, Agozzino M, Franco R, et al
    Image Gallery: Dermoscopy of lichen amyloidosis.
    Br J Dermatol. 2018;179:e231.
    PubMed    


  1174. CHALMERS RJG
    Documenting and defining psoriasis severity: an ongoing challenge.
    Br J Dermatol. 2018;179:1244-1245.
    PubMed    


  1175. COUGHLIN CC, Siegel DH
    Cutaneous findings in paediatric solid organ transplant recipients.
    Br J Dermatol. 2018;179:1235-1236.
    PubMed    


  1176. ELOSUA-GONZALEZ M, Lopez-Estebaranz JL, Pampin-Franco A, Garcia-Zamora E, et al
    Image Gallery: Cutaneous lesions of Erdheim-Chester disease treated with carbon dioxide laser therapy.
    Br J Dermatol. 2018;179:e228.
    PubMed    


  1177. LIM HW
    Shedding light on photodynamic therapy for basal cell carcinoma.
    Br J Dermatol. 2018;179:1240-1241.
    PubMed    


  1178. HATA H
    Can we manage refractory cutaneous angiosarcoma?
    Br J Dermatol. 2018;179:1246.
    PubMed    


  1179. DABAS G, Dogra S, Kaushik A, Narang T, et al
    Image Gallery: Multiple cutaneous and oral nodules in histoid leprosy.
    Br J Dermatol. 2018;179:e227.
    PubMed    


    November 2018
  1180. MISERY L, Ezzedine K, Corgibet F, Dupin N, et al
    Sex- and age-adjusted prevalence estimates of skin types and unpleasant skin sensations and their consequences on the quality of life: Results from a study of a large representative sample of the French population.
    Br J Dermatol. 2018 Nov 30. doi: 10.1111/bjd.17467.
    PubMed     Abstract available


  1181. CORRIE PG, Terheyden P, Ten Tije AJ, Herbst R, et al
    A prospective, observational safety study of patients with BRAF(V) (600) -mutated unresectable or metastatic melanoma treated with vemurafenib [Zelboraf Safety Study (ZeSS)].
    Br J Dermatol. 2018 Nov 29. doi: 10.1111/bjd.17465.
    PubMed     Abstract available


  1182. REICH K, Papp KA, Armstrong AW, Wasfi Y, et al
    Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomised VOYAGE 1 and VOYAGE 2 studies.
    Br J Dermatol. 2018 Nov 28. doi: 10.1111/bjd.17454.
    PubMed     Abstract available


  1183. MENZIES S, Daly S, McKenna DB
    Social media and psoriasis treatment: What are people saying on Twitter?
    Br J Dermatol. 2018 Nov 25. doi: 10.1111/bjd.17452.
    PubMed     Abstract available


  1184. SIMPSON RC, Cooper SM, Kirtschig G, Larsen S, et al
    Future research priorities for lichen sclerosus - results of a James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2018 Nov 25. doi: 10.1111/bjd.17447.
    PubMed     Abstract available


  1185. NOWROUZIAN FL, Ljung A, Nilsson S, Hesselmar B, et al
    Neonatal gut colonisation by Staphylococcus aureus strains with certain adhesins and superantigens is negatively associated with subsequent development of atopic eczema.
    Br J Dermatol. 2018 Nov 25. doi: 10.1111/bjd.17451.
    PubMed     Abstract available


  1186. LAGRELIUS M, Wahlgren CF, Matura M, Bergstrom A, et al
    Atopic dermatitis at preschool age and contact allergy in adolescence: a population-based cohort study.
    Br J Dermatol. 2018 Nov 22. doi: 10.1111/bjd.17449.
    PubMed     Abstract available


  1187. SIEGEL S, Winthrop K, Ehst B, Ortega Loayza A, et al
    Ustekinumab use in patients with severe psoriasis co-infected with hepatitis B and/or C.
    Br J Dermatol. 2018 Nov 20. doi: 10.1111/bjd.17444.
    PubMed     Abstract available


  1188. POTRONY M, Puig-Butille JA, Ribera-Sola M, Iyer V, et al
    POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
    Br J Dermatol. 2018 Nov 19. doi: 10.1111/bjd.17443.
    PubMed     Abstract available


  1189. MAEDA T, Yoshino K, Nagai K, Oaku S, et al
    Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients.
    Br J Dermatol. 2018 Nov 17. doi: 10.1111/bjd.17434.
    PubMed     Abstract available


  1190. OKIYAMA N, Inoue S, Saito A, Nakamura Y, et al
    Antihelix/helix violaceous macules in Japanese patients with anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17431.
    PubMed     Abstract available


  1191. HAMPRAS SS, Tommasino M, Zhao Y, Messina J, et al
    Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17429.
    PubMed     Abstract available


  1192. SCRIVENS LJ, Goulding JMR, Allen KJ
    The views of consultant dermatologists on creating centralised skin lesion units.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17427.
    PubMed     Abstract available


  1193. HAYASHI M, Igarashi A, Okamura K, Suzuki T, et al
    Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17424.
    PubMed     Abstract available


  1194. YIU ZZN, Sorbe C, Lunt M, Rustenbach SJ, et al
    Development and Validation of a Multivariable Risk Prediction Model for Serious Infection in Patients with Psoriasis Receiving Systemic Therapy.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17421.
    PubMed     Abstract available


  1195. VERAITCH O, Lewis F, Craythorne E, Calonje E, et al
    Management of vulval melanoma in situ with imiquimod.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17433.
    PubMed     Abstract available


  1196. GENDREAU S, Amiot A, Le Baleur Y, Charpy C, et al
    Gastro-intestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis : a retrospective case series.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17428.
    PubMed     Abstract available


  1197. AUGUSTIN M, Sommer R, Kirsten N, Danckworth A, et al
    Topology of Psoriasis in Routine Care - Results from a High-resolution Analysis in 2,009 Patients.
    Br J Dermatol. 2018 Nov 14. doi: 10.1111/bjd.17403.
    PubMed     Abstract available


  1198. FREW JW
    We Need to Talk About Notch:Notch Dysregulation as an Epiphenomenon in Inflammatory Skin Disease.
    Br J Dermatol. 2018 Nov 11. doi: 10.1111/bjd.17414.
    PubMed     Abstract available


  1199. MEGNA M, Pecoraro A, Balato N, Villani A, et al
    Psoriasis in a cohort of patients with common variable immunodeficiency.
    Br J Dermatol. 2018 Nov 10. doi: 10.1111/bjd.17408.
    PubMed     Abstract available


  1200. NOVOA M, Baselga E, Beltran S, Giraldo L, et al
    Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review including GRADE assessments.
    Br J Dermatol. 2018 Nov 10. doi: 10.1111/bjd.17407.
    PubMed     Abstract available


  1201. KOSUMI H, Natsuga K, Watanabe M, Okada K, et al
    Multiple cutaneous reticulohistiocytomas after haematopoietic cell transplantation: contribution of donor and host-derived cells.
    Br J Dermatol. 2018 Nov 8. doi: 10.1111/bjd.17406.
    PubMed     Abstract available


  1202. ROUSSET L, Halioua B
    Psychological impact of psoriasis on Vlamidir Nabokov.
    Br J Dermatol. 2018 Nov 5. doi: 10.1111/bjd.17331.
    PubMed     Abstract available


  1203. LI L, You J, Fu X, Wang Z, et al
    Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population.
    Br J Dermatol. 2018 Nov 2. doi: 10.1111/bjd.17392.
    PubMed     Abstract available


  1204. TANEW A, Lim HW
    Phototherapy for psoriasis - outdated or underused?
    Br J Dermatol. 2018;179:1019-1020.
    PubMed    


  1205. FERRARA G, Delfino M, Nappa P, Gelsomina M, et al
    Image Gallery: Cutaneous Langerhans cell histiocytosis: a clinical masquerade.
    Br J Dermatol. 2018;179:e197.
    PubMed    


  1206. SCHMIDT SAJ
    Widely used antihypertensive drugs linked to cutaneous squamous cell carcinoma.
    Br J Dermatol. 2018;179:1027-1028.
    PubMed    


  1207. IANHEZ M
    Skin field cancerization - an in vivo model to prevent nonmelanoma skin cancer: expanding the alternatives for treatment.
    Br J Dermatol. 2018;179:1026-1027.
    PubMed    


  1208. MARUTHAPPU T, Posafalvi A, Castelletti S, Delaney PJ, et al
    Loss of function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.
    Br J Dermatol. 2018 Nov 1. doi: 10.1111/bjd.17388.
    PubMed     Abstract available


    October 2018
  1209. FRIIS NU, Hoffmann N, Gyldenlove M, Skov L, et al
    Glucose metabolism in patients with psoriasis.
    Br J Dermatol. 2018 Oct 30. doi: 10.1111/bjd.17349.
    PubMed     Abstract available


  1210. CRANWELL WC, Sinclair R
    Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study.
    Br J Dermatol. 2018 Oct 27. doi: 10.1111/bjd.17354.
    PubMed     Abstract available


  1211. DOBBS TD, Samarendra H, Hughes S, Hutchings HA, et al
    Patient reported outcome measures for facial skin cancer: A systematic review and evaluation of the quality of their measurement properties.
    Br J Dermatol. 2018 Oct 26. doi: 10.1111/bjd.17342.
    PubMed     Abstract available


  1212. DANILENKO M, Hodgson K, Stones R, Husain A, et al
    Diverse assays from a single skin punch biopsy to assess topical drug intervention.
    Br J Dermatol. 2018 Oct 26. doi: 10.1111/bjd.17353.
    PubMed     Abstract available


  1213. REICH K, Sullivan J, Arenberger P, Mrowietz U, et al
    Effect of secukinumab on clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial.
    Br J Dermatol. 2018 Oct 26. doi: 10.1111/bjd.17351.
    PubMed     Abstract available


  1214. ELLIS AG, Flohr C, Drucker AM
    Network meta-analyses of systemic treatments for psoriasis: a critical appraisal.
    Br J Dermatol. 2018 Oct 22. doi: 10.1111/bjd.17335.
    PubMed     Abstract available


  1215. BONNET P, Battistella M, Bouaziz JD, Ram-Wolff C, et al
    Thymic localization of erythrodermic cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17340.
    PubMed     Abstract available


  1216. VERYKIOU S, Alexander M, Edwards N, Plummer R, et al
    Harnessing autophagy to overcome MEK-inhibitor induced resistance in metastatic melanoma.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17333.
    PubMed     Abstract available


  1217. SMIRNOVA J, von Kobyletzki L, Lindberg M, Svensson A, et al
    Atopic dermatitis, educational attainment and psychological functioning: a national cohort study.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17330.
    PubMed     Abstract available


  1218. LANGLEY RG, Armstrong AW, Lebwohl MG, Blauvelt A, et al
    Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials.
    Br J Dermatol. 2018 Oct 17. doi: 10.1111/bjd.17318.
    PubMed     Abstract available


  1219. AUGUSTIN M, Langenbruch A, Gutknecht M, Reich K, et al
    Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management.
    Br J Dermatol. 2018 Oct 17. doi: 10.1111/bjd.17128.
    PubMed     Abstract available


  1220. DE GIORGI V, Salvati L, Barchielli A, Caldarella A, et al
    The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study.
    Br J Dermatol. 2018 Oct 16. doi: 10.1111/bjd.17321.
    PubMed     Abstract available


  1221. EMTENANI S, Yuan H, Lin C, Pan M, et al
    Normal human skin is superior to monkey esophagus substrate for detection of circulating BP180-NC16A-specific immunoglobulin G antibodies in bullous pemphigoid.
    Br J Dermatol. 2018 Oct 13. doi: 10.1111/bjd.17313.
    PubMed     Abstract available


  1222. DESCHAMPS O, Ram-Wolff C, Beylot-Barry M, Grange F, et al
    Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma.
    Br J Dermatol. 2018 Oct 9. doi: 10.1111/bjd.17269.
    PubMed     Abstract available


  1223. ZILL JM, Christalle E, Tillenburg N, Mrowietz U, et al
    Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: A systematic review and meta-analysis.
    Br J Dermatol. 2018 Oct 6. doi: 10.1111/bjd.17272.
    PubMed     Abstract available


  1224. PILKINGTON SM, Barron MJ, Watson REB, Griffiths CEM, et al
    Aged human skin accumulates mast cells with altered functionality which localise to macrophage and VIP(+) nerve fibres.
    Br J Dermatol. 2018 Oct 6. doi: 10.1111/bjd.17268.
    PubMed     Abstract available


  1225. HEFEZ L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, et al
    Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients.
    Br J Dermatol. 2018 Oct 3. doi: 10.1111/bjd.17267.
    PubMed     Abstract available


  1226. PLUMPTRE I, Stuart G, Cerullo A, Kinsler V, et al
    Use of sedation instead of general anaesthesia for screening MRI in congenital melanocytic naevi under the age of 1 year is a successful, safe, and economical first line approach.
    Br J Dermatol. 2018 Oct 3. doi: 10.1111/bjd.17263.
    PubMed     Abstract available


  1227. BECHER G, Burden AD
    Ixekizumab in genital psoriasis.
    Br J Dermatol. 2018;179:811-812.
    PubMed    


  1228. LLOYD-LAVERY A
    Long-term safety data for tofacitinib, an oral Janus kinase inhibitor, for the treatment for psoriasis.
    Br J Dermatol. 2018;179:815-816.
    PubMed    


  1229. LEUNG DYM
    Can antibiotics be harmful in atopic dermatitis?
    Br J Dermatol. 2018;179:807-808.
    PubMed    


  1230. CHEN Z
    What's new about the mechanism of methotrexate action in psoriasis?
    Br J Dermatol. 2018;179:818-819.
    PubMed    


  1231. FUJIMOTO M, Inaba Y, Takahashi T, Nakanishi G, et al
    Image Gallery: Granulomatous dermatitis due to infection with the chlorophyllic green alga Desmodesmus.
    Br J Dermatol. 2018;179:e167.
    PubMed    


  1232. MIURA H
    Image Gallery: 308-nm ultraviolet B excimer laser treatment for cutaneous B-cell lymphoma nodular lesions on the face.
    Br J Dermatol. 2018;179:e166.
    PubMed    


  1233. TRAUPE H
    Revealing the mysteries of X-linked recessive ichthyosis.
    Br J Dermatol. 2018;179:821-822.
    PubMed    


  1234. DRUCKER AM, Bercovitch L
    Generating new evidence for old medications: the TREAT trial in paediatric atopic dermatitis.
    Br J Dermatol. 2018;179:813-814.
    PubMed    


    September 2018
  1235. SAMPOGNA F, Puig L, Spuls P, Girolomoni G, et al
    Reversibility of alexithymia with effective treatment of moderate to severe psoriasis: longitudinal data from EPIDEPSO.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17259.
    PubMed     Abstract available


  1236. TARAZI M, Gaffney RG, Pearson D, Kushner CJ, et al
    Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17257.
    PubMed     Abstract available


  1237. YAN JJ, Qiao M, Li RH, Zhao XT, et al
    Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17256.
    PubMed     Abstract available


  1238. DEENEN NJ, Koens L, Jaspars EH, Vermeer MH, et al
    Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Br J Dermatol. 2018 Sep 27. doi: 10.1111/bjd.17252.
    PubMed     Abstract available


  1239. KOREKAWA A, Akasaka E, Rokunohe D, Fukui T, et al
    Nagashima-type palmoplantar keratoderma and malignant melanoma in Japanese patients.
    Br J Dermatol. 2018 Sep 26. doi: 10.1111/bjd.17251.
    PubMed     Abstract available


  1240. ROGIERS A, Thomas D, Vander Borght S, van den Oord JJ, et al
    Dabrafenib plus trametinib in BRAF K601E-mutant melanoma.
    Br J Dermatol. 2018 Sep 24. doi: 10.1111/bjd.17250.
    PubMed     Abstract available


  1241. PATEL K, Singam V, Vakharia PP, Chopra R, et al
    Measurement properties of three assessments of burden used in atopic dermatitis in adults.
    Br J Dermatol. 2018 Sep 23. doi: 10.1111/bjd.17243.
    PubMed     Abstract available


  1242. MARANO AL, Clarke JM, Morse MA, Shah A, et al
    Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death (PD)-1 therapy.
    Br J Dermatol. 2018 Sep 23. doi: 10.1111/bjd.17245.
    PubMed     Abstract available


  1243. LIOPYRIS K, Navarrete-Dechent C, Yelamos O, Marchetti MA, et al
    Clinical, dermoscopic and reflectance confocal microscopy characterization of facial basal cell carcinomas presenting as small white lesions on sun-damaged skin.
    Br J Dermatol. 2018 Sep 21. doi: 10.1111/bjd.17241.
    PubMed     Abstract available


  1244. EGEBERG A, Thyssen JP, Wu JJ, Skov L, et al
    Risk of first-time and recurrent depression in patients with psoriasis - a population-based cohort study.
    Br J Dermatol. 2018 Sep 19. doi: 10.1111/bjd.17208.
    PubMed     Abstract available


  1245. REDDY N, Nguyen BT
    The utility of optical coherence tomography for diagnosis of basal cell carcinoma: A quantitative review.
    Br J Dermatol. 2018 Sep 14. doi: 10.1111/bjd.17201.
    PubMed     Abstract available


  1246. XU S, Stump TK, Jain J, Alshurafa N, et al
    Variation in daily ultraviolet light exposure and sun protection behaviours of melanoma survivors: an observational single-arm pilot study with a wearable sensor.
    Br J Dermatol. 2018 Sep 12. doi: 10.1111/bjd.17196.
    PubMed     Abstract available


  1247. PAPP KA, Gooderham M, Jenkins R, Vender R, et al
    GM-CSF as a therapeutic target in psoriasis: randomised, controlled investigation using namilumab - a specific, human anti-GM-CSF monoclonal antibody.
    Br J Dermatol. 2018 Sep 12. doi: 10.1111/bjd.17195.
    PubMed     Abstract available


  1248. VAN LEE CB, Roorda BM, Wakkee M, Voorham Q, et al
    Recurrence rate of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery versus standard excision: a retrospective cohort study.
    Br J Dermatol. 2018 Sep 10. doi: 10.1111/bjd.17188.
    PubMed     Abstract available


  1249. SCHREINER M, Baumler W, Eckl D, Spath A, et al
    Photodynamic inactivation of bacteria to decolonize Methicillin resistant Staphylococcus aureus (MRSA) from human skin.
    Br J Dermatol. 2018 Sep 7. doi: 10.1111/bjd.17152.
    PubMed     Abstract available


  1250. LARSABAL M, Ly S, Sbidian E, Moyal-Barracco M, et al
    "GENIPSO": a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17147.
    PubMed     Abstract available


  1251. STROBER BE, Gottlieb AB, van de Kerkhof PCM, Puig L, et al
    Benefit-risk of tofacitinib in patients with moderate to severe chronic plaque psoriasis: Pooled analysis across 6 clinical trials.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17149.
    PubMed     Abstract available


  1252. SCHAUER F, Kern JS, Virtic O, Technau-Hafsi K, et al
    A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17146.
    PubMed     Abstract available


  1253. GISONDI P, Bianchi L, Calzavara-Pinton P, Conti A, et al
    Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17133.
    PubMed     Abstract available


  1254. WANG X, Wang A, Wang X, Li R, et al
    Cutaneous Mucormycosis caused by Mucor irregularis in a patient with CARD9 deficiency.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17144.
    PubMed     Abstract available


  1255. BRANCACCIO G, Napolitano S, Troiani T, Franco R, et al
    Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17145.
    PubMed     Abstract available


  1256. THIESEN I, Wehkamp U, Bruggemann M, Ritgen M, et al
    Skin involvement by chronic lymphocytic leukemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17135.
    PubMed     Abstract available


  1257. MATTHEWS NH, Risica PM, Ferris LK, Beatson M, et al
    Psychosocial impact of skin biopsies in the setting of melanoma screening - A cross-sectional survey.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17134.
    PubMed     Abstract available


  1258. ALBRECHT S, Jung S, Muller R, Lademann J, et al
    Skin type differences in solar simulated radiation-induced oxidative stress.
    Br J Dermatol. 2018 Sep 3. doi: 10.1111/bjd.17129.
    PubMed     Abstract available


  1259. GKOGKOLOU P, Sarna M, Sarna T, Paus R, et al
    Protection of glucotoxicity by a tripeptide derivative of alpha-melanocyte-stimulating hormone in human epidermal keratinocytes.
    Br J Dermatol. 2018 Sep 1. doi: 10.1111/bjd.17125.
    PubMed     Abstract available


  1260. SIMON M
    Effects of environmental skin stressors on filaggrin degradation products: importance for eczema.
    Br J Dermatol. 2018;179:560-561.
    PubMed    


  1261. PASSI A
    Hyaluronan is a key regulator of skin homeostasis and wound healing.
    Br J Dermatol. 2018;179:558-559.
    PubMed    


  1262. HAUG V, Schilling B
    Programmed death-1 blockade for multiple basal cell carcinomas: clearing the field systemically?
    Br J Dermatol. 2018;179:566-567.
    PubMed    


  1263. TOBIN DJ
    Early evidence for opposing effects of full versus fragmented adiponectin on melanogenesis in human epidermal melanocytes.
    Br J Dermatol. 2018;179:561-562.
    PubMed    


  1264. KEMPF W
    Multifocal anaplastic large cell lymphoma - insight into its biology and treatment.
    Br J Dermatol. 2018;179:565-566.
    PubMed    


    August 2018
  1265. LEONARDI C, Papp K, Strober B, Thaci D, et al
    Comprehensive Long-Term Safety of Adalimumab from Eighteen Clinical Trials in Adult Patients With Moderate to Severe Plaque Psoriasis.
    Br J Dermatol. 2018 Aug 31. doi: 10.1111/bjd.17084.
    PubMed     Abstract available


  1266. LIU NF, Yu ZY, Lou Y, Sun D, et al
    A Milroy case with FLT4/VEGFR3 mutation and an unusual skin biopsy.
    Br J Dermatol. 2018 Aug 31. doi: 10.1111/bjd.17120.
    PubMed     Abstract available


  1267. WARREN RB, Marsden A, Tomenson B, Mason KJ, et al
    Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.
    Br J Dermatol. 2018 Aug 28. doi: 10.1111/bjd.16776.
    PubMed     Abstract available


  1268. KOGUCHI-YOSHIOKA H, Watanabe R, Fujisawa Y, Ishitsuka Y, et al
    Skin resident memory T cell population is not effectively constructed in systemic sclerosis.
    Br J Dermatol. 2018 Aug 18. doi: 10.1111/bjd.17100.
    PubMed     Abstract available


  1269. IGHANI A, Georgakopoulos JR, Shear NH, Walsh S, et al
    Long-term 52-week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series.
    Br J Dermatol. 2018 Aug 18. doi: 10.1111/bjd.17099.
    PubMed     Abstract available


  1270. GROOT J, Nybo Andersen AM, Adam A, Tind Nielsen TE, et al
    Associations between maternal socioeconomic position and psoriasis: A cohort study among the offspring of the Danish National Birth Cohort.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17091.
    PubMed     Abstract available


  1271. NAVASIOLAVA N, Gnanou M, Douillard M, Saulnier P, et al
    The Extent of PXE Skin Changes is Related to Cardiovascular Complications and Visual Loss: a Cross-sectional Study.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17094.
    PubMed     Abstract available


  1272. FOGARTY GB, McLaren KR, Moutrie Z, Poon TSC, et al
    Locally advanced skin cancers of the frail and elderly - consider adaptive split course radiotherapy (ASCRT).
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17037.
    PubMed     Abstract available


  1273. HUET F, Dion A, Batardiere A, Nedelec AS, et al
    Sensitive skin can be small fiber neuropathy: Results from a case-control quantitative sensory testing study.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17082.
    PubMed     Abstract available


  1274. WATSON N, Wu K, Farr P, Reynolds N, et al
    Ustekinumab Exposure during Conception and Pregnancy in Patients with Chronic Plaque Psoriasis - a case series of 10 pregnancies.
    Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17086.
    PubMed     Abstract available


  1275. CUST AE, Aitken J, Baade P, Whiteman D, et al
    Why a randomised melanoma screening trial may be a good idea.
    Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17089.
    PubMed     Abstract available


  1276. FERTITTA L, Sicre de Fontbrune F, Battistella M, De Masson A, et al
    Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation.
    Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17081.
    PubMed     Abstract available


  1277. CLASSEN A, Buhl T, Schubert S, Worm M, et al
    The frequency of specific contact allergies is reduced in psoriasis patients.
    Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17080.
    PubMed     Abstract available


  1278. TSAI TY, Yen H, Huang YC
    Serum homocysteine, folate, and vitamin B12 levels in patients with psoriasis: A systematic review and meta-analysis.
    Br J Dermatol. 2018 Aug 3. doi: 10.1111/bjd.17034.
    PubMed     Abstract available


  1279. YIU ZZN, Ashcroft DM, Evans I, McElhone K, et al
    Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17036.
    PubMed     Abstract available


  1280. CLAUSEN ML, Edslev SM, Norreslet LB, Sorensen JA, et al
    Temporal Variation of Staphylococcus aureus clonal complexes in Atopic Dermatitis - a follow up study.
    Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17033.
    PubMed     Abstract available


  1281. THOMAS KS
    Could we be doing more to provide an evidence base for rare skin conditions?
    Br J Dermatol. 2018;179:240-241.
    PubMed    


  1282. PROKSCH E
    Lowering skin pH: improved barrier function, anti-ageing and beyond.
    Br J Dermatol. 2018;179:254-255.
    PubMed    


  1283. GJERSVIK P
    Biologics: targeting systemic inflammation in psoriasis.
    Br J Dermatol. 2018;179:247-248.
    PubMed    


  1284. TOWER RL
    Kaposiform haemangioendothelioma: new insights and old problems.
    Br J Dermatol. 2018;179:253-254.
    PubMed    


  1285. MONTGOMERY K, Thompson AR
    Developing sensitivity to the psychological burden associated with skin conditions: a call for training.
    Br J Dermatol. 2018;179:237-238.
    PubMed    


  1286. VAN DOORN R
    Methylation marks melanoma metastasis.
    Br J Dermatol. 2018;179:250-251.
    PubMed    


  1287. THYSSEN JP
    The trade-off: evolutionary benefits of epidermal filaggrin deficiency on cheek skin came at the price of the atopic dermatitis epidemic.
    Br J Dermatol. 2018;179:235-236.
    PubMed    


  1288. WALSH S, Creamer D
    Severe cutaneous adverse reactions syndromes and prescribing autonomy.
    Br J Dermatol. 2018;179:242-243.
    PubMed    


  1289. CAHOON EK
    Repurposing clinical trial data for skin cancer aetiology.
    Br J Dermatol. 2018;179:243-244.
    PubMed    


  1290. MELLODY KT, Horn J, Watson REB
    Heterogenity of dermal fibroblasts: skin equivalent models that aim to recreate the cutaneous microenvironment.
    Br J Dermatol. 2018;179:248-250.
    PubMed    


  1291. KIRBY B, Lynch M
    Adipokines and psoriasis: the obesity link.
    Br J Dermatol. 2018;179:239.
    PubMed    


    July 2018
  1292. KUSHNER CJ, Tarazi M, Gaffney RG, Feng R, et al
    Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in pediatric cutaneous lupus among pediatric dermatologists and rheumatologists.
    Br J Dermatol. 2018 Jul 23. doi: 10.1111/bjd.17012.
    PubMed     Abstract available


  1293. KANZAKI A, Kato Y, Kariya T, Kanda Y, et al
    Basal cell carcinoma response to imiquimod was associated with the Gli1/Gli3 expression ratio.
    Br J Dermatol. 2018 Jul 17. doi: 10.1111/bjd.17015.
    PubMed     Abstract available


  1294. POLUBOTHU S, Glover M, Holder SE, Kinsler VA, et al
    Uniparental disomy as a mechanism for CERS3-mutated autosomal recessive congenital ichthyosis.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.16999.
    PubMed     Abstract available


  1295. PARISI R, Webb RT, Kleyn CE, Carr MJ, et al
    Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17004.
    PubMed     Abstract available


  1296. CONNOLLY A, Grandi V, Stefanato CM, Palmer R, et al
    Primary cutaneous CD30(+) anaplastic large cell lymphoma associated with fingolimod.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17003.
    PubMed     Abstract available


  1297. PAPIER K, Gordon LG, Khosrotehrani K, Isbel N, et al
    Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.
    Br J Dermatol. 2018 Jul 13. doi: 10.1111/bjd.17001.
    PubMed     Abstract available


  1298. HULSHOF L, Hack DP, Hasnoe QCJ, Dontje B, et al
    Stratum corneum analysis provide a minimal invasive tool to study immune response and skin barrier in atopic dermatitis children.
    Br J Dermatol. 2018 Jul 10. doi: 10.1111/bjd.16994.
    PubMed     Abstract available


  1299. CHIJIWA C, Takeoka S, Kamata M, Uchida H, et al
    Secukinumab decreases the serum KL-6 level in psoriasis patients with elevated serum KL-6 level.
    Br J Dermatol. 2018 Jul 9. doi: 10.1111/bjd.16993.
    PubMed     Abstract available


  1300. THYSSEN JP, Egeberg A
    Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16939.
    PubMed     Abstract available


  1301. TSAKOK T, Woolf R, Smith CH, Weidinger S, et al
    Atopic dermatitis: the skin barrier and beyond.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16934.
    PubMed     Abstract available


  1302. RENCZ F, Gulacsi L, Pentek M, Poor AK, et al
    Proposal of a new scoring formula for the DLQI in psoriasis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16927.
    PubMed     Abstract available


  1303. BRANDWEIN M, Fuks G, Israel A, Nejman D, et al
    Identification of a unique Staphylococcus aureus ribosomal signature in severe atopic dermatitis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16936.
    PubMed     Abstract available


  1304. GUNN DA
    Histone H3 acetylation is a conduit of gene expression perturbations in photodamaged skin.
    Br J Dermatol. 2018;179:10-11.
    PubMed    


  1305. GISONDI P
    The multidimensional burden of psoriasis.
    Br J Dermatol. 2018;179:13-14.
    PubMed    


  1306. MAYBURY CM, Di Meglio P, Smith CH
    Aldara-induced dermatitis is associated with development of liver fibrosis in mice.
    Br J Dermatol. 2018;179:9-10.
    PubMed    


  1307. POWELL J, Badminton M
    Shedding light on recent advances in our understanding of cutaneous porphyrias.
    Br J Dermatol. 2018;179:1-2.
    PubMed    


  1308. NOBILI V
    Liver-skin axis: a new view or viewed already?
    Br J Dermatol. 2018;179:6.
    PubMed    


    June 2018
  1309. AHLSTROM MG, Thyssen JP, Menne T, Midander K, et al
    Short contact with nickel causes allergic contact dermatitis: an experimental study.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16935.
    PubMed     Abstract available


  1310. ZHAO J, Zhang X, Sun H, An R, et al
    Is psoriasis a risk factor of angiography-proven coronary artery disease?
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16925.
    PubMed     Abstract available


  1311. JOLY-TONETTI N, Wibawa JID, Bell M, Tobin DJ, et al
    An explanation for the mysterious distribution of melanin in human skin - a rare example of asymmetric (melanin) organelle distribution during mitosis of basal layer progenitor keratinocytes.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16926.
    PubMed     Abstract available


  1312. FUJISAWA Y, Otomo Y, Ogata Y, Nakamura Y, et al
    Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis.
    Br J Dermatol. 2018 Jun 28. doi: 10.1111/bjd.16924.
    PubMed     Abstract available


  1313. HARMS FL, Nampoothiri S, Kortum F, Thomas J, et al
    Coinheritance of biallelic SLURP1 and SLC39A4 mutations cause a severe genodermatosis with skin peeling and hair loss all over the body.
    Br J Dermatol. 2018 Jun 27. doi: 10.1111/bjd.16912.
    PubMed     Abstract available


  1314. SKOV L, Thomsen SF, Kristensen LE, Dodge R, et al
    Cause-specific mortality in patients with psoriasis and psoriatic arthritis.
    Br J Dermatol. 2018 Jun 27. doi: 10.1111/bjd.16919.
    PubMed     Abstract available


  1315. MOCHIZUKI H, Lavery MJ, Nattkemper LA, Albornoz C, et al
    Impact of Acute Stress on Itch Sensation and Scratching Behavior in Atopic Dermatitis Patients and Healthy Controls.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16921.
    PubMed     Abstract available


  1316. KALAKI E, Mizara A
    The role of parenting experiences, rather than age of onset or presence of the skin condition, in the development of maladaptive schemas in a community sample of patients with atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16920.
    PubMed     Abstract available


  1317. HURAULT G, Schram ME, Roekevisch E, Spuls PI, et al
    Relationship and probabilistic stratification of EASI and oSCORAD severity scores for atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16916.
    PubMed     Abstract available


  1318. HABJANIC N, Koytchev R, Yankova R, Kerec-Kos M, et al
    Therapeutic equivalence of two formulations of calcipotriol-betamethasone ointment: a multi-centre, randomized, double-blind study in adult patients with chronic plaque psoriasis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16913.
    PubMed     Abstract available


  1319. TINA E, Prosen S, Lennholm S, Gasparyan G, et al
    Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma.
    Br J Dermatol. 2018 Jun 25. doi: 10.1111/bjd.16905.
    PubMed     Abstract available


  1320. GOUSSOT R, Frances C, Cury K, Bessis D, et al
    Prospective evaluation of frequency of genital lichen sclerosus in 79 patients with systemic sclerosis.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16898.
    PubMed     Abstract available


  1321. VAN EGMOND S, Wakkee M, Droger M, Bastiaens MT, et al
    Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16900.
    PubMed     Abstract available


  1322. WARREN RB, Reich K, Langley RG, Strober B, et al
    Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16901.
    PubMed     Abstract available


  1323. NARANG T, Kumar S, Handa S, Dogra S, et al
    Hydroxyurea and Acitretin as a novel combination therapy in severe plaque psoriasis.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16899.
    PubMed     Abstract available


  1324. EATON LH, Dearman RJ, Kimber I, Griffiths CEM, et al
    Keratinocytes derived from late-onset psoriasis skin do not impair Langerhans cell migration.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16896.
    PubMed     Abstract available


  1325. KEOHANE SG, Proby CM, Newlands C, Motley RJ, et al
    The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, United Kingdom.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16892.
    PubMed     Abstract available


  1326. VAN DER LINDEN M, Schuurman MS, Bulten J, Massuger LFAG, et al
    Stop routine screening for associated malignancies in cutaneous non-invasive vulvar Paget disease?
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16894.
    PubMed     Abstract available


  1327. DRUCKER AM, Flohr C
    Revisiting atopic dermatitis and cardiovascular disease.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16891.
    PubMed     Abstract available


  1328. BLAUVELT A, Lacour JP, Fowler JF Jr, Weinberg JM, et al
    Phase 3 randomised study of the proposed biosimilar adalimumab GP2017 in psoriasis - impact of multiple switches.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16890.
    PubMed     Abstract available


  1329. BOSWELL K, Cameron H, West J, Fleming C, et al
    Narrowband-UVB treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16716.
    PubMed     Abstract available


  1330. FUJISAWA Y, Otomo Y, Ogata Y, Nakamura Y, et al
    Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16826.
    PubMed     Abstract available


  1331. SNEKVIK I, Nilsen TIL, Romundstad PR, Saunes M, et al
    Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16885.
    PubMed     Abstract available


  1332. FARAH M, Nagarajan P, Curry JL, Tang Z, et al
    Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in spitzoid neoplasia.
    Br J Dermatol. 2018 Jun 13. doi: 10.1111/bjd.16881.
    PubMed     Abstract available


  1333. HALVORSEN JA, Loberg M, Gjersvik P, Roscher I, et al
    Why a randomized melanoma screening trial is not a good idea.
    Br J Dermatol. 2018 Jun 12. doi: 10.1111/bjd.16784.
    PubMed    


  1334. COLLIER NJ, Haylett AK, Wong TH, Morton CA, et al
    Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    Br J Dermatol. 2018 Jun 11. doi: 10.1111/bjd.16838.
    PubMed     Abstract available


  1335. HESSELVIG JH, Egeberg A, Kofoed K, Gislason G, et al
    Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Br J Dermatol. 2018 Jun 9. doi: 10.1111/bjd.16831.
    PubMed     Abstract available


  1336. PAPIER K, Gordon LG, Khosrotehrani K, Isbel N, et al
    Increase in preventive behaviour by organ transplant recipients after sun protection information in a skin cancer surveillance clinic.
    Br J Dermatol. 2018 Jun 8. doi: 10.1111/bjd.16836.
    PubMed     Abstract available


  1337. FAVRE B, Begre N, Borradori L
    A recessive mutation in the DSP gene linked to cardiomyopathy, skin fragility and hair defects impairs the binding of desmoplakin to epidermal keratins and the muscle-specific intermediate filament desmin.
    Br J Dermatol. 2018 Jun 7. doi: 10.1111/bjd.16832.
    PubMed     Abstract available


  1338. PODLIPNIK S, Moreno-Ramirez D, Carrera C, Barreiro A, et al
    Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with AJCC stage IIB, IIC and III malignant melanoma.
    Br J Dermatol. 2018 Jun 7. doi: 10.1111/bjd.16833.
    PubMed     Abstract available


  1339. MIOLA AC, Roio EF, Lima TRR, Schmitt JV, et al
    Effectiveness and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis and skin field cancerisation of the forearms: a randomized controlled trial.
    Br J Dermatol. 2018 Jun 3. doi: 10.1111/bjd.16824.
    PubMed     Abstract available


  1340. STENEHJEM JS, Veierod MB, Nilsen LT, Ghiasvand R, et al
    Anthropometric factors and Breslow thickness: Prospective data on 2570 cutaneous melanoma cases in the population-based Janus Cohort.
    Br J Dermatol. 2018 Jun 1. doi: 10.1111/bjd.16825.
    PubMed     Abstract available


  1341. VON KOBYLETZKI LB, Svensson A
    Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
    Br J Dermatol. 2018;178:1236-1237.
    PubMed    


  1342. KIM Y, Kraft P, Asgari MM
    Using a Mendelian randomization approach to explore a causal relationship between vitamin D and nonmelanoma skin cancer.
    Br J Dermatol. 2018;178:1241-1242.
    PubMed    


  1343. SEDDON O, Hughes H
    Staphylococcus aureus and atopic dermatitis: a complex relationship.
    Br J Dermatol. 2018;178:1234.
    PubMed    


  1344. YU H, Li R, Yue Y, Li A, et al
    Image Gallery: Skin lesions from jellyfish stings.
    Br J Dermatol. 2018;178:e393.
    PubMed    


  1345. KIRBY B
    Langerhans cells in psoriasis: getting to the core of the disease.
    Br J Dermatol. 2018;178:1240.
    PubMed    


  1346. OFENLOCH RF
    Incontinence-associated dermatitis: a consensus on its severity assessment.
    Br J Dermatol. 2018;178:1238-1239.
    PubMed    


  1347. DRUCKER AM, Flohr C
    Atopic dermatitis and cardiovascular disease: have we seen enough to refute a causal link?
    Br J Dermatol. 2018;178:1235-1236.
    PubMed    


  1348. BALIEVA F
    Psoriasis has a huge impact on teenagers.
    Br J Dermatol. 2018;178:1243.
    PubMed    


    May 2018
  1349. GONNET J, Perrin H, Hutton AJ, Boccara D, et al
    Interleukin-32 promotes detachment and activation of human Langerhans cells in a human skin explant model.
    Br J Dermatol. 2018 May 28. doi: 10.1111/bjd.16721.
    PubMed     Abstract available


  1350. LIN YK, Lee BH
    Does Lindioil (Indirubin) treatment affect the composition of Malassezia species on psoriatic skin?
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16810.
    PubMed     Abstract available


  1351. SBIDIAN E, Mezzarobba M, Weill A, Coste J, et al
    Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16,545 biologic-naive patients from the French national health insurance database (SNIIRAM).
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16809.
    PubMed     Abstract available


  1352. GAITANIS G, Magiatis P, Velegraki A, Bassukas ID, et al
    A traditional Chinese remedy points to a natural skin habitat: Indirubin (indigo naturalis) for psoriasis and the Malassezia metabolome.
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16807.
    PubMed     Abstract available


  1353. VALENZUELA F, Korman NJ, Bissonnette R, Bakos N, et al
    Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.
    Br J Dermatol. 2018 May 21. doi: 10.1111/bjd.16798.
    PubMed     Abstract available


  1354. BRUNET-POSSENTI F, Charpentier C, Collin G, Descamps D, et al
    Impact of anti-IL-17 treatment on cutaneous and genital HPV infection.
    Br J Dermatol. 2018 May 19. doi: 10.1111/bjd.16799.
    PubMed     Abstract available


  1355. WAN MT, Ming ME
    Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16785.
    PubMed     Abstract available


  1356. CHRISTENSEN L, Cooper K, Honda K, Mansur D, et al
    Relapse rates in patients with unilesional primary cutaneous B cell lymphoma treated with radiation therapy: a single-institution experience.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16783.
    PubMed     Abstract available


  1357. ZHU TH, Zhu TR, Tran KA, Sivamani RK, et al
    Epithelial Barrier Dysfunctions in Atopic Dermatitis: A Skin-Gut-Lung Model Linking Microbiome Alteration and Immune Dysregulation.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16734.
    PubMed     Abstract available


  1358. CAYUELA A, Cayuela L, Rodriguez-Dominguez S, Lorente AI, et al
    Is melanoma mortality declining in Spain? Analysis of trends 1975-2016.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16777.
    PubMed     Abstract available


  1359. PILKINGTON SM, Dearman RJ, Kimber I, Griffiths CEM, et al
    Langerhans cells express human beta defensin-3: relevance for immunity during skin ageing.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16770.
    PubMed     Abstract available


  1360. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Assessment of Treatment-Seeking Behaviour in Patients with Psoriasis.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16778.
    PubMed     Abstract available


  1361. MOAWAD S, Reigneau M, de la Fouchardiere A, Soufir N, et al
    Clinical, dermoscopic, histological and molecular analysis of BAP1 inactivated melanocytic nevus/tumor in two familial cases of BAP1 syndrome.
    Br J Dermatol. 2018 May 13. doi: 10.1111/bjd.16740.
    PubMed     Abstract available


  1362. EL KHOURY M, Assier H, Gener G, Paul M, et al
    Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin, and pristinamycin: clinical history and patch testing.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16738.
    PubMed     Abstract available


  1363. RYAN C, Menter A, Guenther L, Blauvelt A, et al
    Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled Phase 3b Study of Patients with Moderate-to-Severe Genital Psoriasis.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16736.
    PubMed     Abstract available


  1364. KIMBALL AB, Augustin M, Gordon KB, Krueger GG, et al
    Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16737.
    PubMed     Abstract available


  1365. BLAUVELT A, Reich K, Papp KA, Kimball AB, et al
    Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Three Randomised Controlled Trials.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16724.
    PubMed     Abstract available


  1366. WEHNER MR, Dalma N, Landefeld C, Pare-Anastasiadou A, et al
    Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16730.
    PubMed     Abstract available


  1367. FUJISAWA Y
    Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors.
    Br J Dermatol. 2018 May 7. doi: 10.1111/bjd.16689.
    PubMed    


  1368. HARKINS CP, McAleer MA, Bennett D, McHugh M, et al
    The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from Atopic Dermatitis patients.
    Br J Dermatol. 2018 May 5. doi: 10.1111/bjd.16722.
    PubMed     Abstract available


  1369. SU KA, Habel LA, Achacoso NS, Friedman GD, et al
    Photosensitizing Antihypertensive Drug Use and Risk of Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16713.
    PubMed     Abstract available


  1370. GARCIA-DOVAL I, Descalzo MA, Mason KJ, Cohen AD, et al
    Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom and Republic of Ireland.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16715.
    PubMed     Abstract available


  1371. DODOO-SCHITTKO F
    Psoriasis: the significance of psychological stress.
    Br J Dermatol. 2018;178:1002.
    PubMed    


  1372. ERGEN EN, Donaldson SL, Stratton MS, Pavlidakey PG, et al
    Image Gallery: Molluscum contagiosum-like facial lesions in a patient with a renal transplant: deep dermatophytosis due to Trichophyton rubrum.
    Br J Dermatol. 2018;178:e328.
    PubMed    


  1373. GOMEZ MOYANO E, Vera-Casano A, Ayala-Blanca M, Martinez-Pilar L, et al
    Image Gallery: Cutaneous findings in Hunter syndrome.
    Br J Dermatol. 2018;178:e329.
    PubMed    


  1374. KRAEMER KH, Tamura D, Khan SG
    Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers.
    Br J Dermatol. 2018;178:1009.
    PubMed    


  1375. ROSSI AM, Navarrete-Dechent C, Nehal KS
    Beyond skin deep: taking bedside dermatology to the next level with noninvasive technologies.
    Br J Dermatol. 2018;178:994-996.
    PubMed    


  1376. LI BS, Cary JH, Maibach HI
    Cutaneous biometrics: guidelines and models.
    Br J Dermatol. 2018;178:1008-1009.
    PubMed    


  1377. BRAY N, Wolf P
    Allocation of biologics: health economics and clinical decision making in plaque psoriasis.
    Br J Dermatol. 2018;178:997-998.
    PubMed    


  1378. DARRIGADE AS, Boniface K, Seneschal J
    Inflammatory skin eruptions induced by anti-tumour necrosis factor-alpha therapy differ undeniably from psoriasis or eczema.
    Br J Dermatol. 2018;178:1007-1008.
    PubMed    


  1379. PAUL C
    Ixekizumab or secukinumab in psoriasis: what difference does it make?
    Br J Dermatol. 2018;178:1003-1005.
    PubMed    


  1380. SCHALKWIJK J
    A role for the microbiome in psoriasis?
    Br J Dermatol. 2018;178:999-1000.
    PubMed    


  1381. SCHMITT J
    After the approval of dupilumab for moderate-to-severe atopic dermatitis: what is next on the research agenda?
    Br J Dermatol. 2018;178:992-993.
    PubMed    


    April 2018
  1382. DARRIGADE AS, Legrand A, Andreu N, Jacquemin C, et al
    Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16711.
    PubMed     Abstract available


  1383. MIYAZAWA H, Fujita Y, Iwata H, Ishikawa Y, et al
    Two cases of generalized pustular psoriasis complicated with IgG4-related disease.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16712.
    PubMed     Abstract available


  1384. TETU P, Monfort JB, Barbaud A, Frances C, et al
    Failure of Rituximab in refractory erosive lichen planus.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16704.
    PubMed     Abstract available


  1385. BAN L, Labbouz S, Grindlay D, Batchelor J, et al
    Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16703.
    PubMed     Abstract available


  1386. WANG R, Song Y, Du M, Yang E, et al
    Skin microbiome changes in patients with interdigital tinea pedis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16706.
    PubMed     Abstract available


  1387. RAUWERDINK DJW, Roach REJ, Etty M, Kukutsch NA, et al
    Melanoma diagnosis during periodic surveillance of patients with multiple atypical naevi.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16708.
    PubMed     Abstract available


  1388. COSTANZO A, Bianchi L, Flori ML, Malara G, et al
    Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16705.
    PubMed     Abstract available


  1389. JENSEN P, Zachariae C, Skov L, Zachariae R, et al
    Sleep disturbance in psoriasis - a case-controlled study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16702.
    PubMed     Abstract available


  1390. FOO SH, Nightingale PG, Gazzani P, Bader E, et al
    A 10 year longitudinal follow up study of a UK paediatric transplant population to assess for skin cancer.
    Br J Dermatol. 2018 Apr 27. doi: 10.1111/bjd.16697.
    PubMed     Abstract available


  1391. MCALEER MA, Jakasa I, Raj N, O'Donnell CPF, et al
    Early life regional and temporal variation in filaggrin-derived natural moisturising factor, filaggrin processing enzyme activity, corneocyte phenotypes and plasmin activity: Implications for atopic dermatitis.
    Br J Dermatol. 2018 Apr 25. doi: 10.1111/bjd.16691.
    PubMed     Abstract available


  1392. NARBUTT J, Philipsen PA, Lesiak A, Liljendahl TS, et al
    Children sustain high levels of skin DNA photodamage, with a modest increase of serum 25(OH)D3 , after a summer holiday in Northern Europe.
    Br J Dermatol. 2018 Apr 24. doi: 10.1111/bjd.16668.
    PubMed     Abstract available


  1393. CHALMERS JR, Thomas KS, Apfelbacher C, Williams HC, et al
    Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16543.
    PubMed     Abstract available


  1394. EGEBERG A, Skov L
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors.
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16690.
    PubMed    


  1395. FUJIMURA T, Sato Y, Kambayashi Y, Tanita K, et al
    Three cases of advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and CXCL10 as possible biomarkers predicting the biological behaviour of angiosarcoma.
    Br J Dermatol. 2018 Apr 17. doi: 10.1111/bjd.16676.
    PubMed     Abstract available


  1396. LANGAN EA, Gratz V, Billmann F, Zillikens D, et al
    Does the gastrointestinal microbiome contribute to the "obesity paradox" in melanoma survival?
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16681.
    PubMed     Abstract available


  1397. CARLAVAN I, Bertino B, Rivier M, Martel P, et al
    Atrophic scar formation in acne patients involves long-acting immune responses with plasma cells and alteration of sebaceous glands.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16680.
    PubMed     Abstract available


  1398. KIM J, Kim YH, Park B, Seo HM, et al
    Multispectral ex vivo photoacoustic imaging of cutaneous melanoma for better selection of the excision margin.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16677.
    PubMed     Abstract available


  1399. VARMA S
    Frequency of squamous cell carcinoma in situ (SCCIS) and SCC in re-excisions of biopsy-proven cutaneous SCCIS.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16674.
    PubMed     Abstract available


  1400. MACHET L, Zaragoza J, Finon A, Garnier M, et al
    Baseline neutrophil to lymphocyte ratio in patients with advanced melanoma treated with immune check point inhibitors.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16675.
    PubMed     Abstract available


  1401. LEE EH, Klassen AF, Cano SJ, Nehal KS, et al
    FACE-Q Skin Cancer Module for Measuring Patient-Reported Outcomes Following Facial Skin Cancer Surgery.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16671.
    PubMed     Abstract available


  1402. SVENDSEN MT, Andersen F, Andersen KH, Pottegard A, et al
    An App Supporting Psoriasis Patients Improves Adherence to Topical Treatment: A randomised controlled trial.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16667.
    PubMed     Abstract available


  1403. MCNOE BM, Reeder AI, de Lange MP
    SunSmart schools: a New Zealand skin cancer primary prevention intervention blueprint for primary school settings.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16670.
    PubMed     Abstract available


  1404. GAN Y, Zhou M, He C, Chen Z, et al
    Lipidomics reveals skin surface lipid abnormity in male youth acne.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16655.
    PubMed     Abstract available


  1405. MENSA E, Recchioni R, Marcheselli F, Giuliodori K, et al
    MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16659.
    PubMed     Abstract available


  1406. THOMPSON AR, Montgomery K
    Stress and more stress: the importance in skin disease of worrying about what others think.
    Br J Dermatol. 2018;178:821-822.
    PubMed    


  1407. OOSTERHAVEN JAF
    Interpretability in atopic dermatitis: all about the anchor.
    Br J Dermatol. 2018;178:832-833.
    PubMed    


  1408. APFELBACHER C
    The Cochrane Skin Group's COUSIN convened for the second time.
    Br J Dermatol. 2018;178:837-838.
    PubMed    


  1409. AKEL R, Fuller C
    Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018;178:823-824.
    PubMed    


  1410. BORRONI RG, Costanzo A
    HLA-C*06 and psoriasis: susceptibility, phenotype, course and response to treatment.
    Br J Dermatol. 2018;178:825.
    PubMed    


  1411. HAAS L, Wiesner T, Obenauf AC
    A new era of proactive melanoma therapy: hit hard, hit early.
    Br J Dermatol. 2018;178:817-820.
    PubMed    


  1412. KEZIC S
    Atopic dermatitis: risk estimates for hand eczema.
    Br J Dermatol. 2018;178:827.
    PubMed    


  1413. MROWIETZ U
    Psoriasis, stress, age and more.
    Br J Dermatol. 2018;178:830-831.
    PubMed    


    March 2018
  1414. JI Y, Yang K, Peng S, Chen S, et al
    Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
    Br J Dermatol. 2018 Mar 30. doi: 10.1111/bjd.16601.
    PubMed     Abstract available


  1415. ANGELOVA-FISCHER I, Fischer TW, Abels C, Zillikens D, et al
    Accelerated barrier recovery and enhancement of the barrier integrity and properties by topical application of a pH 4 compared to a pH 5.8 w/o emulsion in aged skin.
    Br J Dermatol. 2018 Mar 25. doi: 10.1111/bjd.16591.
    PubMed     Abstract available


  1416. VU M, Adler NR, Wee E, Wolfe R, et al
    Impact of naevus association on survival for nodular and superficial spreading melanomas.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16556.
    PubMed     Abstract available


  1417. MAHEVAS T, Bertinchamp R, Battistella M, Reygagne P, et al
    Efficacy of oral sirolimus as salvage therapy in refractory lichen planus associated with immune deficiency.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16555.
    PubMed     Abstract available


  1418. MADDY AJ, Lee EE, Maderal AD, Wang RC, et al
    A case of disseminated follicular spicules in human immunodeficiency virus-associated follicular syndrome in the absence of the seven known human polyomaviruses, suggesting that this disorder is distinct from trichodysplasia spinulosa.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16562.
    PubMed     Abstract available


  1419. YAN K, Xu W, Huang Y, Zhang Z, et al
    Methotrexate restores the function of peripheral blood Treg cells in psoriasis vulgaris via CD73/AMPK/mTOR pathway.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16560.
    PubMed     Abstract available


  1420. PASSARELLI MN, Barry EL, Zhang D, Gangar P, et al
    Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16571.
    PubMed     Abstract available


  1421. LEE EB, Reynolds KA, Pithadia DJ, Wu JJ, et al
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16572.
    PubMed     Abstract available


  1422. FORSCHNER A, Keim U, Hofmann M, Spankuch I, et al
    Diagnostic accuracy of dermatofluoroscopy in cutaneous melanoma detection: Results of a prospective multicentre clinical study in 476 pigmented lesions.
    Br J Dermatol. 2018 Mar 22. doi: 10.1111/bjd.16565.
    PubMed     Abstract available


  1423. ADAN F, Crijns MB, Zandstra WSE, Bekkenk MW, et al
    Cumulative risk of skin tumours in patients with Lynch syndrome.
    Br J Dermatol. 2018 Mar 15. doi: 10.1111/bjd.16552.
    PubMed     Abstract available


  1424. HANSEN PR, Isaksen JL, Jemec GB, Kanters JK, et al
    Pulmonary function in subjects with psoriasis: A cross-sectional population study.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16539.
    PubMed     Abstract available


  1425. HERNANDEZ-BREIJO B, Jurado T, Rodriguez-Martin E, Martinez-Feito A, et al
    Differential blood cellular profile in patients with moderate to severe psoriasis treated with classical systemic therapies: A step forward in personalised medicine.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16537.
    PubMed     Abstract available


  1426. SCHMITZ L, Gambichler T, Kost C, Gupta G, et al
    Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16536.
    PubMed     Abstract available


  1427. DEQUIDT L, Jullie ML, Seneschal J, Werfel T, et al
    Recurrent erysipelas of the face with hyperimmune reaction to group C streptococcus.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16538.
    PubMed     Abstract available


  1428. ROLLS S, Rajan S, Shah A, Bourke JF, et al
    (Meth)acrylate allergy: frequently missed?
    Br J Dermatol. 2018 Mar 10. doi: 10.1111/bjd.16402.
    PubMed    


  1429. PEDROSA AF, Lisboa C, Faria-Ramos I, Silva RM, et al
    Malassezia species retrieved from skin with pityriasis versicolor, seborrheic dermatitis and skin free of lesions: a comparison of two sampling methods.
    Br J Dermatol. 2018 Mar 5. doi: 10.1111/bjd.16521.
    PubMed     Abstract available


  1430. KIM HJ, Bonciani D, Zeidi M, Pena SM, et al
    Itch in dermatomyositis: the role of increased skin interleukin-31.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16498.
    PubMed     Abstract available


  1431. MELCHERS RC, Willemze R, Bekkenk MW, de Haas ERM, et al
    Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16501.
    PubMed     Abstract available


  1432. MARCHAND A, Tallet A, Collin C, Cormier B, et al
    A rare BRAF T599dup mutation conferring sensitivity to BRAF inhibitor in a patient with metastatic melanoma.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16499.
    PubMed     Abstract available


  1433. FLEMING P
    Ixekizumab and psoriasis: an important entry into the therapeutic landscape.
    Br J Dermatol. 2018;178:585-586.
    PubMed    


  1434. CAPON F
    The heterogeneous mutational landscape of pustular psoriasis.
    Br J Dermatol. 2018;178:589-590.
    PubMed    


  1435. NANDA A
    Spectrum of cutaneous manifestations among patients with GATA2 deficiency.
    Br J Dermatol. 2018;178:593-594.
    PubMed    


  1436. ABUABARA K, Flohr C
    Is new better than tried and tested? Topical atopic dermatitis treatment in context.
    Br J Dermatol. 2018;178:583-584.
    PubMed    


  1437. BOUWES BAVINCK JN, van Zuuren EJ
    Light on fumaric acid esters therapy for psoriasis.
    Br J Dermatol. 2018;178:586-587.
    PubMed    


  1438. TSAI YC
    Image Gallery: Contact dermatitis resulting from tarantula-hair injury mimicking ischaemia: a case with dermoscopy follow-up.
    Br J Dermatol. 2018;178:e227.
    PubMed    


  1439. BARRAGAN-ESTUDILLO ZF, Jesus-Silva MA, Chavez-Bourgeois MM, Brito J, et al
    Image Gallery: Transition pattern in acral melanoma.
    Br J Dermatol. 2018;178:e225.
    PubMed    


  1440. EMTESTAM L, Sartorius K
    Interleukin-36 cytokine family signalling in hidradenitis suppurativa.
    Br J Dermatol. 2018;178:591-592.
    PubMed    


  1441. BEWLEY A
    Habit reversal therapy quickly and significantly contributes to the management of children with atopic eczema.
    Br J Dermatol. 2018;178:584-585.
    PubMed    


  1442. NAVARINI AA, French LE
    Autoinflammation behind the curtain.
    Br J Dermatol. 2018;178:581-582.
    PubMed    


  1443. MICHELETTI R
    Tobacco smoking and hidradenitis suppurativa: associated disease and an important modifiable risk factor.
    Br J Dermatol. 2018;178:587-588.
    PubMed    


  1444. UTER W
    Extended patch-test screening for fragrance contact allergy: findings and challenges.
    Br J Dermatol. 2018;178:592-593.
    PubMed    


  1445. STRUNK A, Garg A
    Hidradenitis and smoking: reply from the authors.
    Br J Dermatol. 2018;178:811-812.
    PubMed    


  1446. STOCKFLETH E, Harwood CA, Serra-Guillen C, Larsson T, et al
    Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0.015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp': reply from the authors.
    Br J Dermatol. 2018;178:813-814.
    PubMed    


  1447. LIU RC, Sebaratnam DF
    The need for longer time horizons for cost-utility evaluation in bullous pemphigoid.
    Br J Dermatol. 2018;178:809-810.
    PubMed    


  1448. MALVEHY J, Puig S
    Response to 'Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0.015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp'.
    Br J Dermatol. 2018;178:812-813.
    PubMed    


  1449. SALEEM MD, Arnold DL, Feldman SR
    Hidradenitis and smoking.
    Br J Dermatol. 2018;178:810-811.
    PubMed    


  1450. MASON JM, Williams HC, Wojnarowska F
    The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors.
    Br J Dermatol. 2018;178:810.
    PubMed    


  1451. BALATO A, Caiazzo G, Di Caprio R, Lembo S, et al
    Response to: 'Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop'.
    Br J Dermatol. 2018;178:807.
    PubMed    


    February 2018
  1452. PAPP KA, Gordon KB, Langley RG, Lebwohl MG, et al
    Impact of Previous Biologic Use on Efficacy and Safety of Brodalumab and Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis: Integrated Analysis of AMAGINE-2 and AMAGINE-3.
    Br J Dermatol. 2018 Feb 28. doi: 10.1111/bjd.16464.
    PubMed     Abstract available


  1453. KIM Y, Cho JY, Oh SW, Kang M, et al
    Globular adiponectin acts as a melanogenic signal in human epidermal melanocytes.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16488.
    PubMed     Abstract available


  1454. ENGEBRETSEN KA, Kezic S, Jakasa I, Hedengran A, et al
    Effect of atopic skin stressors on natural moisturizing factors and cytokines in healthy adult epidermis.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16487.
    PubMed     Abstract available


  1455. STROBEL SB, Safferling K, Lahrmann B, Hoffmann JH, et al
    Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16477.
    PubMed     Abstract available


  1456. NARLA S, Silverberg JI
    Association between childhood atopic dermatitis, cutaneous, extracutaneous and systemic infections.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16482.
    PubMed     Abstract available


  1457. HUNTER HJA, Morsman E, Mellody KT, Ogden SK, et al
    Acute psychosocial stress downregulates N-Methyl-d-aspartate receptors (NMDAR) in healthy human skin.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16466.
    PubMed     Abstract available


  1458. ORLOWSKA D, Selman LE, Beynon T, Radcliffe E, et al
    "It's a traumatic illness, traumatic to witness." A qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16447.
    PubMed     Abstract available


  1459. KOTTNER J, Jacobi L, Hahnel E, Alam M, et al
    Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.
    Br J Dermatol. 2018 Feb 14. doi: 10.1111/bjd.16324.
    PubMed     Abstract available


  1460. KYRIAKOU A, Patsatsi A, Sotiriadis D, Goulis DG, et al
    Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16437.
    PubMed     Abstract available


  1461. MORTON CA, Dominicus R, Radny P, Dirschka T, et al
    A randomized, multi-national, non-inferiority, phase III trial to evaluate the safety and efficacy of BF-200 ALA gel versus MAL cream in the treatment of non-aggressive basal cell carcinoma with photodynamic therapy (PDT).
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16441.
    PubMed     Abstract available


  1462. LONGO C, Lallas A, Kyrgidis A, Bassoli S, et al
    Wide skin markings pattern - melanoma descriptor or patient-related factor?: reply from authors.
    Br J Dermatol. 2018 Feb 7. doi: 10.1111/bjd.16430.
    PubMed     Abstract available


  1463. RISHPON A, Marchetti M, Marghoob A
    Wide skin markings pattern - melanoma descriptor or patient-related factor?
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16420.
    PubMed     Abstract available


  1464. VILLARREAL-MARTINEZ A, Bennassar A, Gonzalez S, Malvehy J, et al
    Application of in vivo reflectance confocal microscopy (RCM) and ex vivo fluorescence confocal microscopy (FCM) in most common subtypes of Basal Cell Carcinoma and correlation with histopathology.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16421.
    PubMed     Abstract available


  1465. LANGLEY RG, Papp K, Gooderham M, Zhang L, et al
    Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial (IXORA-P).
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16426.
    PubMed     Abstract available


  1466. FUJISAWA Y, Yoshino K, Otsuka A, Funakoshi T, et al
    Baseline neutrophil to lymphocyte ratio combined with serum LDH level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16427.
    PubMed     Abstract available


  1467. TSAKOK T, Jabbar-Lopez ZK, Smith CH
    Subcutaneous methotrexate in patients with moderate to severe psoriasis: a critical appraisal.
    Br J Dermatol. 2018 Feb 5. doi: 10.1111/bjd.16424.
    PubMed     Abstract available


  1468. ZHANG G, Chen H, Gao Y, Liu Y, et al
    Sirolimus for treatment of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: A retrospective cohort study.
    Br J Dermatol. 2018 Feb 1. doi: 10.1111/bjd.16400.
    PubMed     Abstract available


  1469. DANDO EE, Lim GFS, Ho J, James A, et al
    Image Gallery: Pigmented mammary Paget disease: a rare clinicopathological variant mimicking melanoma.
    Br J Dermatol. 2018;178:e143.
    PubMed    


  1470. RAPHAEL AP, Soyer HP
    Automated diagnosis: shedding the light on skin cancer.
    Br J Dermatol. 2018;178:331-333.
    PubMed    


  1471. CUST AE
    Prognostic features for acral lentiginous melanoma.
    Br J Dermatol. 2018;178:311-312.
    PubMed    


  1472. RENCZ F
    Impact of dupilumab on health-related quality of life in patients with atopic dermatitis.
    Br J Dermatol. 2018;178:319-320.
    PubMed    


  1473. BISSONNETTE R
    JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.
    Br J Dermatol. 2018;178:321.
    PubMed    


  1474. MICALI G, Lacarrubba F
    Standardized classification tools in dermatology: time to focus on cutaneous warts.
    Br J Dermatol. 2018;178:330.
    PubMed    


  1475. BELL KJL, Cust AE
    Beyond country-specific incidence and mortality: the global burden of melanoma.
    Br J Dermatol. 2018;178:315-316.
    PubMed    


  1476. BALATO A, Raimondo A
    Novel interactions among ultraviolet B, skin and adipose tissue.
    Br J Dermatol. 2018;178:327-328.
    PubMed    


  1477. SACH T
    Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid.
    Br J Dermatol. 2018;178:320-321.
    PubMed    


  1478. VON SCHUCKMANN LA
    Is occupational sun exposure important for squamous cell carcinoma risk?
    Br J Dermatol. 2018;178:325-326.
    PubMed    


  1479. STICHERLING M
    Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers?
    Br J Dermatol. 2018;178:333-334.
    PubMed    


  1480. CARMICHAEL AJ, Harman KE
    Orf - a potential trigger for self-limiting epidermolysis bullosa acquisita-like blistering.
    Br J Dermatol. 2018;178:333.
    PubMed    


  1481. HOLMES S
    Alopecia: the questions we need to answer.
    Br J Dermatol. 2018;178:330-331.
    PubMed    


  1482. NAIK HB, Abuabara K
    Systematic reviews of case reports and case series: from anecdote to evidence.
    Br J Dermatol. 2018;178:317-318.
    PubMed    


  1483. BAGATIN E
    Treating actinic keratosis: assessment of effectiveness, discomfort, costs and follow-up.
    Br J Dermatol. 2018;178:322-323.
    PubMed    


  1484. VENDER R
    Survival of the fittest.
    Br J Dermatol. 2018;178:328-329.
    PubMed    


  1485. SCHMITT-EGENOLF M
    What can we learn from 'dropouts' in clinical trials?
    Br J Dermatol. 2018;178:318-319.
    PubMed    


  1486. KEEGEL T, Nixon RL
    Wet work and healthcare workers: use of hand disinfectants not associated with self-reported eczema.
    Br J Dermatol. 2018;178:324-325.
    PubMed    


  1487. MCGRATH JA
    Concurrent hidradenitis suppurativa and Dowling-Degos disease taken down a 'Notch'.
    Br J Dermatol. 2018;178:328.
    PubMed    


  1488. APFELBACHER C
    The time healthcare workers wear disposable gloves daily is associated with hand eczema in a dose-dependent fashion.
    Br J Dermatol. 2018;178:323-324.
    PubMed    


  1489. HERTL M, Hashimoto T
    Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis': reply from authors.
    Br J Dermatol. 2018;178:573-574.
    PubMed    


  1490. JONKMAN MF, Meijer JM, Diercks GFH, Pas HH, et al
    Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis'.
    Br J Dermatol. 2018;178:573.
    PubMed    


  1491. CSOMA ZR, Kemeny L
    Image Gallery: Acquired zinc deficiency of prematurity.
    Br J Dermatol. 2018;178:e144.
    PubMed    


    January 2018
  1492. WANG R, Dunlap RR, Darwish MA, Simpson EL, et al
    Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality of life measure for adult atopic dermatitis.
    Br J Dermatol. 2018 Jan 30. doi: 10.1111/bjd.16398.
    PubMed     Abstract available


  1493. KHOURY LR, Moller T, Zachariae C, Skov L, et al
    A prospective 52-week randomised controlled trial of patient-initiated care consultations for patients with psoriasis.
    Br J Dermatol. 2018 Jan 24. doi: 10.1111/bjd.16369.
    PubMed     Abstract available


  1494. BORSARI S, Pampena R, Benati E, Bombonato C, et al
    In vivo dermoscopic and confocal microscopy multi-step algorithm to detect in situ melanomas.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16364.
    PubMed     Abstract available


  1495. STULL DE, Griffiths CEM, Gilloteau I, Zhao Y, et al
    Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16366.
    PubMed     Abstract available


  1496. CHABY G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, et al
    Severe cutaneous adverse reactions due to inappropriate medication use.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16365.
    PubMed     Abstract available


  1497. MARONAS-JIMENEZ L, Ortiz-Romero PL
    Aprepitant did not modify global disease activity in cutaneous T cell lymphomas.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16374.
    PubMed     Abstract available


  1498. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Abstract available


  1499. GRILL C, Laila B, Rubod A, Aktary Z, et al
    Epidermal melanocytes of segmental vitiligo show altered expression of E-cadherin, but not P-cadherin.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16352.
    PubMed     Abstract available


  1500. DIZON MP, Yu AM, Singh RK, Wan J, et al
    Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16340.
    PubMed     Abstract available


  1501. DE BRUIN-WELLER M, Graham NMH, Pirozzi G, Shumel B, et al
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with Demodex and increased IL-17 levels? Reply from authors.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16348.
    PubMed     Abstract available


  1502. BACHELEZ H
    Pustular psoriasis and related pustular skin diseases.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16232.
    PubMed     Abstract available


  1503. THYSSEN JP
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with demodex and increased IL-17 levels?
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16330.
    PubMed     Abstract available


  1504. KOTB IS, Lewis BJ, Barker RN, Ormerod AD, et al
    Differential effects of phototherapy, adalimumab and betamethasone/calcipotriol on effector and regulatory T cells in psoriasis.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16336.
    PubMed     Abstract available


  1505. YOSHIDA H, Nagaoka A, Komiya A, Aoki M, et al
    Reduction of hyaluronan and increased expression of HYBID (KIAA1199) correlate with clinical symptoms in photoaged skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16335.
    PubMed     Abstract available


  1506. SEO HM, Moon GT, Song YM, Gee HY, et al
    Expression of YAP and TAZ in molluscum contagiosum virus infected skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16333.
    PubMed     Abstract available


  1507. GRIFFITHS CEM, Jo SJ, Naldi L, Romiti R, et al
    A multidimensional assessment of the burden of psoriasis: Results from a multinational dermatologist and patient survey.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16332.
    PubMed     Abstract available


  1508. RANDA H, Lomholt JJ, Skov L, Zachariae R, et al
    Health-Related Quality of Life in adolescents with psoriasis: an interview-based study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16326.
    PubMed     Abstract available


  1509. BEECKMAN D, Van den Bussche K, Alves P, Arnold Long MC, et al
    Towards an international language for Incontinence-Associated Dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorisation Tool (GLOBIAD) in 30 countries.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16327.
    PubMed     Abstract available


  1510. LAINO AM, Berry EG, Jagirdar K, Lee KJ, et al
    Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16323.
    PubMed     Abstract available


  1511. THOMSON J, Wernham AGH, Williams HC
    Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    Br J Dermatol. 2018 Jan 6. doi: 10.1111/bjd.16317.
    PubMed     Abstract available


  1512. LEWIS FM, Tatnall FM, Velangi SS, Bunker CB, et al
    British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018 Jan 4. doi: 10.1111/bjd.16241.
    PubMed     Abstract available


  1513. TSCHANDL P, Wiesner T
    Advances in the diagnosis of pigmented skin lesions.
    Br J Dermatol. 2018;178:9-11.
    PubMed    


  1514. VERYKIOU S, Edwards N, Hill D
    How breakthroughs in translational research have impacted treatment strategies for melanoma.
    Br J Dermatol. 2018;178:5-8.
    PubMed    


  1515. CHASSET F, Haroche J
    Cutaneous manifestations of paediatric Erdheim-Chester disease, a histiocytosis of the 'L' group.
    Br J Dermatol. 2018;178:31-32.
    PubMed    


  1516. PRINSEN CAC
    T-QoL: a quality of life outcome measure specifically developed for adolescents with skin diseases.
    Br J Dermatol. 2018;178:23-25.
    PubMed    


  1517. SANCLEMENTE G
    What can we learn from psoriasis pharmacogenomics research?
    Br J Dermatol. 2018;178:17.
    PubMed    


  1518. MILLINGTON GWM, Collins A, Lovell CR, Leslie TA, et al
    British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018.
    Br J Dermatol. 2018;178:34-60.
    PubMed    


  1519. MUTHIAH S, Tang D, Nasr B, Verykiou S, et al
    A new era in holistic care: bridging the gap between dermatologists and oncologists for the treatment of malignant melanoma.
    Br J Dermatol. 2018;178:1-4.
    PubMed    


  1520. RENCZ F
    Patients with psoriasis on a new trajectory: long-term improvement in quality of life with biologics.
    Br J Dermatol. 2018;178:29-30.
    PubMed    


  1521. WIESNER T, Zbyszewski A
    Progress in the diagnosis and therapy of melanoma.
    Br J Dermatol. 2018;178:12-14.
    PubMed    


  1522. NALDI L
    Biologic treatment for psoriasis and cancer: an increased risk for most cancers could not be ruled out.
    Br J Dermatol. 2018;178:19.
    PubMed    


  1523. SILLING S, Akgul B
    Treatment success in cutaneous warts: morphology and human papillomavirus type matter.
    Br J Dermatol. 2018;178:30-31.
    PubMed    


  1524. SEKHON S, Koo J
    Indirubin: a novel topical agent in the treatment of psoriasis.
    Br J Dermatol. 2018;178:21.
    PubMed    


  1525. WEHNER MR
    Sunscreen and melanoma prevention: evidence and expectations.
    Br J Dermatol. 2018;178:15-16.
    PubMed    


  1526. COHEN AD, Zisman D
    Growing evidence for coronary artery disease risk factors in patients with severe hidradenitis suppurativa.
    Br J Dermatol. 2018;178:27-28.
    PubMed    


  1527. FELDMAN SR
    Yet another step forward!
    Br J Dermatol. 2018;178:22.
    PubMed    


  1528. EZZEDINE K, Eleftheriadou V
    Vitiligo and quality of life: the dark face of whiteness.
    Br J Dermatol. 2018;178:28-29.
    PubMed    


  1529. HWANG SJE, Fernandez-Penas P
    Pigmentary evolution with pembrolizumab use.
    Br J Dermatol. 2018;178:32-33.
    PubMed    


  1530. ALBRECHT J, Gerdes S
    When to switch biologics: some answers, but lots of questions too.
    Br J Dermatol. 2018;178:20.
    PubMed    


  1531. TEASDALE E
    The benefit of nested qualitative studies in dermatology randomized controlled trials.
    Br J Dermatol. 2018;178:25-26.
    PubMed    


  1532. DRUCKER AM, Doiron PR
    Understanding common but understudied diseases in dermatology.
    Br J Dermatol. 2018;178:22-23.
    PubMed    


  1533. GAMBICHLER T, Wolf P
    Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythemal dose: reply from the authors.
    Br J Dermatol. 2018;178:298-299.
    PubMed    


  1534. ALBRECHT J, Mehta S, Bigby M
    Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?'
    Br J Dermatol. 2018;178:300.
    PubMed    


  1535. EADIE E, Ibbotson SH, Dawe RS
    Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythema dose.
    Br J Dermatol. 2018;178:297-298.
    PubMed    


  1536. DAVILA-SEIJO P, Descalzo MA
    Registries as real-world cohort studies that are useful and necessary in the pyramid of evidence.
    Br J Dermatol. 2018;178:300-301.
    PubMed    


    December 2017
  1537. MCINERNEY-LEO AM, Wheeler L, Sturm RA, Tan JM, et al
    Point mutation in p14(ARF) -specific exon 1beta of CDKN2A causing familial melanoma and astrocytoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16275.
    PubMed     Abstract available


  1538. DE UNAMUNO BUSTOS B, Murria Estal R, Perez Simo G, Simarro Farinos J, et al
    Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16254.
    PubMed     Abstract available


  1539. AAREBROT AK, Solberg SM, Davies R, Bader LI, et al
    Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16269.
    PubMed     Abstract available


  1540. KRASUSKA M, Lavda AC, Thompson AR, Millings A, et al
    The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16268.
    PubMed     Abstract available


  1541. SALOMON G, Maza A, Boulinguez S, Paul C, et al
    Efficacy of anti-PD-1 on skin carcinomas and melanoma metastases in an Xeroderma Pigmentosum patient.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16270.
    PubMed     Abstract available


  1542. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Reply to: "An exploratory study using framework analysis to investigate health-seeking behaviour in patients with psoriasis".
    Br J Dermatol. 2017 Dec 22. doi: 10.1111/bjd.16266.
    PubMed     Abstract available


  1543. GHETTI M, Topouzi H, Theocharidis G, Papa V, et al
    Sub-Populations of Dermal Skin Fibroblasts Secrete Distinct Extracellular Matrix: Implications for Using Skin Substitutes in the Clinic.
    Br J Dermatol. 2017 Dec 20. doi: 10.1111/bjd.16255.
    PubMed     Abstract available


  1544. TSAI TF, Weng HJ, Wang TS
    Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series.
    Br J Dermatol. 2017 Dec 19. doi: 10.1111/bjd.16252.
    PubMed     Abstract available


  1545. SVENSSON A, Ofenloch RF, Bruze M, Naldi L, et al
    Prevalence of skin disease in a population based sample of adults out of five European countries.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16248.
    PubMed     Abstract available


  1546. KLIJN SL, van den Reek JMPA, van de Wetering G, van der Kolk A, et al
    Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16247.
    PubMed     Abstract available


  1547. DE WIT J, Totte JEE, van Buchem FJM, Pasmans SGMA, et al
    The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16251.
    PubMed     Abstract available


  1548. KAMSTRUP MR, Skov L, Zachariae C, Thyssen JP, et al
    Psoriasis and risk of malignant lymphoma: A population-based cohort study.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16245.
    PubMed     Abstract available


  1549. OLSEN CM, Wilson LF, Green AC, Biswas N, et al
    How many melanomas might be prevented if more people applied sunscreen regularly?
    Br J Dermatol. 2017 Dec 14. doi: 10.1111/bjd.16079.
    PubMed     Abstract available


  1550. GERBENS LAA, Hamann SAS, Brouwer MWD, Roekevisch E, et al
    Methotrexate and azathioprine in severe atopic dermatitis: a 5-year follow up study of a randomised controlled trial.
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16240.
    PubMed     Abstract available


  1551. PRUSSICK RB, Miele L
    Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden?
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16239.
    PubMed     Abstract available


  1552. NEMOTO O, Hirose K, Shibata S, Li K, et al
    Safety and Efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study.
    Br J Dermatol. 2017 Dec 9. doi: 10.1111/bjd.16236.
    PubMed     Abstract available


  1553. THYSSEN JP, Halling-Overgaard AS, Andersen YMF, Gislason G, et al
    The association between cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 6. doi: 10.1111/bjd.16215.
    PubMed     Abstract available


  1554. AHMED A, Solman L, Williams HC
    Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal.
    Br J Dermatol. 2017 Dec 3. doi: 10.1111/bjd.16046.
    PubMed     Abstract available


  1555. EATON LH, Mellody KT, Pilkington SM, Dearman RJ, et al
    Impaired Langerhans' cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17.
    Br J Dermatol. 2017 Dec 1. doi: 10.1111/bjd.16172.
    PubMed     Abstract available


  1556. GONZALEZ-QUESADA A, Bastida J, Rivero-Vera JC, Piris-Pinilla MA, et al
    Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    Br J Dermatol. 2017;177:e355.
    PubMed    


  1557. TOLLEFSON M, Siegel D
    Advancing paediatric psoriasis treatment options for children.
    Br J Dermatol. 2017;177:1470-1471.
    PubMed    


  1558. SCARISBRICK JJ
    Brentuximab vedotin is an effective therapy for CD30(+) mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
    Br J Dermatol. 2017;177:1474-1475.
    PubMed    


  1559. LAIMER M
    MAPK14 as candidate for genetic susceptibility to diabetic foot ulcer.
    Br J Dermatol. 2017;177:1482-1483.
    PubMed    


  1560. LUO Y, Liu J
    Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant.
    Br J Dermatol. 2017;177:e353.
    PubMed    


  1561. KIRBY B
    Worldwide perspective of biosimilars for psoriasis.
    Br J Dermatol. 2017;177:1473.
    PubMed    


  1562. VILLANI R, Khosrotehrani K
    Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma.
    Br J Dermatol. 2017;177:1472-1473.
    PubMed    


  1563. GALLUCCI RM
    Transforming growth factor-beta and psoriasis: a new link.
    Br J Dermatol. 2017;177:1480-1481.
    PubMed    


    November 2017
  1564. TOTTE JEE, Pardo LM, Fieten KB, de Wit J, et al
    The IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16153.
    PubMed     Abstract available


  1565. PALLER AS
    Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16047.
    PubMed